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ABSTRACT 
The aim of this study was to determine whether dietary fats constituting specific 
ω-6/ω-3 fatty acids (FA) ratio has chemopreventive modulating effects on the 
development of colon cancer. Western diets intake of saturated FA (SATS) and ω-6 
polyunsaturated FA (PUFA) are very high relative to low ω-3 PUFA consumption. 
This high ω-6 and low ω-3 FA intake, resulting in a high ω-6/ω-3 FA ratio, appears to 
have a promoting effect on disease outcome, whilst increased ω-3 FA intake 
exhibiting anti-cancer effects. An animal cancer model was employed to evaluate the 
effects of dietary fat ratios on chemically induced carcinogenesis during cancer 
promotion. This was to determine whether the FA diets have a promoting or 
inhibitory effect on early neoplastic lesions by quantifying aberrant crypt foci (ACF) 
development and monitoring the crypt cells proliferative and apoptotic indices. The 
expressions of genes associated with changes in cells redox balance were also 
assessed. Common dietary fats were combined to produce the dietary fat ratios: 
sunflower oil (S), borage oil (B) and fish oil (F). Combinations of these oils generated 
the different ω-6/ω-3 FA ratios: SB (ω-6/ω-3: 38:1), SF (ω-6/ω-3: 13:1) and SBF 
(10:1). To represent the Western diet’s high ω-6/ω-3 FA ratio profile, S (ω-6/ω-3: 
501: 1) was used as a control, and canola oil and olive oil as additional reference. 
The dietary fats had no toxic effects on the liver and kidney based on serum clinical 
biochemical measurements. Diets containing borage oil (SB and SBF diets), canola 
and olive oil decreased (p<0.05) the crypt multiplicity of large (7 crypts/focus) ACF, 
exhibiting anti-cancer effects by decreasing (p<0.05) the proliferative activity of the 
rat colon crypts. Borage oil’s protective effect resulted from the enhanced supply of 
C18:3ω-6 that has anti-inflammatory and anti-proliferative properties. The observed 
decrease (p<0.05) in apoptosis in the ACF was also facilitated by the up- and down-
regulation of DNA repair and DNA replication associated genes, Xpa and Ercc2 by 
borage oil, respectively. Canola oil and olive had the largest inhibitory effect on 
suppressing crypt multiplicity by reducing (p<0.05) proliferation in the colon. Both oils 
effected the up-regulation (p<0.05) of the expression of several oxidative stress and 
anti-oxidant defence genes mediating the regulation of cell proliferation. The 
increased supply of C18:1ω-9 (canola and olive) and total polyphenolic content 
(olive) protected cells against oxidative stress induced apoptosis, which provided 
interesting interactive effects between FA and polyphenolic oil constituents that 
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should be further elucidated. In contrast, the fish oil containing (SF diet) and the 
control sunflower (S diet) increased (p<0.05) the total ACF and colon crypt 
multiplicity (7 crypts/focus) when compared to the SB, SBF, olive oil and canola oil 
diets. An increased resistance to oxidative stress induced apoptosis appears to 
facilitate fish oil’s enhancing effect on crypt multiplicity despite the increased supply 
of LC ω-3 FA, which are prone to oxidation and leads to increased oxidative stress. 
This protective effect on crypt multiplicity and ACF development was mainly due to 
enhanced cellular antioxidant and DNA repair responses through the up-regulation 
(p<0.05) of Gpx4 and Nudt1, which favoured the increase (p<0.05) of crypt cells 
proliferation.  
 
The in vitro study demonstrated that oil ratio emulsions (S: ω-6/ω-3 = 249:1; SB: 
ω-6/ω-3 = 28:1; SF: ω-6/ω-3 = 12:1 and SBF: ω-6/ω-3 = 12:1) had differential 
effects on the survival indices of HT-29 and Caco-2 colon cancer cells. Contrary to 
the in vivo model, fish oil (SF and SBF emulsions) significantly (p<0.05) reduced the 
viability and proliferation of both cell lines, with the HT-29 cells showing greater 
sensitivity to the oil’s anti-proliferative effect. The HT-29 cells exposure to increased 
levels of C20:5ω-3 and C22:6ω-3 predisposes it to lipid peroxidation that increases 
the potential for cell removal via apoptosis. However, apoptotic effects were absent 
due to the HT-29 cells removal via necrosis as the cells energy status (ATP 
production) was significantly (p<0.05) depleted. Similar to the animal cancer model, 
borage oil (SB and SBF emulsions) had a reducing (p<0.05) effect on cell 
proliferation in both cell lines. However, as ATP was decreased (p<0.05), the S, SF 
and SBF emulsions resulted in an increased (p<0.05) apoptotic response in the 
Caco-2 cells in a dose dependent manner. This response resulted from the altered 
FA and lipid composition effected by the oil emulsions. Increased (p<0.05) 
incorporation of C20:5ω-3 and C22:6ω-3 in membrane phospholipid, 
phosphatidylethanolamine (PE), resulted in a significant decrease (p<0.05) in total 
SATS and MUFA content. A decrease (p<0.05) in membranes ω-6/ω-3 FA ratio was 
noted as well. This effect seems to selectively favour the induction of apoptosis by 
borage oil (SB and SBF). Similarly, an increase (p<0.05) in the PC/PE ratio by all oil 
emulsions, and a decrease (S and SB) and increase (SF and SBF) (p<0.05) in the 
chol/PL ratio appears to facilitate apoptosis too. A different threshold of the FA and 
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lipid composition parameters elicits the inhibition of cell proliferation utilising lower oil 
emulsion concentrations. Therefore, the dietary supply of fats characterised by a 
defined low ω-6/ω-3 FA ratio can selectively modulate the growth indices of colon 
cancer. Specific oil ratio combinations by incorporating borage oil and fish oil hereby 
provide a selective strategy for chemoprevention in the colon, although underlying 
interactions and threshold effects of specific FA seems to prevail that should be 
further unravelled. 
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GENERAL INTRODUCTION 
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1.1 GENERAL INTRODUCTION 
Dietary intake is an essential part of our existence as humans, providing sources of 
nutrients and energy that are required to sustain our physiology. However, coupled 
to sedentary living, inadequate or excessive dietary practices have impacted 
negatively on the maintenance of good health. This fact is demonstrated by the 
continuous and increasing pandemic of diet related chronic ailments worldwide 
(Nishida et al., 2004). Excessive caloric intake of fats above the recommended level 
is a characteristic feature of the modern Western diet (Simopoulos, 1999). The diet 
comprises a high proportion of saturated fats (>10%), is rich in ω-6 polyunsaturated 
fatty acids (PUFA) and low in ω-3 PUFA, resulting in dietary ω-6/ω-3 ratios in the 
range 20-30:1 (Gómez Candela et al., 2011; Simopoulos, 1999). This dietary pattern 
appears to impact significantly on the development of cancers in the colon, breast 
and prostate (Bartsch et al., 1999; Leitzmann et al., 2004).  
 
The cancer promoting effects of certain dietary fatty acids (FA) are linked to their 
functional role in maintaining cellular homeostasis under optimal cellular conditions. 
FA are important macromolecules influencing cell membranes structure, as well as 
affecting cellular functions (Ibarguren et al., 2014). The interaction of PUFA from 
both ω-6 and ω-3 classes greatly influence mechanisms regulating cell proliferation 
and apoptosis that are critical processes determining cell survival (Bartsch et al., 
1999; Calviello et al., 1999). Some of the responses elicited by these FAs include 
altering signal transductions, generating eicosanoids, as well as modifying gene 
expressions and cells oxidative status (Abel et al., 2004; Cathcart et al., 2011; Jump 
and Clarke, 1999).  
 
The metabolism of diet supplied essential FA linoleic acid (C18:2ω-6) increases 
arachidonic acid (C20:4ω-6), which is a key regulator of normal cellular function 
(Brash, 2001). With regards to colon cancer development though, colonic cells 
C20:4ω-6 levels are high (Nicholson et al., 1991). This has been shown to enhance 
the synthesis of eicosanoids such prostaglandin E2 (PGE2) that has a mitogenic 
effect, associated with the increased proliferative characteristic of cancers (Chan, 
2006; James et al., 2000; Murff et al., 2012). Conversely, increased intake of long 
chain ω-3 PUFA such as eicosapentaenoic acid (C20:5ω-3) and docosahexaenoic 
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acid (C22:6ω-3) have shown anticancer effects by eliciting anti-inflammatory 
responses by increasing PGE3 production, reducing C20:4ω-6 accumulation and cell 
proliferation (Barham et al., 2000; Chapkin et al., 2007; Huang et al., 1996) and 
increasing apoptosis (Giros et al., 2009).  
 
The aforementioned opposing effects rely greatly on the proportion of ω-6 and ω-3 
FA (i.e. ω-6/ω-3 and C20:4ω-6:C20:5ω-3 ratios) available (Barham et al., 2000), and 
thus could be regulated by dietary FA intake. Dietary PUFA can also increase the 
level of oxidative stress, which acts as a critical modulator of cell survival by 
inhibiting cell proliferation and enhancing apoptosis (Alexander-North et al., 1994; 
Martindale and Holbrook, 2002).  The ω-3 FA PUFA composition of cell membranes 
increases the susceptibility of cells to lipid peroxidation (LPO), an indicator of 
oxidative stress (Song and Miyazawa, 2001). LPO is generally very low in cancer 
cells as a result of reduced PUFA content in cell membranes (Horrobin, 1990) and 
an adaptive increase in antioxidant activity also provides cancer cells with protection 
against any deleterious events initiated by oxidative stress (Landriscina et al., 2009). 
Therefore, increasing cancer cells supply of PUFA via dietary intakes could 
potentially prevent cancer development by modulating the intensity of oxidative 
stress to undermine any tumour protective responses (e.g. increased antioxidant 
activity). Dietary sources of these biologically important FAs are abundant in nature. 
Thus the potential for eliciting selective responses to inhibit cancer growth is possible 
by the dietary manipulation of the supply of these macromolecules.  
 
Studies suggest that in addition to the quantity of dietary FA consumed, adjusting the 
type of FA constituting the ω-6/ω-3 ratio may have a chemopreventive effect against 
cancer development (Simopoulos, 2008). Therefore, the PUFA ratio (ω-6/ω-3) 
composition requires critical assessment in the development of such a dietary 
intervention strategy. This current study investigates the chemopreventive potential 
that specific dietary fat sources may have on the process of colon carcinogenesis. 
With each fat source featuring varied ω-6/ω-3 FA content, the theory is that the 
dietary FA supply would elicit different responses with respect to cancer promoting 
and/or protective effects. Chapter 2 will briefly outline current knowledge pertaining 
to colon cancer development, the role of FA regarding their potential harmful role in 
promoting and/or preventing carcinogenesis. The influence of experimental dietary 
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fat ratios on early biomarkers of colon cancer development such as aberrant crypts 
foci (ACF), histological indicators of proliferative and apoptotic indices in colonic 
crypts, as well as blood biochemistries will be critically assessed in Chapter 3 
utilizing a rat colon carcinogenesis model. Chapter 4 highlights the experimental fat 
ratios modulatory effects on the expression of genes responding to oxidative stress 
and antioxidant defences in the same animal model. In Chapter 5, utilizing an in vitro 
model, the survival of human colon cancer cell lines will be monitored in terms of the 
modulation of cell viability, proliferative responses and the induction of apoptosis 
utilising the different experimental dietary fat emulsions with varying ω-6/ω-3  FA 
ratios in relation to the degree of FA incorporation into cellular membranes. The main 
findings and conclusions of the investigations will be critically discussed in Chapter 
6.  
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2.1 Cancer 
Cancer is a disease that affects individuals worldwide, regardless of the boundaries 
of class, race, gender or age. Although cardiovascular disease, strokes and lower 
respiratory infections accounts for the top 3 causes of global deaths (Mathers et al., 
2009), as a non-communicable disease the mortality rate resulting from cancer 
incidences remains high. In a recent report by the International Agency for Research 
on Cancer (IARC), according to GLOBOCAN 2012, an estimated 14.1 million new 
cases and 8.2 million cancer related deaths occurred in 2012 (Ferlay et al., 2015).  
 
According to this report, the most commonly diagnosed cancers were those of the 
lungs, breast and colorectum (Fig. 2.1), with the incidence rate for cancer 
development being 25% higher in males than females. Furthermore, worldwide 
trends illustrate the greater increasing burden of cancer in the more affluent 
countries, compared to poor developing nations. However, there appears to be 
discrepancies in the incidence numbers reported due to the lack of early detection 
and access to treatment facilities in the poorer countries.  
 
 
 
Figure 2.1:  Estimates of the commonly diagnosed cancers worldwide in 2012. 
(adapted from Ferlay et al., 2015) 
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2.1.1  Biology of cancer 
(a)  Nomenclature of cancers 
The uncontrolled proliferative state of cells, a feature of all tumours, can occur in 
various types of tissue. Hence the types of cancer can be subdivided into 4 groups: 
1) Carcinomas: malignancies of epithelial cell origin (e.g. colon, breast) 
2) Sarcomas: solid tumours of the connective tissue (e.g. muscle, bone, 
cartilage and fibrous tissue) 
3) Lymphomas: cancers arising in lymph tissue 
4) Leukemia: cancer of blood cells  
 
Tumours that arise from these cells can be defined as either being benign or 
malignant. Slow growing benign tumours are non-invasive growths that remain 
confined to its original location of development. Conversely, malignant tumours 
proliferate rapidly, and are capable of both invading surrounding normal tissue and 
spreading throughout the body via the circulatory or lymphatic systems (metastasis) 
(Mareel and Leroy, 2003).  
 
(b)  Gene mutations and carcinogenesis 
Malfunctions within cells regulatory processes arises from dynamic changes 
occurring in the genome that provides cancer cells with the ability to proliferate 
independent of a growth stimulus. This unregulated growth is caused by damage to 
DNA, resulting in mutations in genes that encode for proteins controlling cell division 
(Dixon and Kopras, 2004). These mutations can be caused by chemical or physical 
agents called carcinogens, or by exposure to UV radiation or by certain viruses that 
can insert their DNA into the human genome (Chang et al., 2014; Mancebo and 
Wang, 2014; Shubik, 1995). Also, mutations can occur spontaneously (sporadic), or 
are passed down generations as a result of germline mutations (Kim et al., 2007; 
Zhang et al., 2014). 
 
At least 3 important classes of genes play key roles in tumour initiation: proto-
oncogenes, tumour suppressor genes, and genes involved in DNA repair 
mechanisms (Tysnes and Bjerkvig, 2007). Mutations, amplifications or deletions in 
these genes may lead to the disruption of biological mechanisms involved in the 
regulation of normal cell growth.  
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Alteration in the genetic material is only the first, irreversible step in the multi-staged 
process of carcinogenesis. Following this initiation step is a promoting phase in 
which initiated or transformed cells are stimulated to undergo further proliferation and 
is desensitized to cell regulatory processes such as apoptosis (Evan and Vousden, 
2001). Numerous environmental factors, including diet, have been identified as 
acting as tumour promoters by activating signal transductions that gives the initiated 
condition a proliferative advantage over normal neighbouring cells (Bode and Dong, 
2014; Van Engeland et al., 2003). Thus, at this stage cancer development can be 
reversed by the selective modulation of cancer stimulatory mechanisms (Lee and 
Herceg, 2014; Shukla et al., 2014). Progression is the final stage, and is 
characterized by the accumulation of additional mutations in tumour suppressor 
genes and oncogenes that enables tumour cell invasion and metastasis (Yokota, 
2000). This stage is also irreversible, and can ultimately lead to death. 
 
(c)  Critical cellular processes disrupted during cancer development 
Abnormalities in the regulation of critical signaling pathways mediating cell 
proliferation and apoptosis are typical behaviours in the establishment of all cancers 
or tumours (Evan and Vousden, 2001). Under normal conditions these processes 
are tightly regulated in the cell cycle, which is subdivided into 5 sequential phases 
that go from quiescence (G0 phase) to proliferation (G1, S, G2, and M phases) (Fig. 
2.2). Regulation of these phases involves the controlled interaction of key regulatory 
cyclin-dependent kinases (CDKs), cyclins and checkpoints that ensures the 
transition of one phase to the next. In cancer these interactions and checkpoints are 
deregulated (Foster, 2008; Hanahan and Weinberg, 2011). Therefore, cancer is 
essentially the result of defects occurring in the cell cycle, which usually maintains a 
balance between proliferation, growth arrest and apoptosis to ensure cellular 
homeostasis.  
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Figure 2.2:  The cell cycle involving sequential phase transitions from quiescence (G0 phase) to 
proliferation (G1, S, G2, and M phases) of the cell. G0 phase accounts for a non-growing, non-
proliferating stage in the cycle (i.e. cell cycle arrest); DNA synthesis occurs during the synthesis (S) 
phase, which is preceded by a gap phase called G1, where the cell prepares for DNA synthesis, and 
is followed by G2 during which the cell prepares for mitosis (M phase).Checkpoint G1S and G2M 
induces a temporary halt in cell cycle progression to check for chromosomal errors and ensures DNA 
repair before transitioning to the following phase (adapted from 
http://medicinembbs.blogspot.com/2011/02/tissue-repair.html, accessed 11 September 2013). 
 
(i) Cell proliferation 
In the cell cycle, during the M (mitosis) phase, cells divide and replicate their genome 
in order to generate new cells to replace old and damaged cells. This process is 
regulated by the interaction of cyclins and CDKs that assist in controlling cell growth 
and proliferation and inhibits apoptosis (Kishimoto, 1994). In normal cells proto-
oncogenes contain the codes for proteins that transmit signals to the cell nucleus to 
stimulate cell division (Oshima and Campisi, 1991). Mutations in these genes (i.e. 
oncogenes) results in the continuous and increased activation of growth stimulatory 
effects that is typical in all cancers (Yokota et al., 1986) 
 
(ii) Apoptosis 
Apoptosis, or programmed cell death, is an essential component of cell number 
regulation that prevents damaged or mutated cells from surviving and dividing 
(Elmore, 2007). It is distinctly different from necrotic cell death in which cells lose 
their membrane integrity and lyse when subjected to toxic stimuli (Zong and 
Thompson, 2006). Meanwhile apoptosis occurs in a well ordered sequence of events 
that involves the activation of proteolytic enzymes that result in cell degradation 
(Elmore, 2007). In pathological conditions such as cancer, the deregulation of 
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apoptosis allows damaged cells to live beyond their lifespan (Reed, 1999). 
Deregulation of this process normally results from mutations in tumour suppressor 
genes such as p53, which usually causes cell cycle arrest in the event of DNA 
damage and prevent its replication into progeny cells under normal conditions (Duffy 
et al., 2014). Consequently, modulation of the apoptotic pathway has been identified 
as a key target for chemopreventive strategies. 
 
2.2 Colon Cancer  
Malignant neoplasms arising in the colon or bowel is one of the leading causes of 
death in both men and women in the developed world (Jemal et al., 2011). Although 
advances in radiotherapy, chemotherapy and surgery have improved survival rates, 
approximately 1 in 17 people over the age of 50 years will develop colon cancer in 
their lifetime, with more than 50% of these individuals eventually dying from the 
disease (Harewood and Lawlor, 2005).  
 
There are enormous country-to-country differences in the incidence of the disease 
throughout the world. International correlation studies have shown that the highest 
incidences of colon cancer occur in North America, Great Britain and parts of 
Europe, and that the lowest incidences occur in Asia, Latin America and Africa 
(Center et al., 2009). According to the National Cancer Registry, in South Africa the 
risk of developing colorectal cancer for individuals aged between 0-74 years are 1 in 
115 men and 1 in 199 women. However, as traditional diets are replaced by so 
called “western” diets, a rise in the incidence of colon cancer have been experienced 
in these low risk population groups (Center et al., 2009; Kanavos, 2006). 
 
2.2.1 The Colon: Structure, function and morphology 
The colon, also referred to as the large intestine or bowel, is a muscular U-shaped 
tube located within the lower abdominal cavity (Fig. 2.3a). The major function of the 
organ is to extract water, salts and nutrients from partially digested food and to 
propel the residue to the rectum and anus for expulsion. Also, the colon serves as a 
critical barrier for the organism, protecting it from toxic agents found within the 
luminal environment (Ashida et al., 2012). Therefore, in addition to being exposed to 
luminal nutrients, the intestinal mucosa is constantly challenged by diet-derived 
oxidants, mutagens and carcinogens, as well as endogenously generated reactive 
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oxygen species (ROS) (Sanders et al., 2004; Wakabayashi et al., 1992). As a result, 
the colon has developed a highly regulated system to ensure for the maintenance of 
cellular integrity and tissue homeostasis. 
 
Figure 2.3:  The human colon: Organ facilitating the final process of digestion. (a) Structure and 
location in the lower abdominal cavity (www.newshealthguide.org/Rectum-Function.html, accessed 22 
October 2014), (b) Cross section of the intestine illustrating the multiple tissue layers (adapted from 
www.purdue.edu/uns/html4ever/0002.Badylak.SIS.html, accessed 22 October 2014). 
 
The organ is composed of multiple tissue layers: the mucosa, the submucosa, the 
muscle layer/muscularis propia (i.e. containing circular and smooth muscle) and the 
serosa (Fig. 2.3b). Within the inner colon mucosal wall a complex organization of 
epithelial cells is situated. Here crypts, folds of the colonic epithelium lining the inner 
surface, are continuously renewed by stem cell division (Lipkin, 1974). These 
epithelial cells have a much higher turnover rate compared to tissues in the rest of 
the body (Lipkin, 1974). Under optimal growth conditions, undifferentiated precursor 
epithelial cells at the base of crypts proliferate and rapidly undergo morphological 
and functional differentiation as they migrate to the surface (Lamprecht and Lipkin, 
2002). Here at the surface the epithelial cells undergo apoptosis and extrude into the 
lumen of the gastrointestinal tract. These functional compartments along the crypt 
axis are maintained within precise boundaries by multiple homeostatic signals. 
Disruptions of these processes can lead to colon carcinogenesis (Boman et al., 
2008). 
 
2.2.2 Colon carcinogenesis: The process of transformation from normal 
tissue to a tumour 
The development of tumours in the colon is dependent on the progressive 
perturbation of the normal signalling pathways involved in cell proliferation, thus 
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conferring a growth advantage to the cells (Ferrand et al., 2005). To commence 
cancer initiation and progression, first several genetic changes occur in the epithelial 
cells lining the intestinal tract (Michor et al., 2005). Besides familial genetic 
predispositions, these genomic changes can be caused by multiple environmental 
factors (Ponz de Leon and Roncucci, 2000). In the multi-step carcinogenesis model 
proposed by Fearon and Volgestein (1990), genetic alterations occur in a stepwise 
fashion such that a clone that has growth advantage proliferates, acquires more 
genetic alterations and undergoes another selection for survival and growth, 
eventually resulting in cancer (Fig. 2.4). In this model, the accumulation of mutations 
in oncogenes and several tumour suppressor genes are the critical catalysts 
facilitating normal colonic mucosal cells conversion to malignancy. The most 
common changes noted are K-ras point mutations, mutations in growth suppressor 
gene p53 on chromosome p17 and allelic loss in chromosome 5 (apc gene), and the 
growth suppressor gene DCC on chromosome 18q (Armaghany et al., 2012; 
Wilmink, 1997). The clonal expansion of these genetically altered cells is further 
propagated by reducing inhibitory signals produced by normal cells (Hanahan and 
Weinberg, 2011). Furthermore, these responses may be enhanced by dietary 
influences that result in an increase in DNA damaging oxidative stress and 
subsequent modulation of cell regulatory signalling pathways favouring an increase 
in proliferation (Bartsch and Nair, 2004; Caderni et al., 1999). Clinical and 
histopathological manifestations of the disease’s stepwise development are 
demonstrated through a series of stages ranging from single crypt lesions through 
small benign tumours (adenomatous polyps) to malignant cancers (carcinomas). 
This adenoma-to-carcinoma sequence of colon carcinogenesis has provided the 
baseline for studies into the mechanisms pertaining to the disease’s progress. 
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Figure 2.4: The multistep model of colon carcinogenesis illustrating some of the genetic and 
physiological changes that occur during the process (adapted from Aspinall and Taylor-Robinson, 
2000). 
 
Small areas of focal damage termed aberrant crypt foci (ACF) develop as an early 
physical evidence of this mutation process as seen in rodents and humans (Di 
Gregorio et al., 1997; Roncucci et al., 2000), and can be identified microscopically as 
a localised cluster of enlarged crypts (Fig. 2.5). These early neoplastic lesions 
display an enhanced proliferative state compared to normal colon crypts (Corpet et 
al., 1997). The total number of ACF may be considered to be a valid biomarker in 
rats at a very early stage of carcinogenesis, while in subsequent weeks (later stages 
of development) ACF with higher crypt multiplicity (i.e. >4 crypts per focus) are 
considered a more specific biomarker than the total number of ACF (Bird, 1995). A 
small percentage of these will develop into tumours over a period of 10-20 years 
(Johnson, 2004) with environmental influences such as diet having a significant 
effect on the process (Rao et al., 2001).  
 
 
 
Figure 2.5:  Microscopic identification of aberrant crypt foci (ACF) with methylene blue staining 
(adapted from Takayama et al., 1998). 
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2.2.3  The role of diet in colon carcinogenesis 
Migrant studies show an elevation in the risk of developing colon cancer in 
populations that have moved from low incidence (Japan, China) to high incidence 
(United States) areas (Haggar and Boushey, 2009). These findings suggest that the 
variation in colon cancer incidence is strongly influenced by environmental factors. 
Numerous reports have shown associations between diet and colon cancer 
(Kasdagly et al., 2014; Key et al., 2002; Lipkin et al., 1999). A relation commonly 
found in epidemiological studies is an increase in risk associated with a high fat and 
low fibre dietary pattern (Pericleous et al., 2013; Woutersen et al., 1999). 
 
Numerous mechanisms whereby dietary fat intake influences the carcinogenesis 
process have been proposed. A common hypothesis is that it induces the excretion 
of bile salts (Breuer and Goebell, 1985). Increased secretions of bile salts have a 
non-specific effect on the colon lumen, damaging the colon mucosa and resulting in 
an increased risk for endogenous mutations (Bernstein et al., 2005). In many cases, 
however, colon cancer is considered as a disease resulting from chronic 
inflammation (Itzkowitz and Yio, 2004). Certain dietary fatty acids can irritate colon 
tissue by increasing pro-inflammatory responses (Chan, 2006). Prostaglandin E2, a 
derivative of the ω-6 fatty acid arachidonic acid sourced either directly by diet or de 
novo synthesis, is widely accepted as playing a significant role in promoting cancer 
cell growth (Pai et al., 2002).  
 
Dietary fat can also influence colon cancer cells oxidative status by generating lipid 
radicals that lead to DNA damage that initiates the transformation of normal cells to a 
neoplastic phenotype (Bartsch and Nair, 2006), as well as prompting mechanisms 
that maintain its survival (Erdelyi et al., 2009). Furthermore, dietary fats may also 
influence colon cancer risk through its involvement with insulin resistance, altered 
immunological responses and changes in the fatty acid composition of membranes 
(Bruce et al., 2000; Szachowicz-Petelska et al., 2007). 
 
2.3 Polyunsaturated fatty acids 
Fatty acids (FA) both free and as part of complex lipids, are important 
macromolecules that play a major role in cellular function (Tvrzicka et al., 2011). 
Most mammals, including humans, are able to synthesize saturated FA and 
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monounsaturated FA (Mashima et al., 2009). However, they are unable to 
manufacture unsaturated FA with more than a single carbon double bond due to the 
lack of Δ12- and Δ15-desaturases (Huang et al., 2004). As a result, polyunsaturated 
fatty acids (PUFA) linoleic acid (C18:2ω-6) and α-linolenic acid (C18:3ω-3) can only 
be obtained through dietary intake (Simopoulos, 1999). Both these FA serve as 
precursors for the synthesis of longer chain unsaturated FA. Therefore, the term 
essential fatty acid (EFA) is applied only to these two PUFA that are necessary for 
good health and cannot be synthesized by the body. 
 
2.3.1  Nomenclature and chemical structure 
FA are long-chain (LC) hydrocarbon molecules containing a carboxylic acid moiety at 
one end and a methyl group at the other, with either no double bond or at least one 
double bond in the molecule. There are 3 classes of FA: i) saturated fatty acids 
(SATS) with no double bond, ii) monounsaturated fatty acids (MUFA) with a single 
double bond, and iii) PUFA with 2 or more double bonds. Unsaturated FA are 
classified according to the location of the last double bond relative to the terminal 
methyl group (-CH3) at one end of the molecule. MUFA and PUFA are subdivided 
into additional families (i.e. ω-3, ω-6, ω-7 and ω-9). For example, EFA C18:3ω-3 has 
18 carbon (C)-atoms with three double bonds, with the first bond at the 3rd carbon 
atom counted from the methyl group at the end (Fig. 2.6a). Similarly, C18:2ω-6 has 
18 C-atoms and two double bonds, with the first double bond located at the 6th 
carbon atom counted from the methyl end (Fig. 2.6b).  
 
 
 
Figure 2.6:  The nomenclature and chemical structure of essential fatty acids (a) α-linolenic acid 
(C18:3ω-3), and (b) linoleic acid (C18:2ω-6) (adapted from 
http://lipidlibrary.aocs.org/Lipids/whatlip/index.htm, accessed 27 October 2014). 
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2.3.2 Dietary sources and intake recommendations 
FA represent 30-35% of total energy intake in many industrial countries and the most 
important dietary sources of FA are vegetable oils, dairy products, meat products, 
grain and fatty fish or fish oils (Rustan and Drevon, 2001). The FA C18:2ω-6 is 
abundant in all vegetable oils, including corn, sunflower, safflower and olive oil (Kaur 
et al., 2012). The recommendation for intake of this FA is set at 2.5-9% of total fat 
intake (Elfmadfa and Kornsteiner, 2009). But in the United States alone, for example, 
the average intake of C18:2ω-6 is 84-89% of the total PUFA energy (Kris-Etherton et 
al., 2000), illustrating the excessive intake pattern. 
 
Sources of EFA C18:3ω-3 includes soybeans, walnuts, and dark green leafy 
vegetables such as kale, spinach, broccoli and Brussels sprouts. Also seeds or their 
oils such as flaxseed, mustard seed and rapeseed (canola) contain C18:3ω-3 (Abedi 
and Sahari, 2014). Most of these oils, however, are also rich in C18:2ω-6 (Larsson et 
al., 2004). The marine food chain is based on ω-3 FA that are present in plankton 
and algae on which fish feed on (Bartsch et al., 1999). Several species of cold water 
fish are rich in ω-3 LC PUFA eicosapentaenoic acid (C20:5ω-3) and 
docosahexaenoic acid (C22:6ω-3). These include fatty fish such as salmon, tuna, 
herring, mackerel and anchovy. Recommendations regarding the daily intake of ω-3 
FA vary between 400-1000 mg C20:5ω-3 + C22:6ω-3 in the form of food or 
supplements (Kris-Etherton et al., 2009; Meyer et al., 2003; Vannice and 
Rasmussen, 2014).  
 
However, with the Western diet intake of fish is minimal, thus the predominant intake 
of ω-3 FA is C18:3ω-3. With this dietary pattern the dominant intake of ω-6 FA 
(C18:2ω-6) coupled to minimal ω-3 FA (C20:5ω-3 and C22:6ω-3) provides a high 
dietary ratio of ω-6/ω-3 FA that has been linked to the onset of numerous diseases 
including colon cancer (Simopoulos, 2008). Thus, to circumvent any negative effects 
caused by excessive ω-6 PUFA intake, an increase in fish or fish oils intake is 
recommended to elevate tissue levels in C20:5ω-3 and C22:6ω-3 that have 
numerous protective effects (Bartram et al., 1993). 
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2.3.3 Metabolism of PUFA 
PUFA, largely consumed in the form of triglycerides from various food sources, are 
digested in the small intestine (Iqbal and Hussain, 2009). These macromolecules are 
considered important nutrients required by the body in order to function. Thus the 
digestion process allows for the absorption of these FA by enterocytes and their 
transport in the blood to various organs for assimilation (Niot et al., 2009). Some of 
these FA are degraded through the multistep process of -oxidation in mitochondria 
to generate energy or are esterified to lipid molecules (Sprecher, 2000). 
Furthermore, while mammals cannot synthesize ω-3 and ω-6 EFA de novo, 
mammalian cells can manufacture longer carbon chain PUFA by elongation and 
desaturation (Nakamura and Nara, 2003).  
 
The liver and adipose tissue are the major sites for FA biosynthesis, however it does 
occur in other tissue as well (Bonet et al., 2012). The ω-3 and ω-6 FA cannot be 
metabolically interconverted but the metabolism of one can moderately impede the 
metabolism of the other (Simopoulos, 1999). The first part of the synthesis pathway 
leading to eicosapentaenoic acid (C20:5ω-3) and arachidonic acid (C20:4ω-6) takes 
place in the endoplasmic reticulum (ER) and consists of sequential alternating 
elongation and desaturation steps catalysed by FA elongase, Δ6- and Δ5-
desaturases (Nakamura and Nara, 2003). C18:3ω-3 is desaturated and elongated to 
eicosapentaenoic acid (C20:5ω-3), while C18:2ω-6 is metabolized into arachidonic 
acid (C20:4ω-6) using these same enzymes (Fig. 2.7). The enzyme Δ6-desaturase 
seems to be the rate limiting step in the pathway due to its greater affinity for ω-3 FA 
(Larsson et al., 2004). Therefore the FA synthesis outcome is dependent on 
competition between C18:3ω-3, C18:2ω-6 and some of their longer chain products 
for Δ6-desaturation, and negative feedback regulation of LC PUFA on both Δ5- and 
Δ6-desaturases (Horrobin, 1993). 
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Figure 2.7:  The biosynthesis of longer chain PUFA from EFA α-linolenic acid (ω-3) and linoleic acid 
(ω-6) involving sequential desaturation and elongation steps (adapted from Kaur et al., 2012). 
 
2.3.4 Structural and biological functions of PUFA 
FA have diverse roles in cells. They are important components of lipid molecules that 
are the building components for plasma membranes (Abbott et al., 2012). 
Consequently, any PUFA produced in the ER may be removed from the biosynthetic 
cascade and used for membrane lipid synthesis by enzymes localized in the ER. 
Therefore, the bioavailability of these FA in membranes has great influence on both 
their structural integrity and critical membrane associated functions (Ibarguren et al., 
2014).  
 
2.3.4.1 Structural components 
The plasma membrane represents the barrier of life, the structure that separates 
living cells from their surroundings. Its bilayer structure is composed of several 
phospholipid, cholesterol and protein molecules (Spector and Yorek, 1985). The lipid 
types and their distribution within membranes may be unique to different cell types, 
but are altered by the availability of dietary FA, particularly PUFA (Alexander, 1998). 
Phospholipids are the dominant lipid in all membranes, only varying in their FA 
content (Abbott et al., 2012). These lipid molecules include a hydrophilic “head” (i.e. 
choline, ethanolamine, serine or inositol) connected through phosphoric acid to a 
hydrophobic part. Phosphatidylcholine (PC) and phosphatidylethanolamine (PE) are 
the most abundant phospholipids in membranes containing a SATS or MUFA at the 
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sn-1 position on the glyceride backbone and a PUFA at the sn-2 position (Escribá et 
al., 2008). The FA content in individual lipid class affects membrane fluidity 
substantially, thus impacting on cellular function (Kullenberg et al., 2012). Besides 
affecting membrane fluidity, the lipid composition greatly influences the formation of 
receptors, binding of ligands to their receptors, and the activation of intracellular 
pathways (Alexander, 1998). 
 
PUFA esterified to membrane phospholipids occupy greater space in the 
hydrophobic head due the cis configuration of the molecules, hereby increasing 
membrane fluidity, whereas SATS and MUFA have a trans configuration (i.e. “flat”) 
and cause more rigid membrane structures (Kremmyda et al., 2011). PUFA are also 
involved in cholesterol transport and metabolism. Cholesterol is transported in the 
body largely in the form of fatty esters. Found in large amounts in plasma 
membranes, cholesterol also has a rigidifying effect on the membrane by inhibiting 
the overall flexing motion of the acyl hydrocarbon chains (Petrache et al., 2005). 
Dietary intakes of ω-6 PUFA has been shown to lower plasma cholesterol (Horrobin 
and Manku, 1983), whilst an increase in its content in rat platelet membranes has 
also been noted with ω-6 and ω-3 FA rich diets (Heemskerk et al., 1995). Therefore, 
the type of dietary FA consumed impacts significantly on the lipid composition 
(structure), as well as membrane fluidity and associated functions. Aberrations in 
these features have been shown to participate in disease development (Hulbert et 
al., 2005). 
 
2.3.4.2 Biological functions 
(a) Precursor for eicosanoid biosynthesis 
Eicosanoids are important hormone-like molecules that stimulate critical cellular 
responses in all mammalian cells (Tapiero et al., 2002). These lipid derived 
signalling molecules include prostaglandins (PG), leukotrienes, thromboxanes, 
prostacyclins, lipoxins and hydroperoxy FA. The effects elicited by these molecules 
include the modulation of inflammation, cytokine release, immune responses, 
platelet aggregation, vascular reactivity, thrombosis and allergic reactions (Tapiero et 
al., 2002). Biosynthesis of these critical stimulants is dependent on the bioavailability 
of Δ5-desaturation products LC PUFA C20:4ω-6 (Leslie, 2004). In unstimulated 
cells, this 20-carbon FA is found sequestered in phospholipids from which it is 
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released upon stimulation. It is cleaved from membrane phospholipids by 
phospholipase A2 (PLA2) and is released as a free FA to react with enzymes that 
cause their oxygenation and is further modified to yield the cell stimulatory 
eicosanoids (Fig 2.8). For example, C20:4ω-6 is the precursor of 2-series PG that 
promote inflammation, which is generated by the metabolizing action of 
cyclooxygenases on this FA (James et al., 2000). Eicosanoids are produced only on 
demand.  Therefore, their synthesis is tightly regulated by the cellular concentrations 
and activities of the enzymes involved in their biosynthesis (Funk, 2001). These 
enzymes are subdivided into 4 major groups: phospholipases for the signal induced 
release of C20:4ω-6 from membrane phospholipids; prostaglandin endoperoxidase 
synthases or cyclooxygenases (COX) for the metabolism of C20:4ω-6 to 
prostanoids; lipoxygenase (LOX) for the formation of hydroxylated eicosatetranoic 
acids (HETEs), leukotrienes and cytochrome P450-controlled monooxygenases for 
epoxidation and hydrolation of C20:4ω-6 (Marks et al., 2000). 
 
Eicosanoids derived from ω-3 FA have less biological potency for inducing cellular 
responses than those derived from C20:4ω-6. Consequently, the metabolism of ω-3 
FA is associated with anti-inflammatory responses. For example, prostanoids 
derived from C20:5ω-3 (PG of the 3-series) (Fig. 2.8) have been shown to provide 
anti-inflammatory, protective effects in cancer tissue (Chapkin et al., 2007). Also, 
C20:3ω-6, an elongation product in the ω-6 metabolism pathway, provides a less 
prominent cascade and yields PG of the 1-series (Wang et al., 2012). Although the 
production of eicosanoids from C20:5ω-3 is formed at a slower rate, it can suppress 
the production C20:4ω-6 derived eicosanoids by competing for a common enzyme 
(e.g. COX) in the eicosanoid biosynthesis pathway (Schmitz and Ecker, 2008). The 
balance of these FA precursors in membranes is regulated by dietary supply; 
therefore diet can influence the eicosanoid response (von Schacky et al., 1985).  
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Figure 2.8:  Metabolic pathway depicting the biosynthesis of eicosanoids derived from C20:4ω-6 and 
C20:5ω-3. The 20-carbon chains are released from membrane phospholipids by action are 
phospholipase A2. Subsequent reactions involve cyclooxygenases (COX), lipoxygenases (LOX), and 
cytochrome P450-controlled monooxygenases to generate the multitude of eicosanoids that elicit 
various cellular responses (adapted from Larsson et al., 2004). 
 
(b) PUFA regulation of cell signalling pathways and gene expression 
FA are important secondary messengers or mediators of cell signal transductions, 
particularly of signals triggered at the level of cell membranes (Sumida et al., 1993). 
As briefly highlighted in the previous section, modulation of inflammatory responses 
is a key example of PUFAs role in metabolic cascade pathways (Awada et al., 2013). 
The stimulatory action of PLA2, for example, releases unsaturated FA from the sn-2 
position on the glycerol backbone of membrane phospholipids. These free 
unsaturated FA act directly as secondary messengers (Dennis et al., 1991). For 
example, C20:4ω-6 plays an important role as a secondary messenger by activating 
pathways regulating cell proliferation and apoptosis (Cao et al., 2000; Khan et al., 
1995; Wolf and Laster, 1999). 
 
PUFA also have a role in regulating gene expressions by directly binding to 
transcription factors and controlling its activity (Duplus et al., 2000). The peroxisome 
proliferator activated receptors (PPAR), which function as transcription factors 
regulating genes expression, are the best recognized sensor systems for FA 
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(Schoonjans et al., 1996). These ligand-activated nuclear transcription factors play 
important roles in cellular differentiation, insulin sensitization and cancer 
(Krishnakumar and Kraus, 2010). Various PUFA, especially those in the class of ω-3 
PUFA, are natural ligands for PPAR (Jump and Clarke, 1999). C20:5ω-3 and 
C22:6ω-3 are potent activators of the alpha isoform of the molecule compared to ω-6 
FA (Heuvel et al., 2006). Subtypes PPARα and PPARγ appear to play an important 
role in FA catabolism and storage of FA, respectively (Kliewer et al., 1997).  
 
Alternatively, PUFA act indirectly on gene expression through their effects on a) 
specific enzyme-mediated pathways, such as COX, LOX, protein kinase C (PKC), or 
sphingomyelinase signal transduction pathways; or b) pathways that involve 
changes in membrane lipid composition that affect G-protein receptor or tyrosine 
kinase-linked receptor signalling (Jump, 2004). For example, the activation of PKC is 
dependent on the release and interaction of PUFA from lipid membranes. PKC 
belongs to a family of phospholipid depend serine/threonine kinases that play 
important roles in signal transduction by phosphorylating target protein associated 
with a variety of cellular responses, including cell growth and differentiation, gene 
expression, hormone secretion, apoptosis and membrane function (Newton, 1995). 
Also, it participates in immune responses and inflammatory processes, and is 
essential for the activation of numerous specialised cells such as neutrophils, 
lymphocytes and macrophages (Giroux and Descoteaux, 2000; Tan and Parker, 
2003). There are numerous isoforms of PKC, which may explain the different effects 
of different LC PUFA (Newton, 1995). 
 
(c) Substrates for lipid peroxidation 
Reactive oxygen species (ROS) and other free radicals are constitutively generated 
in cells as a by-product of numerous metabolic processes (Valko et al., 2007). These 
reactive species include free radicals such as superoxide anion (O2 
-•), perhydroxyl 
radical (HO2 
•), hydroxyl radical (•OH), nitric oxide (NO) and other reactive species. In 
the absence of adequate antioxidant defences, the accumulation of ROS generates 
oxidative stress in cells, and can lead to the damage of DNA, proteins and lipids 
(Jacob and Burri, 1996). 
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Plasma membranes PUFA content, particularly in ω-3 FA, are prone to oxidation 
reactions due to the double bond nature of these macromolecules (Song and 
Miyazawa, 2001). Lipid peroxidation (LPO) is a free radical mediated chain reaction 
(Fig. 2.9) that starts with the abstraction of a hydrogen atom from the methyl group (-
CH2-) on PUFA molecules by 
•OH (Catalá, 2009). Lipid molecules can be oxidized by 
both enzymatic and non-enzymatic free radical mediated LPO (Niki et al., 2005). 
Although the resultant lipid hydroperoxides have a relatively short lifespan, their 
breakdown results in the formation of secondary products of LPO (aldehydes such 
as malondialdehyde (MDA) and the 4-hydroxyalkenals) that last longer and can 
attack a variety of cellular targets (Barrera et al., 2008). This process of oxidative 
lipid damage produces a gradual loss of cell membrane fluidity, reduces membrane 
potential and increases permeability to ions like Ca2+ (Guéraud et al., 2010).  
 
The responses elicited by these LPO products are dependent on their concentration 
levels in tissue: low level PUFA-induced oxidative stress is cytostatic, higher levels 
result in apoptosis, and extreme levels cause cellular necrosis (Niki, 2009). Due to 
the potentially toxic nature of lipid radicals, organisms have developed free radical 
scavenging mechanisms that protect macromolecules from oxidative damages. 
These include enzymatic antioxidants such as superoxide dismutase (SOD), 
glutathione peroxidase (Gpx) and catalase, as well as non-enzymatic glutathione 
(GSH) and other antioxidant (Valko et al., 2007). Dietary antioxidants also supply a 
measure of protection against LPO (Ashokkumar and Sudhandiran, 2008; 
Bonanome et al., 1992; Kasdallah-Grissa et al., 2008). 
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Figure 2.9:  The 3 step pathway of free radical mediated lipid peroxidation. Initiation: 1) Unsaturated 
FA reacts with free radical (X•) to generate a carbon centred radical through hydrogen abstraction. 
Propagation: 2) Addition of oxygen to the pentadienyl radical to give rise to lipid peroxyl radicals. 
Termination: 3) Release of oxygen from peroxyl radical to give pentadienyl radicals, and 4) 
intramolecular addition of the peroxyl radical to yield bicyclic prostaglandin-type products (i.e. 
aldehydes and alkenals. (Adapted from Niki, 2009). 
 
2.3.5 Role of PUFA in cancer development 
The potential role of PUFA in cancer development was first observed in the 
Greenland Eskimo population in the 1970s.The dietary patterns of this population 
was rich in marine species, that contain high levels of LC PUFA C20:5ω-3 and 
C22:6ω-3 (Bang et al., 1976). The incidence of cancer was much lower in these 
populations when compared to Eskimos who had migrated to Denmark, where 
individuals consumed a high fat, animal and plant based diet (Boysen et al., 2008; 
Dyerberg et al., 1975).  
 
However, since then further studies into the role dietary PUFA have in human cancer 
development has yielded inconsistent reports (Arem et al., 2013; Bartsch et al., 
1999; O’Doherty et al., 2012; Wynder et al., 1997). This may be related to the 
complexity of the human genome and its interaction with a diverse number of 
environmental exposures (Lee and Herceg, 2014; Liu et al., 2008; Willett, 2002). 
Consequently, to elucidate the potential role of PUFA in cancer development, 
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numerous in vitro and animal cancer models have provided great insight into their 
role in the process. 
 
 (a) Altered lipid profile and FA metabolism  
A study by Meng et al. (2004) demonstrated that the membranes of malignant cell 
lines have a significantly altered FA composition compared to normal cells. Similar 
effects have been observed in both animal and human cancer studies (Abel et al., 
2001; Oraldi et al., 2009; Shim et al., 2005). Cancer cells appear to have a higher 
proportion of SATS and MUFA esterified to membrane phospholipids than PUFA 
(Horrobin, 1990). This reduction in PUFA content is due to a loss or reduction in Δ6-
desaturase activity (Horrobin, 1990). Impairment of this enzyme reduces the 
synthesis of biologically functional LC PUFA. Consequently, the loss in availability of 
these FA may play an important role in abnormal cellular growth that is found in 
malignant transformations.  
 
(b) Increases pro-inflammatory eicosanoid synthesis 
Disturbances in eicosanoid production have been highlighted as a major factor in the 
development of cancers (Marks et al., 2000). LC PUFA C20:4ω-6 is a critical 
bioactive that plays a significant role in numerous biological functions (Brash, 2001). 
Under normal conditions cells utilize unesterified C20:4ω-6 as an important signal for 
inducing apoptosis (Cao et al., 2000). However, cancer cells favour an increase in 
cell production, thus utilizes C20:4ω-6 and other FA to construct membrane lipids. 
As a result, the level of unesterified or free C20:4ω-6 becomes depleted. Hereby, a 
potential pro-apoptotic signal is removed, and thus may promote carcinogenesis. 
Different products of C20:4ω-6 metabolism are also implicated in carcinogenesis. As 
much as 80-90% of colon carcinomas show an enhanced cyclooxygenase-2 (COX-
2) expression compared with normal mucosa (Cathcart et al., 2011). COX-2 is the 
enzyme that catalyses the rate limiting step in eicosanoid synthesis, converting 
C20:4ω-6 to PG. Consequently, the level of PG, particularly PGE2, is high in colon 
cancers (Castellone et al., 2005). Conversely, ω-3 FA have been reported to inhibit 
the production of the 2-series of eicosanoids, including PGE2 (Chapkin et al., 2007; 
James et al., 2000).  
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(c) Lipid peroxidation in cancer 
Oxidative stress has been identified as having a critical role in the development of 
cancers by both promoting tumour cell initiation and its progression towards a 
malignancy (Bakalova et al., 2013; Costa et al., 2014; Jrah-Harzallah et al., 2013; 
Perše, 2013). LPO, a consequence of oxidative stress, has been implicated as a 
significant causative factor. In patients with cancer prone diseases, the formation of 
ethno ()-modified DNA bases were a consequence of increased trans-4-hydroxy-2-
nonenal, a major product of LPO (Bartsch and Nair, 2004). However, during the early 
phases of development or the promotion stage, the level of LPO is found to be low in 
colon adenomas (Kondo et al., 1999). This is likely due to cancer cells reduction in 
esterified ω-3 and ω-6 FA (Cheeseman et al., 1988), which reduces their 
susceptibility to LPO and provides a stable environment for cancer cell growth and 
survival. Furthermore, the activation of exogenous antioxidant systems may also 
play a role (Valko et al., 2007). In Morris hepatoma cells, changes in membranes 
PUFA content and the loss of protective enzymes against oxygen radicals, such as 
SOD, increased membranes resistance to LPO (Galeotti et al., 1986). Enhancing 
membranes PUFA content can impact on cell regulatory processes that control cell 
numbers by inhibiting cell growth and/or inducing apoptosis (Bartsch et al., 1999). 
Thus increasing cancer cell membranes resistance to LPO may be a critical factor 
for promoting tumour growth, depending on the stage of development. 
 
(d) PUFA induced changes in gene expression in cancers 
In human prostate cancer cell line PC3 it has been demonstrated that certain FA can 
enhance cell growth by activating specific gene expressions (Hughes-Fulford et al., 
2001). The addition of ω-6 PUFA C18:2ω-6 and C20:4ω-6 to prostate cancer cell 
significantly increased their growth by inducing the expressions of c-fos and cox-2 
genes, whilst MUFA C18:1ω-9 and PUFA C20:5ω-3 had a reducing effect on cell 
growth. Other studies also show that LC PUFA ω-3 FA C22:6ω-3 has a protective 
effect against cancer development by down-regulating the family of prostaglandin 
genes, as well as COX-2 expression and several cell cycle related genes 
(Narayanan et al., 2001; Singh et al., 1997). Thus evidently, the type of FA supplied 
has a significant influence on which signal transductions (stimulatory or inhibiting) 
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are activated. The activation of PARP, for example, which is up-regulated in cancers, 
can modulate tissue specific responses dependent on the FA supply (Heuvel, 1999).  
 
Biomarkers of oxidative stress  
As noted earlier, the interaction of ROS with lipid membrane components (e.g. 
PUFA) elevates oxidative stress levels, which may lead to the induction of apoptosis 
or necrosis in normal/healthy cells (Chandra et al., 2000). Low or transient ROS 
exposure can affect several cellular responses, including its influence on 
transcriptional factors and the expression of genes encoding growth factors and 
proto-oncogenes that regulates cell proliferation (Allen and Tresini, 2000). The 
activation of the redox sensitive nuclear transcriptional factor κB (NF-κB) by lipid 
peroxides, for example, plays an important role in the molecular responses of 
enterocytes that initiates signals which stimulates cells to proliferate or die during 
increased oxidative stress (Aw, 1999). Cancer cells, however, have an adaptive 
nature that allows it to thrive under conditions of high oxidative stress, which support 
and sustains a persistent proliferative profile (Klaunig et al., 2010). Identifying target 
biomarkers such as genes that are responsive to changes in cancer cells pro-
oxidant/antioxidant (redox) balance, is therefore critical in understanding the 
disease’s pathology. Microarray technologies have provided an invaluable tool in 
determining the modification in cancer gene expressions associated with these 
effects (Cortes et al., 2011; Kachroo et al., 2011). 
 
The up-regulation of several stress-responsive genes is a common feature in cancer 
cells, many of which include genes encoding antioxidant enzymes that assist their 
survival under extensive ROS onslaught (Mates et al., 1999). The expression of 
manganese-SOD was shown to be increased in both gastric adenocarcinomas and 
oesophageal carcinomas when comparing normal and cancerous cells (Janssen et 
al., 2000). In colorectal cancer, an increase in lipoperoxide levels coincided with 
increased activities in of Gpx, SOD and -glutamylcysteine synthase (Ozdemirler et 
al., 1998). Such responses illustrate cancer cells nature to ensure its protection 
against oxidative damage by eliciting selective gene expressions. Peroxiredoxins 
(Prdx 1, Prdx2, Prdx3, Prdx4, Prdx5,), a family of abundant and ubiquitously 
expressed thiol-dependent peroxidases, acts as a redox sensor of hydrogen 
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peroxide (H2O2), and regulates its associated effects on cell signalling (Poynton and 
Hampton, 2014; Riquier et al., 2014). Prdx1 is commonly overexpressed in many 
human tumour types, in which it may suppress apoptosis via interactions with the 
enzyme Jun N-terminal kinase (JNK). Prdx1 suppresses the pro-apoptotic activity of 
JNK by suppressing its release from a glutathione S-transferase Pi/JNK complex. 
Furthermore, activation of oxidative stress responsive genes such as the NADPH 
oxidases (Nox1, Nox2, Nox3, Nox4, Nox5, Duox1 and Duox2) also plays a role in the 
negative regulation of signalling pathways such as (phosphatidylinositol kinase) PI3-
kinase/Akt that affects apoptotic responses (Smolková et al., 2011). Genes encoding 
for ROS metabolizing proteins like the redox sensitive transcriptional factor NF-E2-
related factor 2 (Nrf2) promotes cell survival through the regulation of several other 
oxidative stress inducible genes: Prdx1, catalase, Gpx, SOD and Trx (Ishii et al., 
2000). An increase in Nrf2 expression has also been noted in numerous tumour cells 
(Ohta et al., 2008; Wang et al., 2008). With changes in cancer cells redox balance 
having a significant role in promoting mechanisms sustaining its survival, modulating 
the level of oxidative stress to infer the expression of specific stress responsive 
genes provides an ideal target for cancer prevention strategies. 
 
2.6 Chemopreventive effects of dietary FA 
The multi-staged nature of cancer development provides numerous targets for 
intervention strategies due to each stage profiling distinct biochemical responses 
(Pitot, 1993). Initiation and progression, the first and last stages in cancer 
development, involves irreversible modifications to cells genome. However, 
promotion, the reversible intermediate stage, is characterized by alterations in gene 
expressions that provide transformed cells with a proliferative advantage. This 
makes promotion an ideal target for intervention since its control mechanisms can be 
manipulated (Russo, 2007). 
 
Therefore, the aim of chemoprevention is to utilize natural or chemical agents that 
either inhibits the process entirely or retards the growth of malignant cells to reduce 
the risk of invasive cancers. Key characteristics of a chemopreventive agent is that i) 
it should target malignant cells with minimal damage to the surrounding, healthy 
cells, ii) impede or block the mechanisms initiating cells neoplastic transformation or 
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sustaining cancer cells survival and iii) the chemopreventive agent should be 
pharmacologically safe, inexpensive and freely available. 
As highlighted in previous sections, both ω-3 and ω-6 PUFA have a significant role 
in both healthy and pathological conditions by participating in the regulation of cell 
membranes structure and their associated functions. It was also noted that FA of 
both classes appear to induce opposing responses in cells, demonstrating the 
importance of tissues ω-6/ω-3 FA ratio that likely determines a disease’s outcome.  
 
The supply of these PUFA in cells is greatly influenced by dietary intake. As 
mentioned before, most ω-3 and ω-6 FA are provided in the form of triglycerides 
from various food sources including vegetable, marine and seed oils. Fish oil (FO), 
high in the LC PUFA C20:5ω-3 and C22:6ω-3 has been extensively investigated for 
its numerous health benefits. In animal cancer models, FO have been shown to 
effectively reduce the initiation of tumour development by minimizing the formation of 
DNA adducts, as well as inducing apoptosis as a chemoprotective mechanism (Hong 
et al., 2005). Enhancing membrane ω-3 PUFA content also appears to sensitize 
cancer tissue to the toxic effects of pro-oxidant agents generated by LPO (Das, 
1999; Stoll, 2002). Furthermore, the protective effects of FO’s dominant FA are also 
related to their ability to diminish inflammatory responses in tissue due to their 
effects on eicosanoid production (Wall et al., 2010).  
 
The potential cancer protective effects of ω-6 FA C18:3ω-6 (γ-linolenic acid) has 
also been noted in other pathological conditions. In rheumatic conditions that are 
characterized by an increase in inflammatory mediators (e.g. 4-series leukotriene 
(LTB4) and 2-series prostaglandins), treatments with primrose oil and borage oil 
induced a protective, anti-inflammatory effect (Belch and Hill, 2000). The anti-
inflammatory effects provided by these oils are largely due to the supply of 
C20:3ω-6, a metabolite derived from C18:3ω-6 in the ω-6 FA synthesis pathway, 
which blocks the transformation of C20:4ω-6 into pro-inflammatory eicosanoids by 
increasing the supply in 1-series PG (Kapoor and Huang, 2006). In cancer cells the 
incorporation of C18:3ω-6 into cell membranes effectively blocks cell proliferation in 
a dose dependent manner (Hrelia et al., 1996). This FA has also been shown to 
selectively kill cancer cells due to its ability to initiate oxidative stress induced LPO in 
these cells (Bégin, 1987; Horrobin, 1992). 
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Canola oil and olive oil are other dietary oils that have also been recognized for their 
protective effects. Olive oil is best known for its high content in phenolic compounds 
and MUFA, C18:1ω-9 that displays antioxidant properties (Cicerale et al., 2010; Lee 
et al., 1998). A major component of the Mediterranean diet, olive oil has been shown 
to effectively modulate colon carcinogenesis during both early and late stages in the 
process by reducing aberrant lesions, as well as minimizing pro-inflammatory 
metabolites derived from C20:4ω-6 (Bartolí et al., 2000). In addition, the antioxidant 
content of the oil minimizes oxidative damage (de Kok et al., 1994). The oil’s 
bioactive components also appears to induce apoptotic events in colon cancer cell 
lines by decreasing the expression of Bcl-2 whose translated protein is a potent 
inhibitor of programmed cell (Llor et al., 2003). Meanwhile, canola oil contains a high 
proportion of EFA C18:3ω-3, and has displayed anticancer effects by suppressing 
cancer growth and reducing pro-inflammatory responses (Bhatia et al., 2011; 
Hardman, 2007) 
 
2.7 Summary and aims of the study 
The Western diet is characterised by high fat intake, particularly in ω-6 FA that is 
supplied by vegetable oils such as sunflower oil, which is commonly used in South 
Africa (MacKenzie, 2007). Coupled to low ω-3 FA intake, this dietary pattern 
generates a high ω-6/ω-3 FA ratio that has been associated with the onset of 
numerous diseases, including colon cancer. It has been suggested that by 
incorporating more ω-3 FA into the diet in the form of C20:5ω-3 and C22:6ω-3, this 
ratio will decrease and minimize the likelihood of pathological events associated with 
high ω-6 FA intake. The ensuing investigations utilizes combinations of the some of 
the oils/dietary fats mentioned above (i.e. sunflower + borage oil, sunflower + fish oil, 
sunflower + borage + fish oils) to generate varying dietary ω-6/ω-3 FA ratio. The aim 
of the current investigation is to evaluate whether these dietary fats with varying FA 
ratios can impede colon carcinogenesis by modulating selective biomarkers of colon 
carcinogenesis. 
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CHAPTER 3 
PROMOTION MODULATING EFFECTS OF DIFFERENT DIETARY FAT 
MIXTURES ON THE DEVELOPMENT OF ABERRANT CRYPT FOCI IN 1, 2-
DIMETHYLHYDRAZINE-INDUCED COLON CARCINOGENESIS IN RATS. 
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ABSTRACT 
The modulating effect of dietary fat mixtures composed of different ω-6/ω-3 fatty acid (FA) ratios on 
colon carcinogenesis was investigated by monitoring the development of aberrant crypt foci (ACF), 
colonic crypt cell proliferation and apoptosis. Male Fischer rat weanlings (50g) were maintained on a 
modified AIN-76A diet containing sunflower oil as a fat source (5%) until a body weight (BW) of 150 g 
was reached. Following cancer initiation utilising the colon carcinogen 1, 2-dimethylhydrazine (20 
mg/100 g BW subcutaneously once a week for 5 consecutive weeks), rats were fed the modified AIN-
76A diet composed of different dietary fat sources: (i) sunflower oil only (S), (ii) S + borage oils (SB), 
(iii) S + fish oils (SF), (iv) S + B + F oils (SBF) and the reference dietary oils, (v) canola oil and (vi) 
olive oil for 4 months. Blood chemistry markers of liver function, total bilirubin, direct bilirubin, alanine 
aminotransferase and creatinine were significantly (p<0.05) reduced suggesting that the dietary oils 
did not have any adverse effects on liver and kidney function. The total number of early neoplastic 
lesions or ACF developed was significantly (p<0.05) increased by the SF oil diet. The fish oil diet also 
tended to increase (p<0.05) the crypts multiplicity (≥7 crypts/focus) of the larger ACF, which was also 
noticed with the sunflower (s) only control diet. In contrast, the crypt multiplicity (≥7 crypts/focus) was 
significantly (p<0.05) reduced by the SB, SBF, olive and canola oil based diets when compared to the 
S and SF containing diets. Aberrant crypt cells proliferative and apoptotic activity was significantly 
reduced (p<0.05) by the borage oil containing (SB, SBF) diets as well as canola and olive oil based 
diets when compared to the S and SF diets. The aforementioned oils exhibited a chemoprotective 
effect when considering crypt multiplicity, presumably by reducing cell proliferation. The SF oil diet, 
however, appears to enhance colon carcinogenesis as indicated by the increase in the total number 
of ACF, mainly due to the increased multiplicity of larger ACF lesions. The underlying mechanism 
involved is likely related to an increased resistance of the ACF towards increased oxidative stress, 
which is triggered by the SF diet due to the susceptibility of ω-3 long-chain PUFA to lipid peroxidation. 
Threshold effects regarding the mucosal membrane levels of C20:4ω-6, C18:3ω-6 and C20:5ω-3 and 
the effect of their prostanoid metabolites on cell growth parameters are likely to be main regulators of 
the development of persistent ACF when considering the different oil mixtures. This became evident 
when considering the resultant stimulating effect of the SF diet on ACF development during cancer 
promotion, whilst the SBF oil combination significantly reduced ACF multiplicity. Differential fat diet-
induced effects of the borage/fish oil mixtures on cell proliferation and apoptosis therefore play a 
determining role in the modulation of cell survival indices of ACF in the colon. Specific FA and 
polyphenolic interactions when utilising the reference canola and olive oils provide interesting 
futuristic avenues of research on the chemopreventive potential against colon carcinogenesis 
 
Key words: colon carcinogenesis, dietary fats, ω-6 and ω-3 fatty acids, ω-6/ω-3 ratio, aberrant crypt 
foci, proliferation, apoptosis, oxidative stress 
 
 
 
 
 
 | 51 
 
 
 
3.1 INTRODUCTION 
Early detection of colon cancer remains a critical step in preventing further 
development of the disease, which results in the 3rd largest proportion of cancer 
related deaths in the Western world (Jemal et al., 2011). With colon carcinogenesis 
being a multi-step process (Fearon and Vogelstein, 1990), identifying significant 
biomarkers are key points of interest for researchers in planning preventive 
measures at specific stages of development. In animal studies numerous biomarkers 
for colon cancer has been identified (Anti et al., 1994; Bird et al., 1996; Ferrand et 
al., 2005; Srivastava et al., 2001). 
 
One of these biomarkers includes the aberrant crypt foci (ACF) that were first 
identified by Bird in mice via colorimetric microscopy (Bird, 1987). ACF have been 
regarded as precancerous lesions and are widely used as a biomarker of colon 
cancer in a number of studies (Caderni et al., 1995; Higurashi et al., 2012; Raju, 
2008; Wu et al., 2004; Zheng et al., 1999). These precancerous lesions provide a 
quantitative approach to assess the disease progress in response to either 
preventive or cancer promoting agents treatments (Pereira et al., 1994; Takayama et 
al., 1998). Under experimental conditions, these surface abnormalities on the colon 
appear within weeks after the treatment with carcinogens such as 1, 2 
dimethylhydrazine (DMH) or azoxymethane (McLellan and Bird, 1988). 
 
Although the disease evolves from genetic alterations to specific genes (Rustgi and 
Podolsky, 1992), the influence of numerous environmental factors including dietary 
patterns, has been associated with the development of colon cancer (Bruce et al., 
2000; Slattery et al., 1998). High fat intake, in particular, is considered a major 
contributor towards the development of the disease (Giovannucci and Goldin, 1997). 
More so, the type of fat, rather than just the quantity consumed, is a critical factor for 
consideration (Reddy and Maeura, 1984; Reddy et al., 1996). Diets high in omega-6 
(ω-6) polyunsaturated fatty acids (PUFA) appear to exhibit colon tumour promotion 
activity (Whelan and McEntee, 2004). These effects are demonstrated usually in 
conjunction with low ω-3 PUFA consumption, of which studies have shown to 
suppress the development of tumours (Fan et al., 2011; Reddy and Maruyama, 
1986; Roynette et al., 2004).  
 
 
 
 
 | 52 
 
 
 
Omega-6 PUFA such as C18:2ω-6 (linoleic acid) are mainly sourced from vegetable 
oils and seeds such as those from sunflowers and corn (Meyer et al., 2003). Deep 
cold-water fish, e.g. salmon, mackerel, are a rich source of the long-chain (LC) ω-3 
PUFA C20:5ω-3 (eicospaentaenoic acid) and C22:6ω-3 (docosahexaenoic acid), 
whilst green leafy plants and nuts are a good source of C18:3ω-3 (-linolenic acid) 
(Meyer et al., 2003). Apart from being structural components in cellular membranes, 
the fatty acids (FA) from both classes give rise to a variety of functional metabolites 
that have a significant role in normal physiological and pathological conditions (Lunn 
and Theobald, 2006; Murff et al., 2012; Simopoulos, 1999). Modulation of 
inflammatory effects and oxidative status are the commonly demonstrated responses 
influenced by the availability of these FA (Barham et al., 2000; Chapkin et al., 2007; 
Udilova et al., 2003). Metabolism of the 20-carbon ω-6 PUFA C20:4ω-6 (arachidonic 
acid) via the cyclooxygenase-2 (COX-2) pathway generates pro-inflammatory 
compounds (Goodman et al., 2004; Williams et al., 1999). The excessive supply of 
C20:4ω-6 and uncontrolled generation of pro-inflammatory bioactive compounds are 
positively linked to colon carcinogenesis (Tapiero et al., 2002). The opposite effect is 
observed with ω-3 metabolites derived from C20:5ω-3, which generates anti-
inflammatory compounds that have a suppressive effect on the survival of cancer 
cells (Chapkin et al., 2007). The generation of metabolites derived from ω-6 and ω-3 
PUFA is dependent on the same enzymatic action (James et al., 2000). 
Consequently, the interactive balance between the available FA from both 
polyunsaturated classes (i.e. ω-6/ω-3 ratio) plays a significant role in determining the 
disease’s progress. With diet being a major source of these FA, the supply of 
specific, biologically functional PUFA can be tightly regulated, and thus influence 
disease outcome. 
 
A study by Sarotra et aI. (2010) further illustrates the interactive effects of specific 
dietary FA ratios at the initiation and post-initiation phase of chemically induced 
carcinogenesis. In the study, 1, 2 DMH-induced animals displayed differential 
responses to fish and corn oil ratio (1:1 and 2.5:1) diets. During the initiation phase, 
the 1:1 ratio diet increased antioxidant activity to effectively reduce ROS generation 
and apoptosis, whilst post-initiation, the opposite effects was observed. These 
responses significantly decreased the number of ACF. A similar result was seen in 
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the liver, where diets with increased ω-3 FA content modulated the tissue’s oxidative 
status and reduced the formation of nodules (Abel et al., 2004). Both studies 
highlight the chemopreventive effect diets constituting low ω-6/ω-3 FA ratios, with a 
specified FA composition, have on disease progression. 
 
The assessment of cellular responses to specific dietary manipulations serves as a 
practical tool and/or early biomarkers to monitor the efficacy of diet in disease 
prevention. Such an approach is particularly important when assessing the potential 
delay in disease onset. Therefore, the objective for the current study was to evaluate 
the modulating effect of different dietary fat mixtures and natural oils with specific FA 
ω-6/ω-3 ratios on the presentation of certain tissue biomarkers post-initiation. ACF 
development and cell growth parameters related to cell proliferation and apoptosis 
were determined as prognostic indicators of cancer development in rat colon. 
 
3.2 MATERIALS AND METHODS 
3.2.1 Materials 
Fish oil rich in ω-3 FA was obtained from Equazen UK Ltd. (St Petersburg Place, 
London, UK). Borage oil was purchased from Créde Natural Oils (Strand, South 
Africa). Sunflower oil was supplied by RFS Catering Supplies (Milnerton, South 
Africa). The Cancer Association of South Africa (CANSA) approved brands of canola 
and olive oils were sourced locally. The carcinogen, 1, 2-dimethyl hydrazine (DMH), 
as well as the tissue staining agent methylene blue, was purchased from Sigma-
Aldrich (St Louis, USA). 
 
3.2.2 Preparation of diets 
A rat diet (AIN-76A) (Table 3.1) with a total fat content of 5% (w/w) was used 
throughout the experiment with commercially bought sunflower oil being used as a 
common fat source in 4 of the diets, and canola and olive oil as 2 other individual fat 
sources. For the experimental fat mixture diets, the AIN-76A diet fat content was 
modified with fish oil and borage oil to obtain fats with varying ω-6/ω-3 FA ratios for 
the duration of the experiment. The experimental fat sources consisted of: (i) 
sunflower oil only (S) – the control diet with respect to the ensuing oil mixtures made, 
(ii) sunflower oil supplemented with fish oil (SF), (iii) sunflower oil supplemented with 
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borage oil (SB) and (iv) sunflower oil supplemented with fish oil and borage oil 
(SBF). Two additional dietary fats, canola oil and olive oil, comprising a total 5% 
(w/w) fat content, were also used separately as reference oils. The diets were kept at 
-20 °C under nitrogen until use. The FA profile of the dietary oil mixtures were 
analysed using gas chromatography (Varian 3300) based on the method described 
by Opperman et al. (2011). Briefly, 10 mg oil (mixtures/reference) was dissolved in 
10 ml chloroform/methanol (2:1) containing butylated hydroxytoluene as an 
antioxidant. A volume of 100 μl was removed and dried under nitrogen at 37 C, and 
2 ml sulphuric acid in methanol was added for transmethylation and incubated at 70 
C for 2 hours. After cooling, 1 ml distilled water and 2 ml hexane were added and 
the solution vortexed for 1 minute. After phase separation, the hexane layer 
containing the FA methyl esters was transferred to a glass tube for solvent 
evaporation under nitrogen at 37 C. The dried residue was redissolved in 100 μl 
hexane and 1 μl was injected into a gas chromatograph. A Varian model 3300 
chromatograph was fitted with a BPX-70 fused silica capillary column (30 m x 0.32 
mm i.d., 0.25 mm film thickness, SGE). The injector and flame ionisation detector 
was at 240 C and 280 C, while column temperature was programmed from 160 C 
to 220 C at 3 C per minute. The hydrogen column flow rate was 30 cm/s. 
Heptadecanoic acid was used as an internal standard and added to all samples. The 
FA content of the samples were quantified and expressed as a percentage of total 
FA.
 
Table 3.1: Composition of the AIN-76A purified rat diet per kilogram. 
Ingredients Grams/kg batch 
Casein 200 
D-L-methionine 3 
Cornstarch 150 
Sucrose 500 
Cellulose 50 
Dietary oil  
total fat content of 5% (w/w) 
(see Table 3.2) 
Mineral mix 35 
Vitamin mix 10 
Choline bitartrate 2 
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3.2.3 Animals and treatment  
The Ethics Committee of the Medical Research Council (MRC) of South Africa 
approved the use of laboratory animals for this study (Addendum 1). At weaning 
(body weight 50 g), male Fischer rats, strain 344 (n = 120) were divided and housed 
individually in wire-bottomed cages under controlled lighting (12 hr. cycles) and 
temperature (23-25°C) with free access to water. The animals were initially fed ad 
libitum the AIN-76A diet containing sunflower oil as a fat source (5% w/w) until 
reaching a body weight of approximately 150g. 
 
3.2.4 Experimental design 
After 4 weeks at a body weight (BW) of approximately 150 g, the animals were 
injected subcutaneously with 20 mg/100 g BW 1, 2 dimethylhydrazine (DMH), once 
weekly for 5 consecutive weeks to induce colon carcinogenesis. The animals 
remained on the sunflower oil diet throughout the initiation process. 
 
After a week of acclimatization post-induction, the animals were divided into their 
respective experimental dietary fat mixture groups with 20 animals per treatment: 
SB; SF and SBF. Another group of animals (N=20) was maintained on the sunflower 
oil only diet (S) as a control group. Canola oil and olive oil based diets were also 
used as comparison reference groups. Throughout the experiment, changes in the 
BW and feed intake were recorded. After 4 months (16 weeks post-initiation), 
animals were terminated by exsanguination after an anaesthetising injection (i.p.) 
with sodium pentobarbital (0.15 ml /100 g body weight, 6% solution). Colon samples 
from all dietary groups were excised, sliced open and washed in a phosphate buffer 
solution. Samples were collected and fixed between filter lined microscope glass 
slides in formalin for both the analysis of pre-neoplastic lesion formation (i.e. ACF 
scoring; N = 10/group) and immunohistochemistry analyses (i.e. Ki-67 and caspase-
3 activity; N = 10/group). Blood samples were collected from the abdominal aorta in 
heparin-coated blood vials, centrifuged and the serum sequestered for clinical 
chemical analysis. Samples were stored at - 80 C until analyses.  
 
3.2.5 Methylene blue staining and ACF scoring 
Colon samples preserved in formalin were stained with 0.2% methylene blue 
according to the method of Bird (1995). Briefly, the methylene blue dye was 
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prepared in Kreb’s Ringer buffer and filtered. Samples were blot dried and 
transferred to the dye solution for 2 minutes. This step was repeated once more to 
ensure effective staining. The stained colon was divided into 3 segments for scoring 
under a light microscope (x20 magnification), and the total number of ACF and the 
corresponding number of crypts within the foci (multiplicity) were quantified.  
 
3.2.6 Colon immunohistochemistry analyses  
For the identification of Ki-67 (cell proliferation) and caspase-3 (apoptosis) activity, 
colon samples were cut into sections, and fixed with 4% paraformaldehyde for 5 
hours at room temperature (RT). Samples were then dehydrated and embedded in 
paraffin according to standard histological protocols. Slides were kindly prepared by 
Mrs Charna Chapman at the MRC Diabetes Discovery Platform. Tissue paraffin 
blocks were sliced into 4 µm sections, dewaxed with xylene, and dehydrated by 
gradient alcohol treatment. Endogenous peroxidase activity in the colon samples 
were blocked with 3% hydrogen peroxide (H2O2) for 5 minutes, and then washed 
with distilled water for 5 minutes. Sample slides were treated under high pressure 
(Pascal chamber: 125 C for 3 minutes; 90  for 30 seconds) with 0.01 M citrate 
buffer (pH 6.0), and rinsed with 0.05 M Tris Buffered Solution (TBS), pH 7.2 for 5 
minutes. Normal horse serum and normal goat serum was added to the Ki-67 and 
caspase-3 slide samples, respectively at a 1:20 ratio in a moisture chamber for 20 
minutes at RT. Excess serum was blotted off, and samples were incubated with 100 
µl of the required antibody (anti-Ki-67 or anti-caspase-3) at a ratio of 1:50 per section 
in the moisture chamber, overnight at 4 C. Slides were then rinsed with 0.05 M TBS, 
pH 7.2 for 5 minutes. For anti-Ki-67 activity, slides were stained with biotinylated 
anti-Mouse immunoglobulin G (IgG), and for caspase-3 activity with biotinylated anti-
Rabbit IgG for 20 minutes in a moisture chamber at a ratio of 1:200 for 1 hour and 30 
minutes, respectively. Samples were rinsed with 0.05 M TBS (pH 7.2) for 5 minutes, 
and then stained with the Vectastain for 2 hours (anti-Ki-67 activity) or 1 hour (anti-
caspase-3 activity). Samples were rinsed with 0.05 M TBS pH 7.2 for 5 minutes, 
dried and developed with a 3, 3’-diaminobenzidine tetrahydrochloride substrate 
solution (1 mg/ml). Developing time was controlled under microscope (approximately 
10 minutes). Samples were then washed with distilled water for 5 minutes and 
counterstained with haemotoxylin for 2 minutes. Slides were washed and dried 
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completely before mounting with DPX. Viewed via microscopy (x20 magnification), 
positive Ki-67 and caspase-3 activity was identified by the presence of dark brown 
particles in the nucleus of the colonic crypts. For each section, Ki-67 or caspase-3 
positive cells were scored in 5-10 longitudinal crypts, and expressed as a percentage 
of the total number of colonic crypt cells. 
 
3.2.7 Blood serum clinical biochemistry 
Post termination process, blood samples were immediately centrifuged at 1000g for 
10 minutes at 4°C. Serum was collected and stored at 4°C for clinical pathology. 
Serum parameters were measured using kits and a Technicon RA automated 
analyser at the Nutritional Intervention Research Unit (NIRU) (MRC, Tygerberg, 
South Africa). The following serum parameters were analysed: total and direct 
bilirubin, alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate 
aminotransferase (AST), creatinine, glucose, triglycerides, total cholesterol, high 
density lipoprotein cholesterol (HDL) and low density lipoprotein cholesterol (LDL).  
 
3.2.8 Statistical analyses 
The results presented are expressed as the meanstandard deviation (i.e. graphs or 
tables). Normal distribution amongst all the dietary groups means were determined 
by the Kolmogorov-Smirnov test, with variances homogeneity being tested as well 
(Bartlett’s test). One way analysis of variance (1-ANOVA) was used to investigate 
any differences between all group means. A post hoc Tukey-Kramer test determined 
the significant differences between comparison groups. A 2x2 factor design (2-
ANOVA) was used to determine interaction and main effects with the dietary oil 
mixtures. Interactive effects within these 4 dietary groups (i.e. different combinations 
of oil factors with each other  S, SB, SF and SBF) were determined to assess an 
intervention fish and/or borage oil effect. Analyses were determined with GraphPad 
Prism version 5.00 for Windows, GraphPad Software, San Diego, California USA, 
www.graphpad.com. Significant values were set at p<0.05 or p<0.0001 where 
indicated. 
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3.3 RESULTS 
3.3.1 Dietary oils fatty acid compositions (Table 3.2) 
In control diet (S), the FA content included C18:1ω-9 (26.90%) and saturated FA 
C16:0 and C18:0 at 6%, respectively. The total PUFA (59.42%) content was 
comprised of mainly C18:2ω-6 (59.01%), with a ω-6/ω-3 FA ratio of approximately 
502:1.  
 
The SB oil mixture consisted of C18:1ω-9 (23.79%), C18:2ω-6 (51.42%), and 
C18:3ω-6 (6.53%) with a ω-6/ω-3 FA ratio of approximately 38:1. The total PUFA 
content in the oil was 59.85%, while C16:0 and C18:0 content was 7.34% and 
5.33%, respectively. The SF dietary oil contained mainly C18:1ω-9 (25.38%), 
C18:2ω-6 (36.54%), C16:0 (5.73%), C18:0 (5.62%), C20:5ω-3 (3.53%) and 
C22:6ω-3 (0.55%) with a ω-6/ω-3 FA ratio of 13:1 and a total PUFA content of 
61.50%.  
 
The combination SBF dietary oil provided a FA profile consisting of C18:1ω9 
(22.82%), C18:2ω-6 (48.31%), C18:3ω-6 (6.33%), C18:3ω-3 (1.49), C20:5ω-3 
(3.31%) and C22:6ω-3 (0.54%). The SBF oil mixture had a ω-6/ω-3 ratio of 
approximately 10:1 with a total PUFA of 60.80% and a saturated FA content of 
C16:0 at 6.90% and C18:0 at 5.12%. 
Canola oil had a low PUFA content (29.9%) due to a low C18:2w6 (19.18%), with a 
ω-6/ω-3 FA ratio of approximately 2:1. The SATS, C16:0 (4.49%) and C18:0 (2.23%) 
were also the lowest of all the oils used. The oil contained mainly C18:1ω-9 
(59.19%) and C18:3ω-3 (10.28%). Olive oil had the highest percentage of C16:0 
(9.9%), C18:1ω-9 (77.41%) and the lowest C18:2ω-6 with a total PUFA content of 
only 6.23% and a ω-6/ω-3 FA ratio of 9:1. 
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Table 3.2: The fatty acid profile of dietary oils expressed as a percentage of 
total content. 
Fatty acid 
Dietary oils 
S 
(N=2) 
SB 
(N=2) 
SF 
(N=2) 
SBF 
(N=2) 
Canola 
(N=2) 
Olive 
(N=2) 
C16:0 6.000.01 7.340.07 5.730.01 6.900.21 4.490.01 9.910.01 
C18:0 5.940.01 5.330.08 5.620.18 5.120.14 2.230.01 3.700.01 
       
C18:1ω-9 26.900.01 23.790.53 25.380.20 22.820.43 59.190.01 77.410.01 
       
C18:3ω-3 0.120.01 1.520.03 0.100.01 1.490.08 10.280.01 0.610.01 
C20:5ω-3 <0.01 <0.01 3.530.17 3.310.15 <0.01 <0.01 
C22:6ω-3 <0.01 <0.01 0.550.07 0.540.04 <0.01 <0.01 
ω -3 total 0.120.01 1.520.03 4.370.29 5.450.22 10.280.01 0.610.01 
       
C18:2ω-6 59.010.01 51.420.49 36.540.68 48.310.65 19.180.01 5.620.01 
C18:3ω-6 <0.01 6.530.08 <0.01 6.330.26 0.080.01 <0.01 
C20:4ω-6 <0.01 <0.01 0.210.01 0.150.05 <0.01 <0.01 
ω-6 total 59.310.01 58.330.41 57.130.54 55.350.53 19.500.01 5.620.01 
       
PUFA total 59.420.01 59.850.42 61.500.51 60.800.64 29.780.01 6.230.01 
ω-6/ ω-3 501.820.01 38.360.72 13.110.96 10.160.37 1.900.01 9.240.01 
Values represent the mean  standard deviation of the dietary oils fatty acids profile expressed as a 
percentage of total content. Dietary oils: S = sunflower oil only, SB = sunflower oil + borage oil; SF = 
sunflower oil + fish oil; SBF = sunflower oil + borage oil + fish oil. 
 
3.3.2 Body weight gain and feed intake 
No significant differences in body weight gain (Fig. 3.1A), nor total feed intake (Fig. 
3.1B) were observed with the diets during the 4 month experimental period.  
 
 
Figure 3.10: Average rat total body weight gain (A), and feed intake in grams/100 gram body weight 
(B) over the 4 month experimental period. Diets contained the following oil mixtures: S = sunflower oil 
only, SB = sunflower oil + borage oil, SF = sunflower oil + fish oil, SBF = sunflower oil + borage oil + 
fish oil, Canola = canola oil and Olive = olive oil. 
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3.3.3 Intake of individual fatty acids  
Based on the feed intake and FA analyses of the oil and oil mixtures, the intake of 
individual FA was calculated. Due to the different oil combinations provided by the 
experimental dietary FA ratio groups, sunflower + borage oils (SB), sunflower + fish 
oils (SF), sunflower +borage + fish oils (SBF), as well as the sunflower oil only diet 
(S) and the reference oils canola and olive, altered levels of FA intake were 
observed (Table 3.3). 
 
3.3.3.1   C16:0 (palmitic acid) 
No significant fish/borage oil interaction effects were observed in modulating C16:0 
intakes. Animals’ intake of C16:0 increased significantly (p<0.05) with the SB oil and 
SBF oil diets when compared to the S oil diet (Table 3.3). Borage oil demonstrated 
an increasing (p<0.0001) main effect on C16:0 intake, whilst fish oil resulted in a 
decrease (p<0.05). C16:0 intakes with the diets containing the reference oils canola 
and olive, decreased (p<0.05) and increased (p<0.05), respectively relative to the S 
oil and oil mixture diets. 
 
3.3.3.2   C18:0 (stearic acid) 
No significant fish/borage oil interaction effects influenced the animals’ intake of 
C18:0. Intake of the FA decreased significantly (p<0.05) with diets containing the SB 
and SBF oil mixtures (Table 3.3). Borage oil had a significant decreasing (p<0.0001) 
main effect on C18:0 intake, while fish oil increased (p<0.05) the FA. Diets 
containing canola oil or olive oil reduced (p<0.05) animals’ intake of C18:0 further. 
 
3.3.3.3   C18:1ω-9 (oleic acid) 
No significant fish/borage oil interaction effects were noted. The SBF oil diet resulted 
in a reduced (p<0.05) supply in C18:1ω-9 relative to the S oil diet (Table 3.3). Both 
fish oil and borage oil had a significant decreasing main effect (p<0.05 and 
p<0.0001, respectively) on C18:1ω-9 intake, with the former reducing the FA more. 
Canola and olive oils provided a significantly greater supply of this monounsaturated 
FA, with the latter dietary group demonstrating the highest (p<0.05) intake of 
C18:1ω-9.  
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3.3.3.4   C18:3ω-3 (-linolenic acid) 
No significant fish/borage oil interaction effects were observed. C18:3ω-3 intake was 
significantly higher (p<0.05) with the SB oil and SBF oil containing diets when 
compared to the S oil and SF oil diets (Table 3.2). The elevated intake of the FA was 
due to borage oil’s increasing (p<0.0001) main effect. Animals exposed to the canola 
oil diet ingested the highest level (p<0.05) of C18:3ω-3. 
 
3.3.3.5   C20:5ω-3 (eicosapentaenoic acid) 
Significant fish/borage oil interaction effects were observed with C20:5ω-3 intake. 
The fish oil containing diets, SF and SBF, provided a significantly high (p<0.05) level 
of FA intake, whilst only trace levels were consumed with the S oil and SB oil diets 
(Table 3.2). A significantly higher (p<0.05) intake of C20:5n-3 was noticed with the 
SF oil diet as compared to the SBF oil diet. Overall, individually both fish oil and 
borage oil had a significant main effect (Addendum 1D), with fish oil resulting in an 
increase (p<0.0001) in C20:5ω-3 intake, whilst borage oil reduced (p<0.05) the FA. 
The reference oils canola and olive only provided trace levels of C20:5ω-3. 
 
3.3.3.6   C22:6ω-3 (docosahexaenoic acid) 
No significant fish/borage oil interaction effects were observed. Only trace levels of 
C22:6ω-3 was consumed with the S oil and SB oil diets (Table 3.3). The fish oil 
containing diets, SF and SBF, provided significantly higher (p<0.05) levels of the FA, 
with the highest of C22:6ω-3 being observed with the SF oil diet. This was due to 
fish oil’s increasing (p<0.0001) main effect on C22:6ω-3 intake. Only trace levels of 
the FA was consumed with the canola and olive oil diets. 
 
3.3.3.7   C18:2ω-6 (linoleic acid) 
No significant fish/borage oil interaction effects were noted. Animals exposed to 
dietary treatments containing either SB oil or SBF oil consumed significantly less 
(p<0.05) C18:2ω-6 when compared to the SF oil and S oil containing diets (Table 
3.3). The reduced intake levels in C18:2ω-6 was due to borage oil’s lowering 
(p<0.0001) main effect. C18:2ω-6 intake from the other reference oils diet, canola 
and olive, was significantly reduced (p<0.05) compared to that of S oil diet.  
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Table 3.3: The individual fatty acid intake of the rats with the dietary oil feeds. 
Fatty acid 
Diet 
S 
(N=17) 
SB 
(N=20) 
SF 
(N=20) 
SBF 
(N=20) 
F/B 
main effects 
Canola 
(N=20) 
Olive 
(N=20) 
C16:0 13.721.38a 16.191.01b 13.071.40a 15.461.45b B#, F* 10.150.80c 23.082.75d 
C18:0 13.591.37a 11.740.73b 12.821.37a 11.451.08b B#, F* 5.040.39c 7.850.93d 
        
C18:1ω-9 61.536.22a 52.393.27ab 57.896.20a 51.124.81b B# ,F* 133.8010.48c 180.3021.47d 
        
C18:3ω-3 0.270.03a 3.350.21b 0.230.03a 3.360.30b B# 23.501.91c 1.430.18d 
C20:5ω-3 <0.01a <0.01a 8.040.87b 7.350.62c B*, F# <0.01
a <0.01a 
C22:6ω-3 <0.01a <0.01a 1.250.13b 1.180.18b F# <0.01
a <0.01a 
        
C18:2ω-6 135.0013.65a 112.306.59b 129.0013.80a 108.909.84b B# 43.353.40c 12.871.24d 
C18:3ω-6 <0.01ac 14.380.90b 0.160.02ac 14.181.34b B# 0.180.02c <0.01
c 
C20:4ω-6 <0.01a <0.01a 0.500.05b 0.380.04c B#,F# <0.01
a <0.01a 
Values represent the mean  standard deviation of the animals’ fatty acid intake expressed in mg FA/100 grams BW. Diets contained the following oil 
mixtures: S = sunflower oil only (control), SB = sunflower oil + borage oil, SF = sunflower oil + fish oil, SBF = sunflower oil + borage oil + fish oil, 
Canola = canola oil and Olive = olive oil. Values in a row followed by different letters differed significantly (p<0.05). Main effects caused by either fish 
oil (F) or borage oil (B) are indicated as follows: increase = , decrease = . Significant main effects set at p<0.0001 (#) and p<0.05 (*) 
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Lower levels of C18:2ω-6 intake was observed with the olive oil based diet compared 
with canola oil (p<0.05).  
 
3.3.3.8   C18:3ω-6 (-linolenic acid) 
No significant fish/borage oil interaction effects were observed. Only trace levels of 
C18:3ω-6 (i.e. <0.01 mg) was provided with the S oil diet, while animals maintained 
on diets containing oil mixtures SB and SBF demonstrated significantly higher 
(p<0.05) intake levels of the FA (Table 3.3). The borage oil enriched diet had a 
significant elevating (p<0.0001) main effect on C18:3ω-6 intake. Trace intake levels 
of the FA were observed with the SF, canola and olive oil diets. 
 
3.3.3.9   C20:4ω-6 (arachidonic acid) 
The fish/borage oil interaction effects significantly (p<0.0001) influenced C20:4ω-6 
intake. Only trace levels of the FA were consumed with the S oil and SB oil diets, 
whilst the SF and SBF oil mixture diets presented significantly higher (p<0.05) intake 
levels (Table 3.3). Both fish oil and borage oil exerted significant main effects, with 
fish oil having the greater effect in increasing (p<0.0001) the FA intake, whilst borage 
oil had a reducing (p<0.0001) effect. Canola and olive oil only provided trace levels 
of C20:4ω-6. 
 
3.3.3   Total ACF and multiplicity  
The total number of early pre-neoplastic lesions (total ACF) increased (p<0.05) 
significantly with the SF diet when compared the S, SB, SBF, canola and olive oil 
diets (Table 3.4). With regards to ACF multiplicity, a great number of small (1-3 
crypts/focus) to medium (4-6 crypts/focus) sized lesions were observed amongst all 
the dietary groups. However, their tally was not significantly different in all the dietary 
treatment groups’ comparisons. The multiplicity of lesions (7 crypts/focus) were 
significantly (p<0.05) decreased by the SBF oil diet, illustrating an interaction 
between the fish and borage oils, despite the fact that the SF oil diet tended to 
increase the multiplicity (not significantly).  Overall borage oil showed a decreasing 
(p<0.05) main effect. Diets containing canola and olive oils exhibited a similar 
decreasing effect.   
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Table 3.4: Total ACF and crypt multiplicity in the colon of rats as a function of 
the dietary oil treatments. 
Diet Total ACF 
Multiplicity (crypts/focus) 
Small 
(1-3) 
Medium 
(4-6) 
Large 
(7) 
F/B 
Main effects 
S (N=8) 57.508.89a 25.677.17a 27.806.53a 8.143.63ab n/a 
SB (N=10) 63.2013.88a 23.717.78a 26.506.66a 6.501.29ac  B* 
SF (N=9) 98.674.51b 23.339.31a 27.296.87a 12.634.21b n/a 
SBF (N=9) 57.759.00a 24.007.93a 23.175.42a 3.170.65c  B* 
Canola (N=9) 67.755.85a 35.838.42a 27.607.60a 1.250.25c n/a 
Olive (N=10) 49.007.78a 26.004.30a 19.204.60a 1.500.29c n/a 
Values represent the meanstandard deviation of the total aberrant crypt foci (ACF) and crypt 
multiplicity. Diets contained the following oil mixtures: S = sunflower oil only (control), SB = sunflower 
oil + borage oil, SF = sunflower oil + fish oil, SBF = sunflower oil + borage oil + fish oil, Canola = 
canola oil and Olive = olive oil. Total ACF = total aberrant crypt foci. Significant differences between 
diet groups in the column Large (7 crypts/focus) indicated by different superscript letters (p <0.05). 
Main effects caused by either fish oil (F) or borage oil (B) are indicated as follows: increase = , 
decrease = , no interactive main F oil effects determined = n/a. Significant main effects set at p<0.05 
(*). 
 
3.3.4   Colon immunohistochemistry 
3.3.4.1  Effect on cell proliferation (Ki-67 activity)  
Tissue samples displayed a significant reduction (p<0.05) in Ki-67 positive cells with 
the oil mixture diets SB and SBF when compared to the diet containing the S oil 
(Table 3.5). Borage oil had a significant reducing (p<0.0001) main effect on the 
extent of proliferative activity within the colonic crypts. A similar reducing effect was 
noted with the canola oil and olive oils based diets. 
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Table 3.5: Proliferative Ki-67 activity of the colon crypts in response to 
         diets. 
Diet 
Proliferation 
F/B  
main effects % Ki-67 positive cells 
per total crypt cells 
S (N=7) 100.0031.31a n/a 
SB (N=8) 66.7725.19b  B# 
SF (N=9) 89.5034.12a n/a 
SBF (N=8) 65.8522.32b  B# 
Canola (N=8) 
63.4326.80b 
n/a 
Olive (N=7) 
62.3119.14b 
n/a 
Values represent the meanstandard deviation of the percentage of Ki-67 positive 
cells relative to the total number of colon crypt cells. Diets contained the following 
oil mixtures: S = sunflower oil only (control), SB = sunflower oil + borage oil, SF = 
sunflower oil + fish oil, SBF = sunflower oil + borage oil + fish oil, Canola = canola 
oil and Olive = olive oil. Values in a column followed by different letters 
(superscript) differed significantly (p<0.05). Main effects caused by either fish oil 
(F) or borage oil (B) are indicated as follows: increase = , decrease =, n/a = no 
interactive main F/B oil effects determined. Significant effects set at p<0.0001 (#) 
and p<0.05 (*). 
 
3.3.4.2   Induction of apoptosis (Caspase-3 activity)  
The inclusion of fish oil (diet SF) did not alter the percentage of cell undergoing cell 
death when compared to the S oil diet (Table 3.6). However, diets containing oil 
mixtures SB and SBF significantly reduced (p<0.05) the level of caspase-3 positive 
cells, illustrating borage oil’s reducing (p<0.0001) main effect. The canola oil and 
olive oils based diets also decreased (p<0.05) apoptosis with the former having the 
greater reducing effect. Canola oil exposure generated the lowest number of 
caspase-3 positive cells relative to the SBF diet as well. 
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Table 3.6: Apoptotic caspase-3 activity of the colon crypts in response 
         to diets. 
Diet 
Apoptosis 
F/B  
main effects % caspase-3 positive 
per total cells per crypt cells 
S (N=7) 100.0032.99a n/a 
SB (N=8) 46.6721.18b  B# 
SF (N=9) 91.1831.45a n/a 
SBF (N=7) 49.1119.95b  B# 
Canola (N=7) 23.5714.86c n/a 
Olive (N=7) 32.158.34bc n/a 
Values represent the meanstandard deviation of the percentage of Ki-67 positive cells 
relative to the total number of colon crypt cells. Diets contained the following oil mixtures: 
S = sunflower oil only (control), SB = sunflower oil + borage oil, SF = sunflower oil + fish oil, 
SBF = sunflower oil + borage oil + fish oil, Canola = canola oil and Olive = olive oil. Values in 
a column (super script) followed by different letters differed significantly (p<0.05). Main 
effects caused by either fish oil (F) or borage oil (B) are indicated as follows: increase = , 
decrease = , n/a = no interactive main F/B oil effects determined. Significant main effects 
set at p<0.0001 (#). 
 
3.3.5   Blood clinical biochemistry parameters 
Only total and direct bilirubin, alanine aminotransferase (ALT) and creatinine levels 
were significantly altered in response to the dietary oil treatments (Table 3.7). Total 
bilirubin content reduced significantly (p<0.05) with the SBF oil diet when compared 
to that of SB. Hereby fish oil demonstrated a significant decreasing (p<0.05) main 
effect. Canola oil had a similar reducing (p<0.05) effect.  Both canola and olive oil 
based diets lowered (p<0.05) the level of direct bilirubin relative to the SB diet.
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Table 3.7: Effect of the dietary oil feeds on the animals’ blood clinical biochemistry. 
Clinical 
Biochemical 
parameter  
 Diet 
S SB SF SBF 
F/B 
main effect 
Canola oil Olive oil 
total bilirubin 0.890.42 1.150.31
a 
0.810.18 0.600.33
b 
 F* 0.620.27
b 
0.780.35 
Direct bilirubin 4.010.32 5.161.17
a 
4.380.79 4.130.76  3.740.95
b 
3.130.88
b 
ALP 61.509.33 49.508.79 64.5013.30 52.809.80  66.9012.33 65.8722.39 
ALT 64.839.13 96.6332.86
a 
78.3820.64 60.0014.20
b  61.0015.70
b 
67.5017.33 
AST 99.2621.33 166.5350.47 103.71 119.2535.11  93.3019.39 110.6429.71 
creatinine 53.654.61
ab 
52.398.72
ab 
47.299.75
b 
29.787.18
c 
F#, B* 40.878.51 43.1716.85 
glucose 9.200.68 9.261.09 9.280.55 9.370.60  9.430.78 8.930.78 
triglycerides 0.500.17 0.640.29 0.420.14 0.450.15  0.680.28 0.680.38 
cholesterol 1.750.16 1.670.29 1.620.22 1.580.29  1.640.23 1.610.53 
HDL cholesterol 1.100.21 1.180.14 1.170.14 1.260.25  1.230.17 1.170.40 
LDL cholesterol 0.590.19
 
 0.440.13 0.470.23 0.420.09  0.370.07 0.340.17
 
 
Values are the mean  standard deviation of rat blood chemistry components. Diets contained the following oil mixtures: S = sunflower oil only, SB = 
sunflower oil + borage oil, SF = sunflower oil + fish oil, SBF = sunflower oil + borage oil + fish oil, Canola = canola oil and Olive = olive oil. Blood serum 
components: ALP = alkaline phosphatase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; HDL = high density lipoprotein; LDL = low 
density lipoprotein. Values in a row followed by different letters (superscript) differed significantly (p<0.05). Main effects caused by either fish oil (F) or borage 
oil (B) are indicated as follows: increase = , decrease = . Significant main effects set at p<0.001 (#) and p<0.05 (*).
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Blood serum levels in ALT was significantly reduced (p<0.05) with the diet containing 
oil mixture SBF when compared to the SB oil diet. The canola oil diet had a similar 
decreasing (p<0.05) effect on ALT content. Creatinine levels were reduced (p<0.05) 
with the SF oil and SBF oil diets when compared to the S oil. Borage oil and fish oil 
had a significant reducing (p<0.05 and p<0.0001, respectively) main effect on 
creatinine, with fish oil enhancing the decrease. 
 
3.4 DISCUSSION 
Aberrant crypt foci (ACF) are one of the widely accepted biomarkers used to monitor 
the progress of early precancerous cells in the colon. These neoplastic lesions, 
appearing on the colon mucosal surface, result from the deregulation of mechanisms 
controlling cellular homeostasis that arise from genetic alterations (Bird, 1995; Chen 
et al., 2005; Michor et al., 2005). Chemopreventive studies demonstrate that 
numerous dietary components, which include dietary fats and its FA constituents, 
modulate the development of ACF (Rao et al., 2001; Schmelz et al., 2000; Volate et 
al., 2005; Zheng et al., 1999). Of interest are the cancer modulating effects of ω-6 
PUFA found in common seed oils and long-chain (LC) ω-3 PUFA, found in fish oils. 
Both classes of PUFA and their metabolites have a variety of physiological roles 
(Zamara, 2004). However, individual PUFA have been identified for their enhancing 
or suppressive role in cancer development (Dommels et al., 2002). Thus, the 
interaction of specific ω-6/ω-3 PUFA dietary FA ratios is an important factor to 
consider in determining disease outcome. 
 
The current study demonstrated that the FA profile of the different dietary oils 
consumed by the animals elicited differential effects on the selected biomarkers 
identified including ACF formation. Certain oil diets (SF, SBF and canola) reduced 
the level of select serum enzymes (total and direct bilirubin, ALP, creatinine), which 
serves as markers of hepato- and nephrotoxicity in the DMH-induced animals 
(Swaroop and Gowda, 2012). Thus, a decrease demonstrated the non-toxic effects 
of the dietary oils with an increase in liver and kidney function during the dietary 
treatment period. Regarding ACF development, a great number of small lesions (1-3 
crypts/focus) tended to develop in response to the effect of canola oil. Medium sized 
lesions (4-6 crypts/focus) appear to decrease with the SBF and olive oil based diets. 
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Interestingly, with the inclusion of fish oil (SF diet) and to some extent the sunflower 
(S) oil only diet, animals displayed a distinct dietary fat input response favouring an 
increase in the multiplicity of the larger ACF (7 crypts/focus), while the SF 
significantly increased the induction in the total number of ACF. Studies suggest that 
ACF with higher crypt multiplicity are more likely to persist and progress into a more 
aggressive cancer phenotype, (Raju, 2008; Srivastava et al., 2001). Thus, it is 
suggested to be a more favourable predictor of tumour incidence, whereas the 
smaller category foci and ACF tend to regress (Perše and Cerar, 2011; Roncucci et 
al., 2000).  
 
ACF arise as a consequence of an imbalance between cell proliferation and 
apoptosis with these lesions favouring increased proliferative activity (Boman et al., 
2008; Yamashita et al., 1994). In other animal studies, exposure to fish oil has 
demonstrated anticancer effects by reducing total ACF and cell proliferation (Latham 
et al., 1999; Rao et al., 2001; Reddy et al., 1991). In the current study, an opposite 
effect was noticed with the SF oil based diet, as indicated by the increased level of 
higher crypt multiplicity. However, the experimental models from the aforementioned 
anticancer fish oil effect differed from the current study with regards to the stage of 
dietary intervention. Most of the studies dietary interventions occurred at a pre-
carcinogen treatment period as opposed to the effects of the dietary oil mixtures 
during the cancer promotion stage in the current investigation. A possible reason for 
the discrepancy in effect is likely associated with the resistance towards oxidative 
stress of persistent ACF in the colon. An increased level of oxidative stress is 
associated with the induction of the initiated cells, which makes them more 
susceptible to the induction of apoptosis and reduces carcinogen-induced initiation 
as reported previously (Latham et al., 1999). A similar effect is noticed in the liver 
where initiated cell populations are very susceptible to undergo apoptosis following 
cancer initiation (Schulte-Herman et al., 1997). However, once established these 
carcinogen initiated cell populations displayed a highly resistant phenotype during 
cancer promotion in the liver, suggesting that they survive in stressful 
microenvironments (Farber et al., 1991). In the colon, the carcinogen DMH is a 
potent inducer of DNA damage (Klaunig et al., 2011; Sasaki et al., 1998), which 
imparts selective growth advantages to the initiated cells during cancer promotion 
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(Foster, 2008). Therefore, to sustain the altered phenotype, protective mechanisms 
are activated to adapt the cancer cells metabolisms which included resistance 
towards oxidative stress, allowing their growth and survival (Cairns et al., 2011; 
Sarotra et al., 2010).  
 
3.4.1   Modulation of cell proliferation 
The modulating effect of fish oil is related to its FA content in LC ω-3 FA such as 
C20:5ω-3 and C22:6ω-3. These FA are potent inducers of apoptosis due to their 
susceptibility to free radical attack and consequent initiation of oxidative stress (Das, 
1999; Hong et al., 2005). A recent study indicated that the fish oil containing diet 
significantly increases oxidative stress in the colon mucosa of rats when fed for 4 
months, which was related to an increase in oxidative stress that resulted from an 
enhanced incorporation of C20:5ω-3 and C22:6ω-3 (Abrahams, 2009 - Addendum 
4). Despite the increase in oxidative stress, cell proliferation was increased in the 
current study, suggesting towards higher proliferative activity in these ACF (Bird, 
1995). This response may be a consequence of an altered oxidative status, e.g. 
increased antioxidant capacity in the pre-cancerous lesions that perpetuates the 
transformed condition’s resistance against oxidative stress. Hereby, an increased 
cell proliferative index is supported as suggested elsewhere (Klaunig and Kamedulis, 
2004). 
 
Diets containing the oil mixtures SB and SBF, and also the reference oils canola and 
olive, exerted a protective effect by reducing cell proliferation, highlighting different 
underlying mechanistic effects in response to the dietary fat supply. This became 
apparent as the SF and control sunflower (S) only oils diets proportionally showed a 
higher proliferative response in the colon under the current experimental conditions. 
The S only diet is known to promote colon carcinogenesis due to the high levels of 
C18:2ω-6 FA that is likely to modulate the levels of the C20:4ω-6-derived PGE2 
prostanoids metabolites known to stimulate cell proliferation (Kawarimori et al., 
2003). Both the S and the SF oil diets provide similar C20:4ω-6 levels in the colon 
mucosa phosphatidylcholine (PC) and phosphatidylethanolamine (PE) phospholipids 
to sustain such an increased proliferative response (Abrahams, 2009 – Addendum 
4). Borage oil contains the PUFA C18:3ω-6, whose metabolism to C20:3ω-6 
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(dihomo-γ-linolenic acid) generates metabolites, such as PGE1, that have both anti-
inflammatory and anti-proliferative properties (Kapoor and Huang, 2006; Wang et al., 
2012). Of interest is that borage oil significantly (main effect) reduced the intake of 
C20:4ω-6 and C20:5ω-3, while selectively increasing the intake of C18:3ω-6. 
However, detailed FA analyses of the colon mucosa of rats fed the same dietary oil 
mixtures used in the current study for 4 months, indicated that borage oil increased 
both C18:3ω-6 and C20:4ω-6 in the colon mucosa in PC and PE phospholipids 
(Abrahams, 2009 – Addendum 4). Borage oil also significantly increased C20:5ω-3, 
which provides interesting interactive responses when considering the reduction of 
ACF in the current study. This became evident as the combination of C18:3ω-6 with 
C20:5ω-3 FA in the SB and SBF oil diets serves as the precursor FA for the anti-
inflammatory PGE1 and PGE3 prostaglandins, respectively, which reduces the 
synthesis of pro-inflammatory prostanoid PGE2, derived from C20:4ω-6 (Barham et 
al., 2000; Pham et al., 2006). Therefore, the combined effect of fish and borage oil 
seems to be a more efficient approach for inhibiting of ACF development. This 
suggests that a threshold of introducing ω-3 FA exists, above which adverse 
responses can be recorded as demonstrated with the SF oil only diet. Olive and 
canola oils, although not dominant in PUFA content, appears to have similar 
mechanistic effects by reducing the synthesis of PGE2 (Bartolí et al., 2000; Bhatia et 
al., 2011).  
 
3.4.2   Modulation of apoptosis 
Apoptosis plays a critical role in the maintenance of the cellular environment in colon 
tissue by providing a controlled removal of damaged cells to balance cell renewal 
(Hall et al., 1994). Inhibition of this process is considered a critical feature in the 
development of colorectal cancer (Bedi et al., 1995; Thompson et al., 1992). 
However, coinciding with the decrease in proliferative activity in the current study, 
apoptosis was also reduced by the diets containing the oils SB, SBF canola and 
olive oils, with canola oil having the largest effect. However, the relative balance 
between the two growth regulatory parameters is not known, but it would appear that 
the reduction in cell proliferation is also associated with a decrease in apoptosis in 
order to maintain cellular homeostasis. With respect to the SB and SBF oils, though, 
subtle changes in the FA profiles could stimulate the induction of apoptosis relatively 
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to the cell proliferative index, and hence the reduction in ACF multiplicity. In this 
regard, the increase in C20:4ω-6 in the colon mucosa by SB (Abrahams, 2009 – 
Addendum 4) is of interest as it is associated with the modulation of ceramide 
levels, a key determinant of apoptosis (Jayadey et al., 1994).  
 
The level of apoptosis in the colon crypts was significantly (p<0.05) higher in the rats 
fed the SF and the control S diet when compared to the other oil mixture diets. This 
coincided with an enhanced cell proliferative index and the increased apoptosis is 
likely to maintain cellular homeostasis in the colon crypts. With respect to the S only 
diet, C18:2ω-6 is the main dietary FA and likely the main driving force behind the 
modulation of cell proliferation by regulating the level of C20:4ω-6 and the production 
of PGE2. The latter prostanoid has been demonstrated to stimulate enhanced 
proliferation in colon cancer cells (Castellone et al., 2005). However, a critical level of 
C20:4ω-6 seems to determine the balance between cell proliferation and apoptosis. 
Animal experiments indicated that a minimum amount of C18:2ω-6 is required to 
promote the growth of carcinogen-induced tumours in rodents and that a threshold 
exists above which the FA did not appear to exhibit a specific tumour-promoting 
effect (Zock and Katan, 1998). A similar response is noticed in the current study 
where specific FA ratios exhibited opposite responses with respect to the crypt cells 
proliferative index in the carcinogen-induced lesions in the colon. Regarding the SF 
oil mixture, the dietary intake FA profile, as well as the level of FA incorporation in 
the colon mucosa, the ω-3 FA content was significantly increased, which decreased 
the ω-6/ω-3 ratio in both PC and PE phospholipids (Abrahams, 2009 – Addendum 
4). The increased incorporation of the ω-3 FA significantly increased the level of lipid 
peroxidation (LPO) in the colon mucosa, which is related to an increased level of 
oxidative stress and the induction of apoptosis. This is in accordance with the 
literature where an increased dietary PUFA intake and associated LPO plays a 
determining role in the induction of apoptosis (Das, 1999; Valko et al., 2007; Serini et 
al., 2009). Clearly a critical balance between cell proliferation and the level of 
apoptosis will determine the effect of a specific oil mixture on the growth of altered 
pre-neoplastic lesions in the colon. In the current study, the SB and SBF oil mixtures 
are likely to favour the induction of apoptosis at the cost of cell proliferation. This 
effect results in a reduction in the multiplicity of ACF lesion, while the opposite effect 
is noticed with the SF and S oils. 
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The reference oils provided a very low supply of PUFA compared to the SB and SBF 
oil diets, thereby reducing the potential for initiating LPO. Furthermore, the high 
intake of FA C18:1ω-9, major constituents of olive and canola oil, exerts a protective 
affect against oxidative stress (Bonanome et al., 1992; Duval et al., 2002; Lee et al., 
1998). In addition, the polyphenolic content of the reference oils may also be a 
contributing factor in protecting the initiated condition against oxidative stress 
(Kuwahara et al., 2004; Manna et al., 1997). However, the polyphenolic content of 
the oils has also demonstrated anticancer affects. Canolol or 4-vinyl-2, 6-
dimethoxyphenol, a novel and potent antioxidant in canola oil has been shown to 
reduce the level of COX-2 expression that enhances PGE2 induced cell proliferation 
in gastric cancer cells (Jiang et al., 2013). Similarly, the anticancer effects of 
hydroxytyrosol, a major polyphenol in olive oil, has been linked to its ability in 
arresting the cell cycle in the G2/M phase, thus preventing cell proliferation and 
inducing apoptosis (Corona et al., 2007; Elamin et al., 2013). Therefore, the 
underlying mechanisms required to suppress colon carcinogenesis by these natural 
oils may be related to specific polyphenol and FA interactions that modulate the cell 
growth parameters associated with cell proliferation and apoptosis.  
 
3.4.3   Modulation of membrane lipids 
Apart from changes in the FA content of membranes, the relative distribution of 
membrane lipids including cholesterol and the major phospholipids, PC, PE and the 
sphingolipid, sphingomyelin are also key determinants of cell growth indices as well 
as membrane fluidity. These membrane constituents have been reported to be 
changed by DMH, which reduced the cholesterol and the cholesterol:phospholipid 
ratio in the colon mucosa (Kanwar et al., 2011). In addition, the phospholipids PC 
and PE were also increased, although separate analyse of the individual 
concentrations were not conducted. A comparative study in rats indicated that the SF 
oil diet significantly decreases PE, resulting in an increase in the PC/PE ratio 
(Abrahams, 2009 - Addendum 4). The SB diet significantly decreases the ratio due 
to a marked decrease and increase in PC and PE, respectively. No clear effect was 
noticed on the cholesterol membrane level, although the SBF oil diet showed a 
marked increase. It was suggested that an increase in membranes PC content in the 
DMH treated rats was associated with an increased proliferative capacity (Kanwar et 
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al., 2011). Therefore, changes in the cholesterol, PC and PE levels in the mucosal 
membrane by the different dietary fat mixtures could be indicative of the diverse 
responses related to the induction of cell proliferative and apoptotic indices and the 
development of ACF in the colon. 
 
3.5 CONCLUSIONS 
Colon tissue biomarkers from the carcinogen treated animals displayed varied 
responses relative to the intake of the different FA constituents from the dietary fat 
mixtures supplied. The oil mixtures containing borage oil (SB and SBF), as well as 
canola and olive oil reduced crypt multiplicity and cell proliferation in the colon. 
These responses are likely a consequence of specific FA interactive effects with 
dietary antioxidants on signal transductions pathways related to cell survival indices. 
Conversely, fish oil (SF oil diet) and to some extent sunflower oil (S diet), appears to 
have an enhancing effect on crypt multiplicity during cancer promotion, although 
interactive effects between ω-3 PUFA (SF diet) and ω-6 PUFA (SB diet) in the 
combined SBF diet provide interesting chemopreventive research alternatives. A 
plausible explanation is that the pre-neoplastic lesions may be resistant to the 
oxidative stress environment effected by fish oil. Hereby, the survival of the pre-
existing cancerous lesions is enhanced. Therefore, to allow for the clonal expansion 
of the transformed cells, protective mechanisms are likely activated that deters the 
diet’s potential oxidative stress induced removal of damaged cells (Hardman et al., 
2002). Studies demonstrate that an increased endogenous antioxidant capacity 
plays a significant role in protecting neoplastic cells against oxidative stress-induced 
cell death, allowing these cells to survive and proliferate (Hardman et al., 2002; 
Sarotra et al., 2010). In addition, threshold effects and specific ω-6/ω-3 FA 
interactions, related to the production of prostanoids with differential effects on cell 
proliferation and the induction of apoptosis, also seems to be the main underlying 
driving force in determining the altered growth patterns of pre-neoplastic lesions in 
the colon. Of interest is the potential mechanism involving oxidative stress as well as 
the roles of C20:5ω3, C20:3ω-6 and C20:4ω-6 FA and their respective prostanoids 
in the regulation of cell survival regulatory pathways related to cell proliferation and 
apoptosis.  
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Antioxidants supplied by the diet also have a considerable effect in protecting cells 
against oxidative stress (Lee and Lee, 2006). Therefore, the polyphenolic 
constituents of the dietary oils, particularly those of the canola and olive oils, likely 
exert anti-proliferative properties as noted by the significant decrease in ACF 
multiplicity and its associated proliferative activity. Further investigation into these 
eluded mechanisms may also provide a more comprehensive perspective of the 
possible interactive effects of selected dietary fat mixtures and its bioactive 
polyphenolic constituents.  
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CHAPTER 4 
 
MODULATION OF THE EXPRESSION OF OXIDATIVE STRESS AND 
ANTIOXIDANT DEFENCE GENES BY DIETARY FAT DURING 1, 2-
DIMETHYLHYDAZINE INDUCED COLON CARCINOGENESIS IN RATS. 
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ABSTRACT 
Cancer cells have a highly adaptive nature that enables their survival under abnormal cellular 
conditions. During cancer promotion, pre-neoplastic cells demonstrate resistance to oxidative stress 
that plays a significant role in cell survival. Dietary components can modify cells oxidative status by 
influencing the redox balance associated regulatory responses that include altering gene expressions. 
In the current investigation, the effect dietary fat mixtures with varying ω-6/ω-3 fatty acid compositions 
have on colon carcinogenesis was evaluated by screening the expression of genes associated with 
changes in cells redox balance. Male Fischer rats (150g) feeding on a modified diet containing 
sunflower oil (5% w/w) as a fat source, was administered with 1, 2-dimethylhydrazine (20 mg/100 
grams body weight subcutaneously) for 5 consecutive weeks. One week following cancer initiation rat 
were fed diets with the following dietary fat sources: sunflower oil only (S), S + borage oil (SB), S + 
fish oil (SF), SBF and canola and olive oils as reference. After 4 months, RNA was isolated from the 
colonic mucosa epithelium according to standard protocols, and the expression of 84 genes 
associated with oxidative stress and antioxidant defence mechanisms were assessed by quantitative 
real-time PCR microarrays. The expression of 36 genes was significantly altered relative to the 
sunflower oil diet, with canola and olive oil based diets having the majority of effects. Of the genes 
analysed, the Gpx family of antioxidant enzymes was significantly (p<0.05) up-regulated by the SB, 
SF, canola and olive oil based diets, demonstrating a protective response against increased ROS 
levels in the colon. Other genes up-regulated by canola and olive oils included those involved in DNA 
repair mechanisms, maintenance of cell membrane integrity and immune responses. The canola and 
olive oil induced modulation of redox associated regulatory mechanisms related to the expression of 
genes that mediate cell proliferation and apoptotic pathways. These effects may potentially serve as a 
chemopreventive measure against the development of colon cancer with major emphasises on 
interactions between the FA and polyphenolic constituents. 
 
Key words: colon carcinogenesis, fatty acids, microarrays, gene expression, oxidative stress, 
antioxidants 
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4.1 INTRODUCTION 
The development of colon cancer is a multistage process involving genetic and 
epigenetic events that result in the gradual transformation of altered pre-neoplastic 
cells into tumours (Fearon and Vogelstein, 1990). Identifying the mechanisms that 
triggers these sequential events has been a major research focus in the 
development of intervention strategies (Greenwald et al., 1995; Sharma et al., 2001). 
Of the numerous mechanisms identified influencing this process, modulation of 
oxidative stress parameters has contributed significantly to the aetiology of the 
disease (Perše, 2013; Reuter et al., 2010).  
 
Oxidative stress refers to the imbalance of pro-oxidants and antioxidants favouring 
the former, which can lead to the depletion of the antioxidant capacity of a cell and 
resulting in the damage of critical macromolecules, e.g. DNA, protein and lipids. 
Under normal physiological conditions, cells generate pro-oxidants or free radicals 
such as reactive oxygen species (ROS) as a by-product of numerous aerobic 
regulatory processes (Dröge, 2002). Simultaneously, antioxidant systems are active 
to maintain cellular homeostasis and integrity (Valko et al., 2007). Inadequate 
scavenging by antioxidants or high levels of ROS generates a skewed redox balance 
that leads to oxidative stress, which contributes towards both the initiation and 
promotion stages of malignant transformation (Bakalova et al., 2013; Jrah-Harzallah 
et al., 2013). An increase in ROS is commonly observed during carcinogenesis 
induction in the colon of rats treated with mutagenic agents such as 1, 2-
dimethylhydrazine (DMH) (Arutiunian et al., 1997). In addition, changes in gene 
expression mediated by ROS can either lead to the activation/inactivation of specific 
signal transduction pathways that greatly influence the promotion of tumour 
development (Allen and Tresini, 2000; Aw, 1999). Under normal conditions, ROS 
play a significant role in activating signals for cell proliferation (Chiu and Dawes, 
2012), as wells as influencing apoptotic responses (Dröge, 2002). Both pathways are 
significantly altered during cancer development, with the process favouring 
increased cell proliferation and a reduction/inhibition of apoptosis (Chen et al., 2005; 
Hanahan and Weinberg, 2011).  
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Environmental factors and diet have a major effect on the redox balance within a 
cell. In humans, increased levels of oxidative stress in whole blood and urine have 
been noted after intake of dietary components such as the polyunsaturated fatty 
acids (PUFA) (Jenkinson et al., 1999). Similar effects have been observed in the 
colon and liver (Hong et al., 2002; Song and Miyazawa, 2001). The PUFA 
components of cell membranes are highly susceptible to oxidation with the resultant 
lipid radicals leading to multiple events that influence cell survival indices (Barrera et 
al., 2008; Das, 1999). Metabolites derived from certain PUFA, eicosanoids such as 
the 2-series prostaglandin E2 (PGE2), for example, are important facilitators of 
inflammatory processes (Tapiero et al., 2002). Consequently, the development of 
cancer has strongly been linked as a direct result of inflammation (Chapkin et al., 
2007a; Multhoff et al., 2011; Ramos-Nino, 2013) that arise from oxidative insults 
(Reuter et al., 2010). Studies show that dietary intakes of ω-6 PUFA, arachidonic 
acid (C20:4ω-6), enhances disease development while ω-3 PUFA such as 
eicosapentaenoic acid and (C20:5ω-3) docosahexaenoic acid (C22:6ω-3) reduces 
the risk due to their opposing effects on inflammation (Chapkin et al., 2007b; Jones 
et al., 2003). It is of importance to note that intakes of both classes of fatty acids (FA) 
are critical for normal regulatory functioning. However, the quantity and type of FA 
consumed determines its effects on health and disease development (Simopoulos, 
1999).  
 
As mentioned, antioxidants also play a critical role in regulating oxidative stress. 
Cellular systems have developed an array of endogenous antioxidant enzymes that 
control the effects of free radicals (Birben et al., 2012). However, dietary antioxidants 
also provide a significant measure of protection against oxidative onslaughts 
(Pandey and Rizvi, 2009). Due to the potential genotoxic and epigenetic insults 
caused by excessive oxidative stress, increased ROS has been identified as a major 
risk factor for colon cancer development, while an added supply of dietary 
antioxidants is beneficial in minimizing the effects generated by these harmful 
oxidation products. Therefore, identifying measures that could modify the cellular 
redox status to attenuate the regulatory outputs that sustain cancer growth, may 
serve as a feasible intervention strategy. In the present study, different fat sources 
comprised of varying ratios of ω-6 and ω-3 PUFA were evaluated for their potential 
as modulators of oxidative stress during colon carcinogenesis. The influence of the 
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varying dietary FA contents on the post-initiation stage, with respect to the extent of 
gene expression of 84 genes associated with pro- or anti-oxidant functions was 
assessed in the colon utilizing a real-time polymerase chain reaction (PCR) 
microarray.  
 
4.2 MATERIALS AND METHODS 
4.2.1 Materials and chemicals 
Colon carcinogen 1,2- dimethylhydrazine (DMH) RNA stabilizing reagent Trizol, 
absolute ethanol, isopropanol, sodium carbonate (Na2CO3), HPLC grade methanol, 
hexane and chloroform were all purchased from Sigma-Aldrich (St Louis, USA). 
Agilent technologies provided the RNA 6000 Nano LabChip for RNA quality 
determination. Folin-Ciocalteau was supplied by Merck (Darmstadt, Germany). Kits 
provided by Qiagen/SABiosciences included the RNeasy mini columns, RT2 First 
Strand, RT2 SYBR Green Mastermix and the RT2 PCR profiler oxidative stress and 
antioxidant defence array kits. RNase-free water was supplied by Whitehead 
Scientific (Cape Town, South Africa). 
 
4.2.2 Animals and ethical clearance 
The use of animals for experimentation was cleared by the South African Medical 
Research Council’s Ethics Committee for Research on Animals (ECRA). Male 
Fischer rats, strain 344 (n= 30) were used for all experimentation. Weanlings with 
body weights (BW) of  50 grams (g) were fed the standard AIN-76A containing 
sunflower oil as a fat source (5% w/w). 
 
4.2.3 Experimental design  
A similar experiment design described in Chapter 3 (page 54) was used. The FA 
profile of the experimental dietary oil mixtures was assessed by gas 
chromatography, and summarized in Chapter 3 (Table 3.2, page 58). In addition, the 
total polyphenol content was analysed as described below (section 4.2.4). The 
animals were fed the experimental diets for a period of 4 months with their body 
weights (BW) and feed intakes (FI) being monitored every 2nd week. Colons (N = 3 
per dietary group) were removed, sliced open and cleaned in a phosphate buffer 
solution. Mucosal epithelial cells were collected by scraping the distal end, 
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approximately 1-2 centimetres in length, of the colon with a glass slide. Samples 
were weighed and preserved in 500 μl of the RNA stabilizing reagent Trizol (Sigma-
Aldrich, Germany) and stored at -20 C until total RNA extraction was performed. 
 
4.2.4 Total polyphenol content determination 
The total polyphenol (TTP) content of the experimental dietary oil mixtures was 
determined in triplicate according to the method adapted from Haiyan et al. (2007). 
Three gram of each oil, sunflower, SB, SF, SBF, canola and olive, comprising a 
specific dietary fat ratio, were dissolved in 15 ml hexane and extracted by shaking 
with 5 ml methanol for 10 minutes followed by centrifugation at 500 rpm for 15 
minutes. The resultant bottom methanol layer was collected and the extraction 
repeated twice more, and the combined samples stored at 4 C overnight. The 
combined methanol extract, was extracted by 25 ml hexane by vortexing (1 minute) 
followed by centrifugation at 500 rpm for 15 minutes. An aliquot of the resultant 
methanol extract (0.5 ml) was used for TTP determination. A stock solution of gallic 
acid (1 mg/ml) was prepared in distilled water (dH2O) to obtain a standard series of 
10-100 μg/ml in a final reaction volume. In a test tube, the standard, blank (dH2O) or 
oil methanol extract (0.5 ml), were combined with 10% Folin-Ciocalteau reagent (2.5 
ml) and 7.5% sodium carbonate (Na2CO3) (2 ml) in a total volume of 5 ml. Samples 
were mixed by inversion and incubated for 2 hours in a water bath at 37 C. The 
absorbance was determined at 765 nm, and TTP expressed as mg gallic acid 
equivalents per kilogram oil (Addendum 2A, Table 4.1). 
 
4.2.5 Total RNA extraction from colon epithelial tissue 
Trizol stabilized samples were defrosted on ice and homogenized for 1 minute with a 
single stainless steel bead (Qiagen 5 mm) using a tissue lyser (Retsch MM400, 
Haan, Germany) for 1 minute. Samples were kept on ice for 1 minute and the 
homogenizing process repeated another two times to ensure uniform sample 
dispersion. Chloroform (i.e. 100 μl) was added to each tissue aliquot (i.e. 500 μl), 
and mixed by inversion. Samples were incubated at room temperature (RT) for 5 
minutes, and then centrifuged at 12 000x g for 10 minutes at 4 C. The upper 
aqueous phase containing the RNA was transferred to a clean Eppendorf tube, and 
precipitated with 250 μl isopropanol (trizol:isopropanol ratio equals 2:1). RNA 
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samples were incubated at RT for 10 minutes and centrifuged at 10 000 x g for 10 
minutes at 4 C. Supernatants were discarded, and the pellets were suspended in 
75% ethanol to remove the residual isopropanol. Samples were then centrifuged at 
7500 x g for 5 minutes, and the subsequent pellets air dried for 5 minutes and 
suspended in adequate volumes of RNase-free water (50-100 μl). Further RNA 
clean-up was employed using RNeasy mini columns (Qiagen, Valencia, CA, USA). 
RNA samples were quantified using a UV spectrophotometer (NanoDrop; A260/A280) 
and the quality of the RNA was assessed using the Agilent RNA 6000 Nano kit on a 
sample bioanalyzer (Agilent Technologies, Waldbron, Germany). Only high quality 
RNA with a RIN above 7 was used for subsequent steps. 
 
4.2.6 RNA digestion and precipitation 
To ensure the removal of genomic DNA, 5 µg aliquots of total RNA was digested 
with 5 μl DNase (Fermetas, Thermo Scientific, Wilmington, DE, USA). Briefly, DNase 
treated samples were incubated at 37 C for 30 minutes on a PCR thermal cycler 
(Eppendorf). The digestion process was stopped by adding 5 μl EDTA (50 mM) at 65 
C on the thermal cycler for 10 minutes. The RNA was further concentrated by 
adding ⅟10 volumes of sodium acetate (3 M, pH 5.5) and 2.5 volumes absolute 
ethanol followed by gently mixing by pipetting. Samples were stored overnight at -20 
C, and subsequently centrifuged at 12000 x g for 10 minutes. The supernatant was 
discarded and pellets washed with 100-500 μl 75% ethanol, and centrifuged at 10 
000 x g for 5 minutes. The supernatant was carefully discarded and residual ethanol 
being removed by pipette. The pellet was allowed to air dry for 10 minutes, 
suspended in 20 μl RNase-free water and the RNA allowed to completely dissolve by 
heating for 5 minutes at 55 C. RNA concentration was quantified by UV 
spectrophotometry (Nano Drop Thermo Scientific, Wilmington, DE, USA). 
 
4.2.7 cDNA synthesis and real-time PCR microarray 
cDNA was prepared according to specifications in the RT2 First Strand kit (Qiagen). 
Briefly, cDNA was synthesized from 400 ng of the precipitated RNA, which was 
incubated at 42 C for 5 minutes with a volume of genomic DNA elimination mix. This 
was followed with incubation at 42 C for exactly 15 minutes with an equivalent 
volume of the reverse transcriptase mix provided in the kit. The reaction was stopped 
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by incubating at 95 C for 5 minutes. RNase-free water was added to a total cDNA 
volume of 111 µl. A volume of cDNA (102 μl) was combined with 550 μl RT2 SYBR 
Green Mastermix (Qiagen/SABiosciences) that contains HotStart DNA Taq 
Polymerase. This reaction was then set up to a final volume of 1100 μl with RNase-
free water (i.e. 448 μl). For the analyses, 5x384-well PCR Array plates 
(Qiagen/SABiosciences) embedded with primers encoding for 84 genes (Addendum 
2B, Fig. 4.1 and Addendum 2C, Table 4.2) involved in oxidative stress and 
antioxidant defence mechanisms were used. Sample volumes (10 μl) were 
transferred to the 384-well plate that contains 4 replicates of 96 assays that can be 
used for the analysis of 4 samples. The real-time cycle conditions set on an Applied 
Biosystems cycler (model 7900HT) were as follows: PCR initial activation step at 95 
C for 10 minutes and a total of 40 cycles for melting (95 C, 15 seconds), and 
annealing (60 C, 1 minute). The relative fold change in gene expression with the 
experimental dietary fat ratio diets were determined by using the SA Biosciences 
web-based software that automatically performs quantification using the CT 
method. 
 
4.2.8 Statistical analyses 
(a) Body weight gain, feed, fatty acid and total polyphenol intakes 
The results presented are expressed as the meanstandard deviation (i.e. tables or 
graphs). Normal distribution amongst all the dietary groups means were determined 
by the Kolmogorov-Smirnov test, with variances homogeneity being tested as well 
(Bartlett’s test). One way analysis of variance (1-ANOVA) was used to investigate 
any differences between the control diet sunflower oil only and the experimental 
dietary oil mixtures (SB, SF, SBF), as well as canola and olive oils. A post hoc 
Tukey-Kramer test determined the significant differences between these comparison 
groups. Analyses were determined with GraphPad Prism version 5.00 for Windows, 
GraphPad Software, San Diego, California USA, www.graphpad.com. Significant 
values were set at p<0.05, p<0.001 or p<0.0001 where indicated. 
 
(b) PCR array data normalization and analysis 
All pathway targeted genes were normalized against the assays housekeeping 
genes. The comparative CT (CT) method used calculated the relative amounts of 
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transcripts in the sunflower oil (reference) and experimental dietary fat ratio groups 
(SB, SF, SBF, canola and olive oils). The fold change in gene expression for the 
latter groups relative to the sunflower oil group was calculated using the formula 2-
2Ct. Statistical analysis was determined using the Student’s t-test comparing the 
CT values for each gene in the sunflower oil group versus that of those in the 
experimental dietary fat ratio groups. Significant fold changes observed were set at 
p-values less than 0.05 (p<0.05). 
 
4.3 RESULTS 
4.3.1 Body weight gain and feed intake 
The animals showed no significant differences in body weight gain throughout the 
exposure period to the different diets (Table 4.3). However, feed intake was 
significantly influenced by these diets. Relative to the sunflower oil only diet, animals 
feeding on the olive oil based diet demonstrated the highest level of feed intake at 
4.70 grams feed/100 grams body weight (p<0.001). 
 
4.3.2 Selective fatty acid intake 
The intake of select fatty acids provided by the experimental oil mixture diets (SB, 
SF, and SBF), the reference diets with canola and olive oils, were compared to that 
of the sunflower oil only diet (Table 4.3). 
 
4.3.2.1   C18:1ω-9 (oleic acid) 
Intake of the monounsaturated FA, C18:1ω-9, increased significantly with the canola 
oil (3-fold) and olive oil (5-fold) based diets (p<0.0001) (Table 4.3), with the latter 
providing the highest intake (Chapter 3, Table 3.2). The oil mixture diets, SB, SF and 
SBF demonstrated no significant increase of C18:1ω-9 relative to the sunflower oil 
only diet. 
 
4.3.2.5   C18:3ω-3 (alpha-linolenic acid) 
Compared to the sunflower oil only diet, the inclusion of borage oil with the SB and 
SBF diets significantly (p<0.0001) increased C18:3ω-3 intake (Table 4.3). A similar 
increasing (p<0.05) effect is observed with olive oil. The inclusion of fish oil (SF diet) 
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only supplied trace levels of the FA. Canola oil, however, provided the highest 
(p<0.0001) intake of C18:3ω-3. 
 
4.3.2.6   C20:5ω-3 (eicosapentaenoic acid) 
The fish oil based diets, SF and SBF, provided the highest intake of C20:5ω-3 
(p<0.0001) relative to the control diet containing only sunflower oil as the fat source 
(Table 4.3). The sunflower oil only diet, together with the SB, canola and olive oils 
diets only provided trace levels of the FA. 
 
4.3.2.7   C22:6ω-3 (docosahexaenoic acid) 
Compared to the sunflower oil only diet intake of C22:6ω-3 was significantly 
increased (p<0.0001) with the SF and SBF diets (Table 4.3). The inclusion of fish oil 
with the SF diet supplied a higher intake, while only trace levels of C22:6ω-3 was 
observed with the SB, canola and olive oil based fat diets. 
 
4.3.2.2   C18:2ω-6 (linoleic acid) 
Inclusion of fish oil in the sunflower oil (SF oil diet) significantly increased(p<0.05) the 
intake relative to the sunflower oil only diet while a marked increase was also noticed 
with the SB oil diet (Table 4.3). The canola and olive oil containing diets, however, 
significantly reduced (p<0.0001) C18:2ω-6 intake, especially the olive oil where 
reduction of up to 5 times was noticed.  
 
4.3.2.3   C18:3ω-6 (gamma-linolenic acid) 
Animals’ consumption of the borage oil based diets, SB and SBF, significantly 
increased the intake of C18:3ω-6 (p<0.0001) when compared to the sunflower oil 
only diet that contains negligible amounts (Table 4.3). Low levels of C18:3ω-6 intake 
was observed with the inclusion of fish oil (SF diet), as well as with the canola and 
olive oil diets. 
 
4.3.2.4   C20:4ω-6 (arachidonic acid) 
A significant increase (p<0.0001) in this FA’s intake (Table 4.3) was only observed 
with the SBF oil diet compared to the control sunflower oil only diet. The SF, SB, 
canola and olive oil based diets only provided trace levels of this FA. 
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Table 4.3: Average body weight gain, feed and selected fatty acid intake 
parameters. 
Parameter 
Diet 
S SB SF SBF Canola Olive 
BW 90.67±14.57 97.00±16.85 90.67±4.93 89.00±21.91 69.50±5.00 83.33±14.01 
Feed 
intake 
3.54±0.38 4.06±0.53 3.83±0.48 4.19±0.33 4.11±0.13 4.70±0.56
** 
Fatty acid intake 
C18:1ω-9 37.53±4.07 44.00±5.79 38.55±4.91 40.53±3.24 95.47±2.99
*** 
161.40±8.71
*** 
       
C18:3ω-3 0.27±0.03 2.13±0.28
*** 
<0.01 2.41±0.32
*** 
18.14±1.05
*** 
1.35±0.07
* 
C20:5ω-3 <0.01 <0.01 11.92±1.51
*** 
8.96±0.71
*** 
<0.01 <0.01 
C22:6ω-3 <0.01 <0.01 2.07±0.26
*** 
1.47±0.12
*** 
<0.01 <0.01 
       
C18:2ω-6 96.18±8.08 106.40±11.50 108.20±12.89
* 
102.70±7.74 62.33±1.84
*** 
15.87±0.76
*** 
C18:3ω-6 <0.01 13.44±1.77
*** 
0.08±0.01 13.56±1.09
*** 
0.23±0.01 <0.01 
C20:4ω-6 <0.01 <0.01 <0.01 0.63±0.05 <0.01 <0.01 
Values represent the mean  standard deviations (n = 3/ diet) of body weight (BW) gain in grams and feed intake 
(grams/100 g BW). Fatty acid intake is expressed in mg FA/100 grams BW. Dietary fat sources: Sunflower = sunflower oil, SB 
= sunflower oil + borage oil; SF = sunflower oil + fish oil; SBF = sunflower oil + borage oil + fish oil. Significant differences 
compared to the sunflower oil diet set at p<0.05 (*), p<0.001 (**) and p<0.0001 (***). 
 
4.3.3 Total polyphenol intake 
The dietary intake of total polyphenols (TTP) provided by the animals feed intake via 
the different diets is illustrated in Fig. 4.2. Relative to the sunflower oil only control 
diet, the experimental dietary fat ratios (SB, SF, and SBF) and the reference diets 
canola and olive oils provided significantly different TPP intake levels. Olive oil 
provided the highest (p<0.0001) intake, whilst canola oil the lowest amount 
(p<0.001). Both the inclusion of borage and fish oils (SB and SF diets) increased 
TPP intake significantly (p<0.05). The combination of these two oils (SBF diet) 
further increased animals TPP intake (p<0.0001). 
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Figure 4.2: Total polyphenol intake expressed as mg gallic acid per 100 gram body weight. Animal 
feed diets contained the following oil mixtures: S = sunflower oil only, SB = sunflower oil + borage oil, 
SF = sunflower oil + fish oil, SBF = sunflower oil + borage oil + fish oil, Canola = canola oil and Olive = 
olive oil. Significant differences compared to the sunflower oil only (control) diet set at p<0.05 (*), 
p<0.001 (**) and p<0.0001 (***). 
 
4.3.4 Oxidative stress and antioxidant defences related genes expression 
The influence of the experimental dietary fat ratios (SB, SF, SBF, canola and olive 
oils) on the relative expression of 84 genes involved in oxidant stress and antioxidant 
defences was evaluated. The effect on gene expression of all the experimental diets 
was compared using the sunflower oil only diet as control. The number of genes 
differentially influenced by the dietary treatments is illustrated in Figure 4.3. Genes 
affected are summarised in Table 4.3. 
 
4.3.4.1   Number of genes affected in the colon mucosa 
Animals’ exposure to olive and canola oils demonstrated the highest number of 
genes affected at 26 and 22, respectively (Fig. 4.3). The SB and SF diets altered the 
expression of only 2 genes each, whilst the SBF diet only changed the expression of 
a single gene. 
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Figure 4.3: Functional classification of genes significantly altered in the colon mucosa of carcinogen 
treated male Fischer 344 rats exposed to different diets. 
 
4.3.4.2   Expression of genes affected according to functional classification. 
Out of the 84 genes evaluated per dietary treatment, the expression of only 36 genes 
in total was significantly (p<0.05) altered relative to the sunflower oil diet (Table 4.4). 
 
Antioxidant defence genes 
(i) Glutathione peroxidases 
Several sub-types of this class of potent antioxidants were significantly up-regulated. 
Gpx 2 expression was up-regulated 32.90 fold (p = 0.003) with the canola oil based 
diet, whilst olive oil increased the expression of Gpx5 (p = 0.003) and Gpx8 (p = 
0.01). The SB, SF, canola and olive dietary oils increased Gpx4 expression 
significantly (p<0.05), with olive oil presenting the highest fold increase at 185.03.  
 
(ii) Peroxiredoxins 
Ehd2 encoding the EH-domain containing 2 protein, was significantly up-regulated 
by both canola (p value = 0.008) and olive oil (p = 0.0001), with the former having a 
greater enhancing effect. 
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(iii) Other peroxidases 
The expression of several other peroxidase encoding genes mutually affected by 
canola and olive oils included the up-regulation (p<0.05) of serine (or cysteine) 
peptidase inhibitor, clade B, member b1 (Seprpin1b) and tropomodulin (Tmod1) 
encoding genes. Individually, canola oil resulted in the significant 33.36 fold increase 
(p =0.04) in Mpo, encoding for myeloperoxidase, expression. A similar increasing 
effect is observed for the recombination activating gene 2 (Rag2, p = 0.02). A 
significant up-regulation (p<0.05) in several other peroxidase encoding genes 
expression was observed with olive oil: adenomatous polyposis coli (Apc), cathepsin 
B (Ctsb), eosinophil peroxidise (Epx) and prostaglandin-endoperoxide synthase 2 
(Ptgs2).  
 
(iv) Other antioxidants 
Canola and olive oils mutually affected the expression of sulfiredoxin 1 homolog S. 
cerevisaie (Srxn1) by a fold change of 23.81 and 28.31, respectively. Canola oil up-
regulated (p = 0.01) the expression of thioredoxin 1 (Txnrd1), whilst olive oil 
increased (p = 0.001) the expression of glutathione reductase (Gsr) by a fold change 
of 21.16, and also thioredoxin 2 (Txnrd2, p =0.04) by a 60.97 fold. 
 
Genes involved in ROS metabolism 
(i) Genes involved in superoxide metabolism 
The expression of the Ncf2 gene, encoding for the neutrophil cytosolic factor 2, was 
mutually up-regulated by the canola and olive oil based diets with a respective fold 
change of 24.82 (p = 0.03) and 27.22 (p = 0.02). 
 
(ii) Oxidative stress responsive genes 
In the SB dietary group a down-regulation of -0.36 fold (p = 0.04) was observed in 
the Ercc2 gene, which encodes for the excision repair cross-complementing rodent 
repair deficiency, complementary group 2. The SF diet, as well as the canola oil 
based diet resulted in an increase in Nudix (nucleoside diphosphate linked moiety 
X)-type motif 1 (Nudt1) expression by 45.78 (p = 0.04) and 187.84 (p = 0.01) fold, 
respectively. The SBF diet significantly up-regulated (p = 0.02) xeroderma 
pigmentosum, complementation group A (Xpa) gene expression by 166.96 fold. 
Canola and olive oil mutually up-regulated (p<0.05) the following genes: Parkinson 
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disease (autosomal recessive, early onset) 7 (Park7), peroxiredoxin 1 (Prdx1) and 
thyroid peroxidise (Tpo). An increase of 55.72 fold in peroxiredoxin 2 (Prdx2) 
expression was also observed with canola oil exposure. Olive oil up-regulated the 
expression of the isocitrate dehydrogenase (Idh1), protein phosphatise 1, regulatory 
subunit 15b (Ppp1r15b) and prion protein (Prnp) encoding genes by fold changes of 
43.01, 19.61 and 1110.25, respectively. 
 
Oxygen transporters 
The canola and olive oil based diets mutually affected the expression of genes 
encoding for proteins similar to serine/threonine protein kinase ATR (LOC367198) 
and cytoglobin (Cygb) by up-regulating (p<0.05) their expression. Canola oil 
increased the expression of the Fanconi anemia, complementation group C (Fancc) 
and neuroglobin (Ngb) genes by 51.39 (p = 0.01) and 11.63 (p = 0.001) fold, 
respectively. Dynamin 2 (Dnm2) expression increased significantly (p =0.02) with 
olive oil (103.51 fold). 
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Table 4.4: Select genes expression significantly affected in the colon of carcinogen treated Fisher 344 rats by the 
experimental dietary oils relative to the control, sunflower oil only. 
Functional gene grouping and 
name 
Gene 
symbol 
SB SF SBF Canola Olive 
Fold 
change 
p-value 
Fold 
change 
p-value 
Fold 
change 
p-value 
Fold 
change 
p-value 
Fold 
change 
p-value 
ANTIOXIDANTS            
i. Glutathione peroxidases 
(GPX) 
           
Glutathione peroxidise 2 Gpx2       +32.90 0.003   
Glutathione peroxidise 4 Gpx4 +38.76 0.04 +48.39 0.03   +164.59 0.05 +185.03 0.01 
Glutathione peroxidise 5 Gpx5         +31.05 0.003 
Glutathione peroxidise 8 Gpx8         +17.07 0.01 
ii. Peroxiredoxins (TPX)            
EH-domain containing 2 Ehd2       +29.79 0.008 +25.69 0.0001 
iii. Other peroxidases            
Adenomatous polyposis coli Apc         +30.70 0.004 
Cathepsin B Ctsb         +50.56 0.02 
Eosinophil peroxidase Epx         +20.53 0.003 
Myeloperoxidase Mpo       +33.36 0.04   
Prostaglandin-endoperoxide 
synthase 2 
Ptgs2         +16.06 0.01 
Recombination activating gene 2 Rag2       +36.67 0.02   
Serine (or cysteine) peptidase 
inhibitor, clade B, member b1 
Serpinb1b       +17.11 0.03 +19.88 0.001 
Tropomodulin Tmod1       +35.10 0.04 +33.51 0.01 
Data presented is the average fold change with its respective p-value normalised to the sunflower oil treated animals (n = 3 per dietary treatment). Values are 
significant at p<0.05. + indicates up regulation; - indicates down regulation. 
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Table 4.4 (cont.) 
Functional gene grouping and name 
Gene 
symbol 
SB SF SBF Canola Olive 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
ANTIOXIDANTS            
iv. Other antioxidants            
Glutathione reductase Gsr         +21.16 0.001 
Sulfiredoxin 1 homolog (S. cerevisaie) Srxn1       +23.81 0.01 +28.31 0.03 
Thioredoxin reductase 1 Txnrd1       +67.65 0.01   
Thioredoxin reductase 2 Txnrd2         +60.97 0.04 
GENES INVOLVED IN ROS METABOLISM            
i. Genes involved in superoxide 
metabolism 
           
Neutrophil cytosolic factor 2 Ncf2       +24.82 0.03 +27.22 0.02 
ii. Oxidative stress responsive 
genes 
           
Amyotrophic lateral sclerosis 2 (juvenile) 
homolog (human) 
Als2       +43.41 0.01 +42.22 0.02 
Apolipoprotein E Apoe       +41.39 0.008 +58.62 0.0003 
Dual oxidase 1 Duox1       +36.59 0.02 +37.10 0.0003 
Excision repair cross-complementing rodent 
repair deficiency, complementary group 2 
Ercc2 -0.36 0.04         
Data presented is the average fold change with its respective p-value normalised to the sunflower oil treated animals (n = 3 per dietary treatment). Values are significant at 
p<0.05. + indicates up regulation; - indicates down regulation. 
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Table 4.4 (cont.) 
Functional gene grouping and name 
Gene 
symbol 
SB SF SBF Canola Olive 
Fold 
change 
p-value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-value 
GENES INVOLVED IN ROS METABOLISM            
ii. Oxidative stress responsive genes            
Isocitrate dehydrogenase 1 (NADP+), soluble Idh1         +43.01 0.02 
Nudix (nucleoside diphosphate linked moiety X)- 
type motif 1 
Nudt1   +45.78 0.04   +187.84 0.01   
Parkinson disease (autosomal recessive, early 
onset) 7 
Park7       +43.11 0.01 +106.89 0.004 
Protein phosphatase 1, regulatory 
(inhibitor) subunit 15b 
Ppp1r15b         +19.61 0.0007 
Peroxiredoxin 1 Prdx1       +19.79 0.03 +25.11 0.0009 
Peroxiredoxin 2 Prdx2       +55.72 0.03   
Prion protein Prnp         +111.25 0.03 
Thyroid peroxidase Tpo       +11.42 0.03 +14.69 0.001 
Xeroderma pigmentosum, complementation 
group A 
Xpa     +166.96 0.02     
OXYGEN TRANSPORTERS            
Cytoglobin Cygb       +140.06 0.05 +71.18 0.01 
Dynamin 2 Dnm2         +103.51 0.02 
Fanconi anemia, complementation group C Fancc       +51.39 0.01   
Similar to serine/threonine protein kinase ATR LOC367198       +42.32 0.01 +59.16 0.0003 
Neuroglobin Ngb       +11.63 0.001   
Data presented is the average fold change with its respective p-value normalised to the sunflower oil treated animals (n = 3 per dietary treatment). Abbreviations: NADP
+
 = oxidized 
nicotinamide dinucleotide phosphate, ATR = ataxia telangiectasia and Rad3-related. Values are significant at p<0.05. + indicates up regulation; - indicates down regulation.
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4.4 DISCUSSION 
To ensure their survival, cancer cells have adapted their cellular environment to 
enable the aberrant control of critical biochemical pathways (DeBerardinis et al., 
2008). Alterations to tissues redox balance are considered a major adaptation of 
cancer cells for their survival. Cancer cells have evolved mechanisms to protect 
themselves from intrinsic oxidative stress and have developed a sophisticated 
adaptation system that essentially involves the rearrangement of the antioxidant 
functions and up-regulation of pro-survival molecules (Bakalova et al., 2013; Fiaschi 
and Chiarugi, 2012; Gibellini et al., 2010). Studies show that diet has a significant 
effect on cells redox balance due to its supply of oxidation responsive components 
(e.g. ascorbic acid, vitamin E, polyphenols, FA) (Bouayed and Bohn, 2010; Rahman 
et al., 2006; Sies et al., 2005). Of interest is the research on dietary FA, particular the 
mono- and polyunsaturated FA families. Considerable experimental evidence 
demonstrates their beneficial protective effects against the development of cancer 
(Gerber, 1997; Llor et al., 2003; Simopoulos, 1999; Stephenson et al., 2013). Olive 
oil, best known for its protective properties against an array of pathologies, has a 
high quantity of the monounsaturated FA oleic acid (C18:1ω-9), in addition to many 
phenolic antioxidant compounds (Waterman and Lockwood, 2007). Similarly, 
eicosapentaenoic acid (C20:5ω-3) and docosahexaenoic acid (C22:6ω-3) sourced 
from fish and fish oil, as well as the high -linolenic acid (C18:3ω-3) content of 
canola oils, are known for their anti-cancer properties (Bhatia et al., 2011; Chapkin et 
al., 2008; Deschner et al., 1990; Hong et al., 2005; Lin et al., 2013; Vaughan et al., 
2013). Borage or primrose oils with high levels of -linolenic acid (C18:3ω-6) has 
also demonstrated numerous therapeutic and anticancer benefits (Horrobin, 1992). 
 
The purpose of the current study was to determine whether a varied supply of dietary 
oils, each with a defined ω-6/ω-3 FA ratio, modulates the expression of genes 
responding to oxidative stress that occurs as a result of an imbalanced redox status. 
Although an increase in ROS can lead to cell death via apoptosis or necrosis, these 
reactive molecules can also stimulate cancer cell growth by altering gene 
expression, particularly those encoding growth factors and proto-oncogenes (Klaunig 
et al., 2011). Utilizing the dietary oils mentioned above, the expression of genes 
responding to diet induced changes in the redox balance was assessed within a 
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cellular environment during the cancer promoting phase of colon tumour 
development.  
 
4.4.1 Modulation of genes expression in response to oil-induced changes to 
the redox balance 
Metabolism of the colon carcinogen DMH yields highly reactive molecules that elicit 
oxidative stress due to the imbalance of ROS and endogenous antioxidants 
(Arutiunian et al., 1997). This increase in ROS is mainly responsible for the DNA 
damaging effects of DMH in the colon (Arutiunian et al., 1997). Colon cells that have 
been genetically altered have an adapted microenvironment highly resistant to the 
potential damaging effects caused by oxidative stress, which allows for their 
selective clonal expansion into focal lesions during the promotion stage of 
development (Fiaschi and Chiarugi, 2012). External factors such as diet may either 
further promote the survival of this adapted phenotype (Erdelyi et al., 2009; Wu et 
al., 2004), or result in the delay or removal of the altered pre-neoplastic cells via 
apoptosis (Latham et al., 1999).  
 
The PUFA and MUFA constituents of dietary oils can differentially influence oxidative 
stress in biomembranes (Udilova et al., 2003; Wiseman, 1996). In liver nodules, it 
was demonstrated that an increase in lipid peroxidation (LPO), a biomarker of 
oxidative stress, with diets composed of a low ω-6/ω-3 FA ratio with a specific FA 
content, has a reducing modulating effect on cancer development (Abel et al., 2004). 
Other studies utilizing diets with an enhanced ω-3 PUFA intake show similar effects 
(Bartsch et al., 2002; Sarotra et al., 2010; Song and Miyazawa, 2001). PUFA are 
highly susceptible to damaging, free radical initiated LPO, especially when intakes of 
antioxidants, such as vitamin E, are low (Lord and Bralley, 2002). In the current 
investigation, animals’ exposures to the different dietary fat mixtures (SB, SF, SBF, 
canola and olive oils) provided increased intakes of oxidative prone PUFA, as well as 
antioxidants (i.e. TPP, C18:1ω-9). When oxidative stress occurs, cells function by 
counteracting the oxidant effect and to restore redox balance by resetting critical 
homeostatic parameters. Such cellular activity leads to activation or silencing of 
genes encoding defence enzymes, transcription factors and structural proteins 
(Scandalios, 2005). The dietary supply of redox responsive components is likely to 
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influence the oxidative status in the colon by affecting the up/down-regulation of 
selected genes related to antioxidants and oxidative stress.  
 
4.4.1.1 Antioxidant defence related genes 
Escalated rates of ROS generation are a primary component of highly proliferative 
cancer cell environments (Grek and Tew, 2010). Thus, to delay this accumulation of 
ROS and maintain a higher level of tolerance, tumour cells initiate vast up-regulation 
of multiple antioxidant systems (Mates et al., 1999). Increases in the expression of 
subtypes of the glutathione peroxidase (Gpx) family are a major indication of the 
cell’s response to oxidative stress (Toussaint et al., 1993). As a defence response 
against oxidative onslaught, the Gpx enzymes catalyse the reduction of hydrogen 
peroxide (H2O2) to water at the expense of oxidising glutathione (Brigelius-Flohé and 
Maiorino, 2013). Insufficient Gpx activity in the colon mucosal epithelium may trigger 
oxidative stress resulting in acute and chronic inflammation that is linked to cancer 
development (Chu et al., 2004).  
 
Gpx2, expressed in the epithelium of the gastrointestinal tract, is largely localised in 
the colonic crypt bases and plays a role in the continuous self-renewal and 
differentiation of intestinal cells via the Wnt pathway, thus influencing mucosal 
homeostasis (Brigelius-Flohé and Maiorino, 2013). Canola oil up-regulated the 
expression of Gpx2 in the colon mucosa of rats following cancer initiation. It has 
been suggested that this increase in expression may be a consequence of the 
constitutive activation of a proliferative state regulated by the Wnt pathway, which is 
a distinct feature in colon cancer cells (Brigelius-Flohé and Maiorino, 2013; Kipp et 
al., 2012). 
 
The expression of the gene coding for the selenocysteine protein Gpx4, was 
significantly up-regulated by the SB, SF, canola and olive oil based diets. Gpx4 plays 
an important role in the reduction of lipid membrane peroxides and protects cells 
from hydroperoxides derived from cholesterol and cholesterol esters (Imai and 
Nakagawa, 2003). Furthermore, Gpx4 mediates oxidative stress induced apoptosis 
in the colon (Fan et al., 2011), and also impacts on eicosanoids synthesis (Heirman 
et al., 2006). Olive oil eliciting an apparent hyper up-regulation of the gene suggests 
to an elevated level of oxidative stress in the tissue. This hyper up-regulated state of 
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Gpx4 has demonstrated anti-apoptotic effects in mice (Fan et al., 2011). 
Simultaneously, the significant intake of exogenous antioxidants (i.e. C18:1ω-9 and 
TPP) possibly act synergistically with this up-regulated state to re-establish redox 
homeostasis (Bouayed and Bohn, 2010). Canola oil produced a similar hyper 
response. However, here the interactive input is likely due to the intake of C18:1ω-9, 
which is also known for its antioxidant potential (Lee et al., 1998). The fish and 
borage oil containing diet (SF and SB) also elicited an up-regulated response in 
Gpx4 expression, but not to the same extent as the other two diets containing the 
reference oils. The oil mixture diets significant supply of C20:5ω-3 (SF diet) and 
C18:3ω-6 (SB diet) enhances the level of stress in the tissue due to the FA 
susceptibility to oxidative damage.  
 
Both Gpx5 and Gpx8 were up-regulated only by the olive oil diet. Gpx5 is specific to 
the mammalian epididymis, while Gpx8 is a membrane protein of the endoplasmic 
reticulum (Brigelius-Flohé and Maiorino, 2013). Up-regulation in their expression is 
indicative of oxidative stress present in the colon. Besides acting in an antioxidant 
capacity, however, their additional function in the colon is unknown.  
 
Increases in the expression of the peroxiredoxin EH-domain 2 (Ehd2), as well as 
several peroxidises was exerted by both the canola and olive oil based diets. The 
Ehd2 gene encodes for a plasma membrane associated protein that regulates 
internalisation, and plays a role in membrane reorganization and endocytic transport 
in response to nucleotide hydrolysis (Benjamin et al., 2011). Ehd2 protein mobilized 
to the nucleus functions as a transcriptional co-repressor (Pekar et al., 2012). The 
protein down-regulates the transcriptional activity of the Krüppel-like factor 7 gene 
that stimulates cyclin dependent kinase inhibitors, thus contributing to the 
proliferative state of cells (Pekar et al., 2012). Ehd2 has also been implicated as a 
tumour suppressor gene candidate mapping to a 1.6 Mb 19q region of deletion in 
glioma tumors (Smith et al., 2000). The proliferative nature of normal cells is affected 
by the level of oxidative stress generated by ROS, with low levels stimulating key cell 
surviving processes, whilst high ROS has damaging effects (Dröge, 2002). 
Transformed cells appears to adapt to increased ROS levels that promotes an 
enhanced proliferative nature (Klaunig and Kamendulis, 2004; Matés and Sánchez-
Jiménez, 2000; Schumacker, 2006). Thus a diet induced up-regulation of the anti-
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proliferative Ehd2 gene suggests towards a protective effect by the canola and olive 
oils against possible oxidative stress induced proliferation that is characteristic of 
cancer cells.  
 
Canola oil up-regulated the expression of peroxidises Mpo and Rag2, whilst olive oil 
increased Apc, Ctbs, Epx and Ptgs2 expression. Apc (adenoamtous polyposis coli) 
is a tumour suppressor gene and loss of its function leads to malignant 
transformations in the gut (Fodde, 2002). The olive oil effect resulted in an increase 
in its expression as a protective response, hereby possibly preventing the 
maintenance of damaged/altered mucosal epithelium through the activation of 
apoptosis (Morin et al., 1996). Apc also impacts on cell turnover by inhibiting COX-2 
expression (Lew et al., 2002). The lysosomal protease cathepsin B (Ctbs) functions 
in normal cellular degradation and turnover (Turk et al., 2012), regulating cell 
numbers by activating initiator caspases, thus increasing apoptosis (Vancompernolle 
et al., 1998; Wang et al., 2008). This up-regulated state is a further indication of 
oxidative stress.  
 
The eosinophil peroxidase (Epx) genes encodes a 77,000 Da, 2-subunit protein, and 
is the predominant granular protein of eosinophils, which are specialized phagocytes 
that play a beneficial role in eliminating tissue invasive agents (Acharya and 
Ackerman, 2014). Epx catalyzes the formation of cytotoxic oxidants, leading to tissue 
injury, thus adding to oxidative stress levels present in tissue. Up-regulation of Epx 
by olive oil thus may be indicative of increased oxidative stress in the colon mucosa, 
which is contrary to the oil’s reported protective effects against oxidation (Kasdallah-
Grissa et al., 2008). It is plausible to reason that the dietary supply of antioxidants in 
this case may be insufficient to stem the inherent oxidative stress in the transformed 
state during the promotion phase of development. The protective effect of olive oil 
and its bioactive components (antioxidants) is dependent on its bioavailability in 
cells/tissue, and not just dietary intake thereof (Fitó et al., 2007).  
 
Olive oil’s up-regulation of prostaglandin endoperoxide synthase (Ptgs2) expression 
could also be determined by its protective components actual concentration within 
the tissue (i.e. bioavailability). The increased expression of Ptgs2, also known as 
cyclooxygenase 2 (COX-2) has a significant function in the process of inflammation, 
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by metabolizing C20:4ω-6 into eicosanoids such as prostaglandin E2 that increases 
colon cancer risk (Hendrickse et al., 1994; Marks et al., 2000). Feeding with olive oil 
has been shown to decrease the availability of C20:4ω-6, thus reducing the potential 
for inflammation (Bartolí et al., 2000), as well as reducing oxidative stress (Moreno et 
al., 2001). However, in the current investigation the expression of Ptgs2 was up-
regulated with olive oil consumption despite only trace levels of C20:4ω 6 being 
noted. Up-regulation in this inducible enzyme’s gene may be a consequence of the 
initiated condition wherein the transformed colonic cells display enhanced 
inflammation due to the effect of the carcinogen treatment (Greenhough et al., 2009; 
Huang et al., 2015). Nevertheless, this inflammatory effect is likely counteracted by 
action of the up-regulated expression in Apc noted earlier. 
 
Myeloperoxidase (Mpo) is an abundant lysosomal enzyme produced by neutrophilic 
leucocytes, and catalyzes the formation of hypochlorous acid that is cytotoxic to 
microorganisms. The enzyme influences the initiation of LPO under conditions of 
oxidative onslaught (Zhang et al., 2002), and also contributes towards oxidative 
stress mediated apoptosis (Nakazato et al., 2007). Canola oil’s induction of Mpo 
expression suggests to a cellular environment experiencing an oxidative onslaught, 
likely due to the provision of FA C18:3ω-3, whose metabolism generates long chain 
PUFA highly susceptible to free radical attack. High levels of the enzyme are 
suggested to be a good prognosis for colorectal cancer in terms of initiating the 
removal of oxidatively damaged cells (Droeser et al., 2013). 
 
The gene products of recombination activating gene 2 (Rag2) and Rag1 are crucial 
for the rearrangement of recombining immunoglobulin and T cell molecular receptor 
genes (Kallenbach et al., 1992), thus influencing the adaptive immune response in 
cells. Studies utilizing Rag2 knockouts reveal the lack of functional immune 
responsive cells, resulting in enhanced inflammation (Erdman et al., 2009; Maggio-
Price et al., 2009), a major risk factor for the development of colon cancer. Canola 
oil’s induction of the gene possibly then infers an anti-inflammatory response.  
 
The Serpinb1b and Tmod1 genes were mutually up-regulated by the canola and 
olive oils based diets. Serpinb1b is a gene that encodes for a protein that inhibits 
neutrophil serine proteases that are important for terminating microbes (Benarafa, 
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2011). By blocking the activity of theses proteases, Serpinb1b, which is found in high 
concentrations in the cytoplasm of neutrophils, has an anti-inflammatory effect 
(Benarafa et al., 2007). Tropomodulin protein, of which there are 4 isoforms, 
regulates the organization of actin filaments (Fischer and Fowler, 2003), thus 
impacting on cell cytoskeleton structure and motility. The product of gene Tmod1 
regulates actin filament length and stability in cytoskeletal structures (Gokhin et al., 
2010).  
 
The enzyme glutathione reductase (Gsr) catalyzes the nicotinamide adenine 
dinucleotide phosphate (NADPH)-dependent reduction of glutathione disulfide 
(GSSG) to glutathione (GSH) (Dröge, 2002). In DMH induced rats, Gsr activity 
reduces significantly when compared to untreated animals (Sengottuvelan et al., 
2006). With the current study, the up-regulated expression of the antioxidant gene 
Gsr reflects a protective effect against any harmful oxidants generated by the altered 
environment in response to exposure to the olive oil diet, which likely acts in synergy 
with the diet supplied antioxidants to restore the redox balance.  
 
Sulfiredoxin (Srxn) catalyzes the energy dependent reduction of cysteine sulfinic acid 
of hyperperoxidized peroxiredoxin (Jeong et al., 2012), and also catalyzes the 
removal of glutathione from modified protein (Findlay et al., 2005). Furthermore, it 
has a functional role in protecting cells from apoptosis under low levels of H2O2 due 
to its ability to inhibit the accumulation of hyper-oxidized 2-cysteine peroxiredoxins 
by catalysing the reversal of over oxidation in these scavenging molecules (Baek et 
al., 2012; Woo et al., 2005). Hereby, the inactivation of peroxiredoxins is prevented. 
The sulfiredoxin 1 homolog gene (Srxn1), derived from yeast, was mutually up-
regulated by canola and olive oils, suggesting towards a possible enhanced 
mobilization of peroxiredoxins that actively reduce H2O2, which is toxic to cells. 
The thioredoxin system, composed of thioredoxin reductase (Txnrd), thioredoxin and 
NADPH, plays a central role in regulating cellular redox homeostasis and signalling 
pathways (Arnér and Holmgren, 2000). The Txnrd enzymes are selenium dependent 
flavoproteins with broad substrate specificity that also reduce non-disulfide 
substrates such as hydroperoxides, vitamin C or selenite (Arnér and Holmgren, 
2000). The translated product of the Txrnd1 gene, up-regulated by canola oil’s 
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exposure, is noted for its increased activity in numerous malignant tumours, and 
together with Gpx2 has been shown to have a protective effect against oxidative 
stress mediated apoptosis (Barrera et al., 2012). Similarly, increased expression of 
Txrnd2 was observed with the olive oil diet. This increase in thioredoxin activity, in 
cells with higher than normal oxidative stress levels, may relate to its essential role in 
facilitating transcription in an environment where cytosolic oxidant stress signalling is 
required for stimulation of proliferation (Schumacker, 2006). 
 
4.4.1.2 Genes involved in ROS metabolism 
Under pathological conditions, ROS are critical modulators affecting the activation of 
various signalling mechanisms that lead to the development of cancer (Clerkin et al., 
2008). The expressions of genes (Ncf2, Duox1) whose proteins form subunits of the 
NADPH oxidase complex were mutually up-regulated by both canola and olive oils. 
NADPH oxidase, produced by neutrophils, initiates the innate immune response that 
results in an inflammatory response (Gougerot-Pocidalo et al., 2002). Diet induced 
up-regulation of the neutrophil cytosolic factor 2 (Ncf2) gene, which encodes the 
protein p67phox, is mobilized to the cell membrane, where it activates the NADPH 
oxidase complex to generate NADP+ and superoxide from molecular oxygen (El-
Benna et al., 2005). Activation of the Ncf2 gene is suggested to be a significant 
factor in p53 mediated apoptosis (Italiano et al., 2012). The protein produced by 
gene dual oxidase 1 (Duox1) is another subunit of the NADPH oxidase complex, and 
generates ROS that initiate invading microbes death via phagoctosis (Grandvaux et 
al., 2007). Als2 (amyotrophic lateral sclerosis 2 homolog) protein, functions as a 
guanine nucleotide exchange factor for the small GTPase RAB5, and acts as a 
modulator for endosomal dynamics (Otomo et al., 2003). Expression of this gene 
(Als2) was up-regulated by both canola and olive oils in the current investigation. Its 
role in colon cancer development is not fully understood, since it is largely 
associated with neurodegenerative diseases (Hadano et al., 2007).  
 
Apolipoprotein E (Apoe) is a glycoprotein that functions in lipoprotein metabolism 
and cellular lipid transport (Mahley, 1988). Both the canola and olive oil diets induced 
the up-regulation of Apoe. A deficiency in the gene promotes increased oxidative 
stress (Shea et al., 2002), and has been shown to elicit an apoptotic response in 
macrophages (Elliott et al., 2008). The protein Apoe is a potent inhibitor of tumour 
 
 
 
 
| 108 
 
 
 
cell proliferation due to its competitive interaction with growth factors for binding to 
proteoglycans, as well as its anti-adhesive activity (Vogel et al., 1994). Therefore, the 
canola and olive oil diets likely have a suppressive effect on the transformed colon 
cells proliferative state, as demonstrated by other studies as well (Hardman, 2007; 
Llor et al., 2003).  
 
In humans the expression of Ercc2 generates a protein that is a subunit of TFIIH, a 
protein factor required for transcription initiation by RNA polymerase II (Schaeffer et 
al., 1994). Ercc2, also referred to as xeroderma pigmentosum complementary group 
D, is an 87 kDa ATP-dependent helicase that unwinds DNA in the 5’-3’ direction 
(Schaeffer et al., 1994). Thus, the protein has a significant influence on the process 
of genomic material replication necessary for the production of new daughter cells. 
The SB diet down-regulated the expression of Ercc2, suggesting a reduction in cell 
proliferation. Intake of the FA C18:3ω-6 was significantly higher compared to the SF, 
canola and olive oil based diets. This increase in C18:3ω-6 has been shown to have 
an anti-proliferative effect in cancer cells (Hrelia et al., 1996; Itoh et al., 2010). 
 
Isocitrate dehydrogenase (Idh) is a reversible enzyme that catalyzes the NADP+-
dependent oxidative decarboxylation of isocitrate (ICT) to -ketoglutarate (KG) and 
the NADPH/CO2-dependent reductive carboxylation of KG to ICT (Leonardi et al., 
2012). Due to the enzyme’s metabolizing effect of generating energy source 
NADPH, which is critical for detoxification processes, Idh is required for the efficient 
recycling of GSH, thus affecting cells response to oxidative stress (Lee et al., 2002). 
Olive oil resulted in the up-regulation of the Idh1 gene that also plays a role in FA 
metabolism and glucose sensing. Cells with highly over expressed Idh display 
enhanced resistance against oxidative stress, whilst with low levels, cells become 
more sensitive to oxidative damage by H2O2 (Lee et al., 2002). Mutations in genes 
Idh1 and Idh2 are prevalent in cancers (Molenaar et al., 2014; Reitman and Yan, 
2010). 
 
The protein encoded by the Nudt1 gene, nucleoside diphosphate linked moiety X-
type motif 1, hydrolyzes oxidized purine nucleoside triphosphates, such as 8-oxo-
dGTP and 2-hydroxy-dATP to monophosphates. Hence it plays a role in DNA repair 
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by preventing base misincorporation (Garre et al., 2011). Expression of the gene is 
significantly up-regulated during conditions of elevated oxidative stress (Garre et al., 
2011), as demonstrated by the current study with the SF and canola oil based diets. 
The SF diet provided a significant intake of ω-3 PUFA C20:5ω-3, and to a lesser 
extent, C22:6ω-3, that are prone to oxidation. Therefore, the SF diet likely increases 
the level of oxidative stress present in the colon tissue, as seen with other tissue 
(Song and Miyazawa, 2001). Canola oil induced a much higher response in Nudt1 
expression as a consequence of the high level of C18:3ω-3 intake, also a highly 
susceptible FA to oxidation.  
 
Park7 encodes for the protein DJ-1 that provides cells with protection against 
oxidative stress induced damage (Xu et al., 2010; Yasuda et al., 2013). Canola and 
olive oils mutual up-regulation of the gene thus indicates a protective response 
against the diet induced oxidative stress. Ppp1r15b is a gene that encodes for CReP 
(constitutive repressor of elF2 phosphorylation), which together with the protein 
GADD34 repress the phosphorylation of the translation initiation factor 2 (elF2). 
Phosphorylation of elF2 inhibits translation initiation promoting a cytoprotective 
process referred to as the integrated stress response (Harding et al., 2009). 
Ppp1r15b expression was up-regulated by olive oil, suggesting a protective effect 
against oxidative stress was activated. 
 
Peroxiredoxins are a family of thiol peroxidises that degrade H2O2 to water. 
Furthermore, oxidation of these enzymes indicates towards a disturbance in redox 
homeostasis (Poynton and Hampton, 2014). The expression of peroxiredoxin Prdx1 
was mutually up-regulated by the canola and olive oils based diets, whilst the 
expression of Prdx2 only increased with canola oil. Both enzymes are located in the 
cytosol. The enzyme produced by Prdx1 appears to play a role in cell death as 
knockouts of the gene results in the activation of apoptosis signal-regulating kinase 1 
(ASK1) in response to H2O2 (Kim et al., 2008). Enzyme Prdx 2 has been 
demonstrated to contribute towards cell growth in colon cancer cells by influencing 
the Wnt/-catenin signalling pathway, with its absence inhibiting the process (Lu et 
al., 2014). 
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The prion protein (gene Prnp) acts as a free radical scavenger and/or sensor 
molecule for oxidative stress in tumour cells, thus contributing towards the 
antioxidant defence (Sauer et al., 2003). Up-regulation in the gene’s expression by 
olive oil indicates that protection against oxidative stress is initiated. Thyroid 
peroxidase (Tpo) is mainly responsible for the synthesis of hormones in the thyroid 
gland, and belongs to the NADPH oxidase family that function in the immune 
response (Ruf and Carayon, 2006). Tpo requires H2O2 to initiate hormone synthesis 
(De Deken et al., 2002). Therefore, up-regulation of the gene Tpo by canola and 
olive oils indicate toward increased oxidative stress levels likely due to the presence 
of H2O2. 
 
Xeroderma pigmentosum, complementary group A protein has a critical function in 
the nucleotide excision repair process (Pascucci et al., 2011). Cells that are deficient 
in this protein have abnormal responses to oxidative DNA damaging agents such as 
increased H2O2 genotoxicity, a lower threshold for H2O2-induced cell cycle arrest, 
and reduced repair of H2O2 generated DNA lesions (Low et al., 2008). Up-regulation 
in the expression of gene Xpa by the SBF diet suggest DNA repair is being initiated 
in response to oxidative damage to nucleotide bases. The supply of FA (C20:4ω-6, 
C20:5ω-3 and C22:6ω-3) from the combination of borage and fish oil increases the 
possibility of oxidative stress and its damaging effects on macromolecules such as 
DNA. Hence repair mechanisms (i.e. Xpa up-regulation) are activated. 
 
4.4.1.3 Oxygen transporters  
The expression of five genes (Cygb, Dnm2, Fancc, LOC367198, Ngb) involved in 
oxygen transport was significantly up-regulated by the canola and olive oil diets. 
Cytoglobin (Cygb) is ubiquitously expressed in all vertebrates and is considered a 
hypoxia responsive molecule due to its mRNA expression being augumented under 
hypoxia seen in fibroblast cell lineages and rat brain (Li et al., 2006). In addition, 
Cygb displays tumour suppressor gene function (Shivapurkar et al., 2008). This gene 
was mutually up-regulated by canola and olive oil, suggesting hypoxic conditions 
was present in the tissue. Another globin gene, neuroglobin (Ngb), was up-regulated 
by canola oil. Neuroglobin acts as a scavenger of ROS (Ascenzi et al., 2004), thus 
likely protects against diet induced oxidative stress. 
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The protein dynamin 2 functions in membrane remodelling and endocytosis (Kasai et 
al., 1999; Shpetner and Vallee, 1989). Also, the protein can function as an upstream 
regulator of p53-dependent apoptosis in dividing cells (Fish et al., 2000). Olive oil’s 
up-regulation of the gene Dnm2 expression may therefore be mobilized for the 
induction of the p53 mediated apoptotic pathway in response to oxidative stress 
(Johnson et al., 1996). The Fancc gene encodes the protein fanconi anaemia, 
complementary group C that acts as an intracellular antioxidant (Kruyt et al., 1998). 
In addition, it participates in redox signalling and repair of oxidative DNA damages 
(Zunino et al., 2001). Therefore, oxidative stress induced by canola oil likely resulted 
in the up-regulation of Fancc expression. Proteins ataxia telangiectasia and Rad3-
related (ATR), encoded by the gene LOC367198, plays an essential role in the 
maintenance of genome integrity (Shiloh, 2003), being activated in response to DNA 
damage (Helt et al., 2005). Therefore, up-regulation of the gene may be a 
consequence of the diet (canola and olive oils) induced oxidative stress injury. This 
process has been shown to activate p53, an important regulator of apoptosis (Das 
and Dashnamoorthy, 2004). Interestingly, as noted previously, it appears that the 
anticancer effects of the dietary oils is likely determined by the level of oxidative 
stress within the transformed cells, which serves as an important deciding factor for 
the cellular responses elicited. 
 
4.5 SUMMARY AND CONCLUSIONS 
Under the current study’s experimental conditions, modulation of redox responsive 
genes expression was dominated by canola and olive oils influence, with the dietary 
oil mixtures (SB, SF and SBF) having minimal effects. Exposure to the latter 
experimental dietary fats appears to induce some protection against oxidative 
damage by up-regulating antioxidant defence (Gpx4 – SB and SF) and DNA repair 
(Nudt1 – SF; Xpa – SBF). In addition, an anti-proliferative response was induced by 
the SB oil diet as indicated with the down regulation of Ercc2 expression that 
reduces the occurrence of DNA replication. These responses suggest that these oil 
mixtures bioactive components, particularly its FA supply, marginally stimulate 
mechanisms that alter the oxidative status of the cells, likely by increasing LPO, 
which affects cell survival. Of interest, in a previous study, the oil mixtures (SF and 
SBF) increased membranes incorporation of long chain ω-3 FA, C20:5ω-3 and 
C22:6ωFA in rat colon mucosa that was associated with an increased LPO 
 
 
 
 
| 112 
 
 
 
(Abrahams, 2009). This effect significantly enhanced oxidative stress in the mucosa 
due to an increase in LPO in the colon, known to affect cell survival indices (Barrera 
et al., 2008). 
 
The effects of the canola and olive oil based diets during the post-initiation phase in 
the colon, provide evidence of an anti-cancer response and hence their 
chemopreventive properties. These included mechanisms involving the regulation of 
important genes associated with oxidative stress and antioxidant defence. The 
modulation of a subset of these genes are important in mediating cell proliferation 
and apoptotic pathways, two critical processes affected during carcinogenesis 
(summarised in Fig. 4.4). 
 
 
Figure 4.4: Summary of possible anticancer properties of canola and olive oils resulting from the up-
regulation (+) of redox sensitive genes expression. Canola oil induced effects on gene expressions 
are underlined; olive oil in bold. 
 
The anticancer effects of canola and olive oils are likely related to its FA 
constituents, as well as dietary antioxidants (polyphenolic) content. A study in 
epithelial oesophageal cancer cells has shown that C18:3ω-3 and C18:1ω-9, found 
in high quantities in canola oil, can suppress cell proliferation (Moon et al., 2014). 
Furthermore, although fairly low relative to the other experimental diets TTP content, 
canola oil’s phenolic constituents has also demonstrated anti-proliferative effects by 
reducing the potential of PGE2 induced cell division by down-regulating COX-2 
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expression (Jiang et al., 2013). Apart from its rich C18:1ω-9 content, olive oil’s 
bioactive polyphenols may also induce anti-proliferative and apoptotic effects in 
colon cancer cells (Corona et al., 2007; Notarnicola et al., 2011). These results, 
together with the present study’s diet induced redox modulation of regulatory 
mechanisms illustrate the benefits of utilizing canola and olive oils as a 
chemopreventive measure against the development of colon cancer. 
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CHAPTER 5 
ALTERATIONS IN MEMBRANE FATTY ACID PROFILE BY DIETARY 
FAT EMULSIONS AND THE EFFECT ON SURVIVAL INDICES OF 
HUMAN COLON CANCER CELLS IN VITRO 
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ABSTRACT 
The growth and survival of cancer cells can be affected by fatty acid (FA) mediators that participate in 
cell regulatory mechanisms. ω-3 FA obtained from dietary sources such as fish oil has demonstrated 
numerous anti-cancer effects, whilst certain ω-6 FA appears to enhance neoplastic developments. 
Studies suggest that manipulating the dietary ω-6/ω-3 FA ratio may be a critical factor in determining 
cancer cell survival. This study evaluated the effects of different oil emulsions (sunflower oil: S, S + 
borage oil: SB, S + fish oil: SF and SBF) each with a distinct FA composition and ω-6/ω-3 FA ratio (S 
= 249:1; SB = 28:1; SF = 12:1 and SBF = 12:1) on cell viability (ATP production) and the proliferative 
state of HT-29 and Caco-2 human colon cancer cells. Changes in lipid content and the level of FA 
incorporation associated with apoptotic cell death indices were also characterised. Results show that 
the two colon cancer cell lines exhibited differential sensitivity towards the effects of the FA supplied 
and incorporated into membranes. Fish oil containing emulsions (SF and SBF) reduced (p<0.05) the 
HT-29 cells energy status (ATP production) and proliferative (BrdU incorporation) ability, but were 
resistant to the induction of apoptosis. The Caco-2 cells were less susceptible with respect to the 
reduction in cell viability, however, apoptosis was increased (p<0.05) by the S, SF and SBF emulsions 
in a dose dependent manner. At the highest concentration, ATP-dependent apoptosis was decreased, 
which was associated with a significant (p<0.05) decrease in cell viability. The induction of apoptosis 
in Caco-2 cells was associated with specific changes in membrane lipid and FA composition effected 
by the different oil emulsions. A decrease (p<0.05) in total membrane SATS and MUFA as well as the 
membrane ω-6/ω-3 FA ratio, resulted from an increased C20:5ω-3 and C22:6ω-3 content in the 
phospholipid phosphatidyethanolamine (PE) that appears to selectively favour the induction of 
apoptosis by borage oil (SB and SBF). Similarly, an increase (p<0.05) in the PC/PE ratio by the all oil 
emulsions, and a decrease (S and SB) and increase (SF and SBF) (p<0.05) in the chol/PL ratio 
appears to facilitate apoptosis. A different threshold of the FA and lipid composition parameters elicits 
the inhibition of cell proliferation utilising lower oil emulsion concentrations. Therefore, the dietary 
supply of fats characterised by a defined low ω-6/ω-3 FA ratio can selectively modulate the growth 
indices of cancer. Specific oil ratio combinations by incorporating borage oil and fish oil, provides a 
selective strategy for chemoprevention in the colon. 
 
Key words: colon cancer, oil emulsions, fatty acids, membranes lipid parameters, cell survival indices 
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5.1 INTRODUCTION 
Colon cancer accounts for one of the top 3 causes of cancer related deaths in 
developed countries (Ferlay et al., 2015). Numerous epidemiological studies suggest 
that diet plays a significant role in the development of the disease, particular 
regarding fat intake (Arem et al., 2013; Bruce et al., 2000; Dixon et al., 2004; 
Giovannucci and Goldin, 1997; Slattery et al., 1998). Investigations reveal that 
demographically the incidence of colon cancer is greatly reduced in regions where 
dietary patterns are characterized by low fat intakes with unique dietary 
compositions. This fact is evident in regions consuming a Mediterranean based diet, 
which is composed of high intakes of olive oil rich in beneficial phenolic and  
monounsaturated fatty acid (MUFA), oleic acid (C18:1ω-9), content (Cicerale et al., 
2010; Escrich et al., 2007; La Lastra et al., 2001; Trichopoulou et al., 2000). 
However, with most Western diets the intake of saturated fatty acids (SATS) and ω-6 
polyunsaturated fatty acids (PUFA) are very high relative to low ω-3 PUFA 
consumption (Simopoulos, 1999). This high ω-6 and low ω-3 fatty acid (FA) intake, 
resulting in a high ω-6/ω-3 FA ratio, has been shown to be positively associated with 
cellular mechanisms sustaining the survival of cancer cells (Bartsch et al., 1999; 
Williams et al., 2011).  
 
PUFA are important macromolecules required by cells to regulate their membrane 
structure and associated metabolic functions. These macromolecules are critical 
components of cell membrane phospholipids, affecting cell structure and membrane 
fluidity (Ibarguren et al., 2014). In addition, PUFA participate in cellular homeostatic 
regulation by influencing signalling cascades, gene expressions and cellular 
oxidative status (Alexander-North et al., 1994; Jump, 2004; Sumida et al., 1993). 
Unlike endogenously synthesized SATS and MUFA, the cells PUFA supply are 
largely dependent on dietary intake since mammals cannot synthesize the parent 
essential fatty acids (FA) linoleic acid (C18:2ω-6) and -linolenic acid (C18:3ω-3). 
Obtained mainly in the triglyceride form from plants and dietary oils, these parent 
precursors are digested and absorbed by intestinal cells to where they can be 
metabolized into longer carbon chain and more bioactive, functional molecules 
(Beguin et al., 2013; Iqbal and Hussain, 2009). The cellular responses elicited by 
long chain (LC) ω-6 PUFA arachidonic acid (C20:4ω-6) and ω-3 PUFA 
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eicosapentaenoic acid (C20:5ω-3) and docosahexaenoic acid (C22:6ω-3) appears to 
vary in numerous cancer cell studies due to different cell types and function 
(Dommels et al., 2002; Nano et al., 2003; Di Nunzio et al., 2011). Of particular 
importance are C20:5ω-3 and C22:6ω-3, sourced mainly from fish and fish oils, 
which have demonstrated anticancer effects by retarding the growth of malignant 
cells via inhibiting cell proliferation which could lead to the induction of apoptosis 
(Bégin et al., 1986; Chamras et al., 2002; Giros et al., 2009; Hawkins et al., 1999). In 
contrast, C20:4ω-6 derived from the metabolism of C18:2ω-6, which is obtained 
mainly from vegetable oils, appears to favour cancer cells survival (Cabral et al., 
2013; Whelan and McEntee, 2004). However, γ-linolenic acid (C18:3ω-6), a product 
of Δ6-desaturase metabolism of C18:2ω-6, has also exhibited anticancer effects by 
effectively blocking cell proliferation in cancer cells, as well as by causing cell death 
by inducing apoptosis (Hrelia et al., 1996; Kong et al., 2006) 
 
Most of the effects mentioned above, however, are the result of isolated exposure to 
individual PUFA. Dietary intake of PUFA is complex due to interaction with 
endogenous synthesis and competitive interaction of ω-6 and ω-3 FA. Consequently, 
their resultant differential reactions may potentially have a significant impact on 
disease progress. In a previous investigation, it has been demonstrated that 
interaction of specific dietary ω-6 and ω-3 PUFA can impact significantly on FA 
associated cellular characteristics (Abrahams, 2009). It was shown that a reduced 
dietary ω-6/ω-3 FA ratio intake resulted in the selective incorporation of LC ω-3, 
which altered the lipid and FA composition of colon mucosa. Hereby the level of 
oxidative stress in the colon was enhanced due to an increase in lipid peroxidation. 
Therefore, it has been suggested that by manipulating the type of PUFA consumed 
the incidence of disease development can be modulated (Simopoulos, 2008). The 
objective of this investigation was to evaluate the effect of dietary oils with varying ω-
6/ω-3 FA ratios on the survival of colon cancer cells by monitoring cell viability, cell 
proliferation and apoptosis. The level of FA incorporation in cellular membrane and 
associated lipid changes was also assessed to confirm PUFA uptake and their role 
in the modulation of cell growth indices. 
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5.2 MATERIALS AND METHODS 
5.2.1 Chemicals and reagents 
Culture media McCoy’s 5A was purchased from Sigma-Aldrich, Germany. Eagle’s 
Minimal Essential medium, fetal bovine serum (FBS), L-glutamine, sodium pyruvate 
and non-essential amino acids were supplied by Whitehead Scientific (South Africa). 
L-alpha phosphatidylcholine from eggs yolks, butylated hydroxytoluene (BHT), 2,5-
bis-(5’-tert-butylbenz-oxazolyl-[2’])thiopene (BBOT), sodium chloride, staurosporine, 
bovine serum albumin (BSA), perchloric acid and all organic solvents (chloroform, 
methanol, hexane) was purchased from Sigma-Aldrich. Silica thin layer 
chromatography plates, acetic acid, boric acid, sulphuric acid and diethyl ether was 
obtained from Merck. Petroleum ether was supplied by Fluka (Germany) and 
peroxide free Triton-X100 by Roche Applied Science (Randburg, South Africa) 
 
5.2.2 Preparation of oil emulsions 
Oils utilized for the cell culture experiments were as follows: sunflower oil only (S), 
sunflower + borage oil (SB), sunflower + fish oil (SF) and sunflower + borage + fish 
oil (SBF). Oil in water emulsions, constituting various ω-6/ω-3 FA ratios, was 
prepared by the method adapted from Fox and DiCorleto (1988). Briefly, the 
respective oils (0.1-1.0 grams) were dissolved in chloroform to which 5% (wt/wt) L-
alpha phosphatidylcholine from eggs yolks and 0.03% (wt/wt) butylated 
hydroxytoluene (BHT = antioxidant) was added. The solvents were dried under 
vacuum for 15 minutes, with intermittent washes with a few drops of diethyl ether. 
Samples were then further dried under a nitrogen gas stream for 5-10 minutes, and 
resuspended in phosphate-buffered saline (PBS) to a lipid concentration of 15 
mg/ml. The lipid content was emulsified by sonication for 10 minutes in a water bath 
sonicator at 37 C. Samples were filter sterilized and diluted with culture media as 
required.  
 
5.2.3 Cell culture maintenance and oil emulsion treatments 
The human colon adenocarcinoma cell line HT-29 (ATCC, Rockville, MD, USA) was 
maintained in McCoy’s 5A medium supplemented with 10% fetal bovine serum 
(FBS) and 1% L-glutamine. Caco-2 human colon adenocarcinoma cells (ATCC, 
Rockville, MD, USA) were maintained in Eagles’ minimal essential medium (EMEM) 
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supplemented with FBS (10%), L-glutamine (1%), sodium pyruvate (1%) and non-
essential amino acids (1%). Incubation parameters were set at 5% CO2/95% O2 for 
both epithelial cancer cell lines. Cells were sub-cultured every 2-3 days at 80% cell 
confluence. For all 96-well microtitre plate experimentations, cells were seeded at 
densities 10 000 cells/well (HT-29 cells, passages 151-158) and 5000 cells/well 
(Caco-2 cells, passages 53-62). The colon cancer cell lines were exposed to oil 
emulsions for 48 hours ranging from 0-12.5 mg/ml by dilution in 0.5% FBS culture 
media to the exact concentrations required. 
 
5.2.4 Cell viability  
The cell viability of the colon cancer cell lines were assessed by quantifying ATP 
production as an indication of metabolically active cells. Cells seeded in opaque 
white 96-well microtitre plate (HT-29 = 10 000 cells/well; Caco-2 cells = 5000 
cells/well) were incubated with the oil emulsions (0-10 mg/ml) for 48 hours. 
Thereafter cell cultures were removed from the incubator and cells were equilibrated 
to RT for 30 minutes. Utilizing a luminescent assay kit for ATP content quantification 
(CellTitre-Glo, Promega, Madison, WI, USA), 100 μl of the CellTitre-Glo reagent was 
added in equal volumes to each well (i.e. 1: 1; cell media:reagent). Samples were 
mixed on a plate shaker for 2 minutes to induce cell lysis and to stabilize the 
luminescent signal, the plates were incubated at RT for 10 minutes. The luminescent 
signal was recorded on a Veritas microplate luminometer (Turner Biosystems, 
Sunnyvale, CA, USA). Data was quantified as a percentage of viable cells relative to 
the control (i.e. 0 mg/ml oil emulsion) representing 100% ATP production. From this 
data the inhibitory concentration at 50% ATP production or viability (IC50) was also 
calculated for each oil emulsion and cancer cell line. 
 
5.2.5 Cell proliferation  
Cell proliferation was quantified based on the measurement of 5-bromodeoxyuridine 
(BrdU) incorporation during DNA synthesis in dividing cells utilizing a 
chemiluminescent ELISA assay (Roche Applied Sciences, Randburg, SA). The 
cancer cell lines (HT-29 = 10 000 cells/well; Caco-2 cells = 5000 cells/well) were 
seeded in 100 µl media in opaque 96-well microtitre plates and after a 48 hour 
incubation with the oil emulsions (0-7 mg/ml), the plates were processed according 
to manufacturer’s specifications. Briefly, 10 μl Brdu labelling solution (i.e. diluted in 
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0.5% culture media – 1:100; BrdU labelling solution: 0.5% culture media) was added 
to every 100 μl cells, and incubated at 37 C for 2 hours. The labelling solution and 
cell media was removed by vacuum suction and cells were fixed with 200 ul 
FixDenat solution per well, and incubated at RT for 30 minutes. The FixDenat 
solution was removed by vacuum suction, and a working solution of 100 μl anti-
BrdU-POD (i.e. POD = monoclonal antibody from mouse-mouse hybrid cells 
conjugated with peroxidase) was added per well. Plates were incubated at RT for 90 
minutes. The antibody conjugate was removed and cells were washed in 200 μl 
washing buffer solution for 5 minutes. This step was repeated twice more. The 
washing buffer was discarded and 100 μl substrate solution added per well. 
Microtitre plates were incubated at RT on a plate shaker for 3 minutes. The 
chemiluminescent signal was quantified within 10 minutes after adding the substrate 
solution on a Veritas microplate luminometer. The response was quantified as a 
percentage of BrdU incorporating (proliferating) cells relative to the control (i.e. 0 
mg/ml oil emulsion) representing 100% cell proliferation. The inhibitory concentration 
at 50% BrdU incorporation (IC50) was determined for each oil emulsion and cancer 
cell line from the aforementioned response profile. 
 
5.2.6 Cell cytotoxicity 
The potential cytotoxic effects of the oil emulsions were evaluated by determining 
cellular release of lactose dehydrogenase (LDH). After 48 hours exposure to the oil 
emulsions (0-12.5 mg/ml), a volume of cell culture supernatant (25 μl) representative 
of spontaneous/experimental LDH release, was transferred to clean 96-well plates. 
To the original translucent microtitre plates, 15 μl of 5% Triton-X100 (1% in media) 
was added to each well, and shaken for 3 minutes. Plates containing the remaining 
cell lysates were frozen at -20 C for 30 minutes and thawed on a 37 C heating 
block. This step was repeated twice to ensure total LDH release. Plates were then 
spun at 250 g for 5 minutes at 4 C. A volume (25 μl) of total cell lysates representing 
total LDH release was transferred to clean wells. The kit provided LDH substrate 
(Cytotox96-non radioactive cytotoxicity assay, Promega, Madison, WI, USA) was 
added to the wells containing the spontaneous/experimental and total LDH release 
lysates (i.e. Total volume/well = 50 μl), and incubated at room temperature (RT), 
protected from light, for 30 minutes. To impede further reaction, 25 μl stop solution 
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was added per well. The LDH activity was measured spectrophotometrically at 340 
nm on a plate reader (Synergy Mx, BioTek). The proportion of LDH release (i.e. 
necrotic cell death) induced by the oil emulsions, relative to the totals, was 
expressed as a percentage of the viable cells present. 
 
5.2.7 Apoptosis 
The effect of cell exposure to the oil emulsions on induction of cell death via 
apoptosis was evaluated with the luminescent Caspase-Glo 3/7 assay (Promega, 
Madison, WI, USA). Both colon cancer cell lines were seeded in 96-well microtitre 
plates and exposed to a gradient concentration of oil emulsions (HT-29 = 0-12.5 
mg/ml and Caco-2 = 0-11.5 mg/ml) for 48 hours. Staurosporine (100 nM) was used 
as a positive stimulator of apoptosis. A concurrent run for ATP production was 
included in the investigation due to the process of cell death’s known requirement for 
energy (Zamaraeva et al., 2005). Post the incubatory period, 20 μl of the cell 
suspension was transferred to clean opaque white 96-well microtitre plates. A 
volume of the kit supplied reagent (20 μl) was added to each well. Mix the contents 
of the wells on a plate shaker for 30 seconds, and incubate at RT for 30 minutes. 
Plates were read on a luminometer to measure the luminescent signal generated by 
the cells reactions. Cell death via apoptosis was quantified calculating the treated 
colon cancer cell lines fold change in caspase 3/7 activities relative to the control (0 
mg/ml oil emulsion) set at 1. 
 
5.2.8 Fatty acid incorporation 
The Caco-2 cells were selected for treatment with the 4 oil emulsions and 
subsequent FA analysis due to its susceptibility to apoptosis. Cells were seeded at 
8.6x105 per 100 mm petri dish and maintained in 10% FBS supplemented EMEM 
culture media overnight. Media was discarded and replaced with 0.5% FBS 
supplemented EMEM containing the respective oil emulsions at concentrations 
inducing apoptosis and incubated for 48 hours. The FA profiles of the oil mixtures 
used to make the emulsions were assessed by gas chromatography (Table 5.1) as 
described in Chapter 3 (section 3.2.2). 
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Table 5.1: Fatty acid profile of oil-in-water emulsions expressed as a   
percentage of total content. 
Fatty acid 
Oil-in-water emulsions (% of total fatty acids) 
S SB SF SBF 
C16:0 6.680.18 7.470.15 6.220.03 6.800.41 
C18:0 4.450.07 4.900.01 5.870.01 4.530.01 
Total SATS 12.530.37 13.660.39 13.630.28 12.560.55 
     
C18:1ω-9 25.170.50 19.720.05 18.850.61 18.830.08 
Total MUFA 25.500.55 22.450.13 19.230.71 20.670.50 
     
C18:3ω-3 0.250.01 1.270.01 0.130.05 1.190.25 
C20:5ω-3 <0.01 <0.01 4.400.24 3.520.12 
C22:5ω-3 <0.01 0.330.04 <0.01 0.160.01 
C22:6ω-3 <0.01 <0.01 0.530.18 0.490.10 
Total ω-3 PUFA 0.250.01 2.210.05 5.060.47 5.360.48 
     
C18:2ω-6 62.250.76 54.630.25 61.250.14 54.283.31 
C18:3ω-6 <0.01 6.700.08 <0.01 5.970.41 
C20:3ω-6 <0.01 <0.01 <0.01 <0.01 
C20:4ω-6 <0.01 <0.01 0.220.01 0.180.02 
Total ω-6 PUFA 62.310.77 61.940.37 61.730.17 61.844.77 
     
ω-6/ω-3 ratio 249.241.64 28.037.40 12.200.36 11.541.24 
Total PUFA 62.560.78 64.150.42 66.790.64 67.205.25 
Values represent the mean standard deviation of the water-in-oil emulsions fatty acids profile 
expressed as a percentage of total content (N = 2/treatment group). Dietary oils: S = sunflower oil 
only, SB = sunflower oil + borage oil; SF = sunflower oil + fish oil; SBF = sunflower oil + borage oil + 
fish oil. SATS = saturated fatty acids, MUFA = monounsaturated, PUFA = polyunsaturated fatty acids. 
 
5.2.8.1 Cell harvesting 
After 48 hours of emulsion treatment, the culture media was discarded and cells 
washed three times with ice cold saline (0.9% NaCl). Petri dishes (i.e. 2 plates 
combined representing one sample; 5 samples in total/oil emulsion) were pooled and 
cell suspensions harvested in saline, and centrifuged at 500 rpm for 10 minutes. 
Supernatants were discarded and the pellets were suspended with 1.1 ml saline. An 
aliquot (100 μl) was removed and stored at -20 for protein determination, and the 
remaining cell suspension (1 ml) was used for lipid extraction. 
 
5.2.8.2 Lipid extraction 
Lipids were extracted from the 1 ml saline cell suspension with chloroform:methanol 
(CM; 2:1 v/v) containing 0.01% BHT according to the method of Folch et al. (1957), 
with the cell suspension:CM ratio of 20:1. The solvent and saline cell mixture was 
shaken for 30 minutes, where after saline saturated with chloroform/methanol/saline 
(CMS, 86:14:1, v/v/v, 0.01% BHT) was added, vortexed (1 minute) and then 
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centrifuged at 500 rpm for 15 minutes. The bottom chloroform rich layer containing 
the lipids was removed and transferred into a round bottom flask. This extraction 
step was repeated twice by adding CMS (10 ml) to the initial extraction sample. The 
collected chloroform rich extracts were evaporated and dried under vacuum utilizing 
a rota-vapour set at 40 C. The dried lipid residues were transferred quantitatively 
into glass tubes with 5 x 2 ml CMS. Saline saturated CMS (1 ml) was added to the 
samples, vortexed and then centrifuged at 500 rpm for 15minutes. The top aqueous 
layer was removed, and the solvent lipid extracts stored at 4 C under nitrogen gas 
until further processed. 
 
5.2.8.3 Thin layer chromatography 
The lipid extracts from above were fractionated by thin layer chromatography (TLC) 
according to the method of Gilfillan et al (1983). Briefly, the lipid extract were dried at 
40 C under nitrogen gas, resuspended in 100 μl CMS and aliquot (i.e. 30 μl per 
sample) was applied on silica TLC (10 x 20 mm) plates to separate the major 
phospholipid classes. The plates were developed for 90 minutes using the running 
solvent chloroform: methanol: petroleum ether: acetic acid: boric acid 
(40:20:30:10:1.8; v/v/v/v/wt) containing the fluorescent agent 2, 5-bis-(5’-tert-
butylbenz-oxazolyl-[2’])thiopene (BBOT). Plates were dried under nitrogen gas and 
the major phospholipid fractions (phosphatidylcholine, PC and 
phosphatidylethanolamine, PE) were visualized under ultra violet light by 
identification against a standard mixture of known phospholipids. 
 
5.2.8.4 Fatty acid analysis 
For FA analysis the phospholipid fractions, PC and PE, were scraped off the TLC 
plates and transmethylated with 2 ml methanol/18 M sulphuric acid (95:5; v/v) at 70 
C for 2 hours (Smuts et al., 1994), and the resultant FA methyl esters (FAME) 
extracted with hexane (2 ml) and distilled water (1 ml). The hexane (top layer) was 
removed and dried under nitrogen gas in a 37 C water bath, and the samples 
dissolved in hexane (PC = 20 μl; PE = 10 μl) of which 1 μl  was injected into a gas 
chromatograp (GC). The FAME were analysed by a dual FID channel GC (Thermo 
Scientific Trace GC Ultra, SGE Analytical Science) equipped with two 30 metre 
column of 0.32 mm in diameter and a 0.25 μm film (BPX-70, SGE). Hydrogen was 
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used as the carrier gas. Individual FAME was identified by comparison of the 
retention times to those of a FA standard mixture containing C14:0 to C24:1 (Nu-
Check-Prep, MN, USA). Results for individual FA were quantified using an internal 
standard (C17:0) and expressed both quantitatively (i.e. μg FA/mg protein) and 
qualitatively as a percentage of the total FA. 
 
5.2.8.5 Phospholipid determination 
The inorganic phosphate content of the phospholipid fractions, PC and PE, were 
determined colorimetrically using the malachite green phosphate detection kit (R&D 
Systems). Briefly, PC and PE fractions were separated by TLC (see above), and 
digested in perchloric acid (i.e. PC = 400 µl and PE = 300 µl) on a 170 C heating 
block for 2 hours. After digestion, 6 N potassium hydroxide (PC = 775 µl and PE = 
581 µl) and distilled water (PC = 2 ml and PE = 1.5 ml, 5:1 v/v, water:perchloric 
acid). Samples were vortexed and centrifuged at 1000 rpm for 15 minutes, and 80 µl 
of the samples were aliquoted to translucent 96-well microtitre plates in duplicate. A 
volume of kit reagent A (10 µl) was added to each sample well, mixed and incubated 
at RT for 10 minutes. Thereafter, reagent B (10 µl) was added and mixed with the 
samples, and left at RT for a further 20 minutes. Thereafter, colour development was 
measured at 620 nm on a plate reader (Synergy Mx, BioTek), and samples were 
quantified against a phosphate standard curve. 
 
5.2.8.6 Cholesterol determination 
The cholesterol content of Caco-2 cells was determined by an enzymatic iodide 
method using cholesterin-oxidase and cholesterin-esterase (Richmond, 1973). 
Briefly, 20 µl of the lipid extract in a glass tube (5.2.8.2) was dried under a nitrogen 
gas stream in a 37 C water bath. CM (20 µl) was added to the sample, tubes 
vortexed and then placed on a 50 C heating block for 30 minutes. Thereafter, 50 µl 
of 1% Triton-X100 (peroxide-free) solution was added, vortexed and centrifuged at 
1000 rpm for 1 minute. Aliquots of 20 µl per sample were removed and transferred to 
a translucent UV-grade 96-well microtitre plate in duplicate. Cholesterol reagent (108 
µl) and cholesterol enzyme (20 µl) was added to each sample and incubated at RT 
for 30 minutes. Sample absorbencies were measured at 365 nm in a plate reader 
(Synergy Mx, BioTek) and quantified against a cholesterol standard curve. 
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5.2.8.7 Protein determination 
The 100 μl aliquots removed from the cell suspensions prior to lipid extraction and 
reserved for protein analysis were centrifuged at 2500 x g for 10 minutes. The 
supernatants were discarded and the resultant pellets resuspended with 100 μl M-
PER mammalian protein extraction reagent (Thermoscientific, Rockford, Illinois, 
USA). Samples were agitated gently for 10 minutes at 37 C, and then centrifuged at 
14 000 x g for 15 minutes to remove all cell debris. Sample supernatants were used 
for analysis. The protein content of the supernatants was assessed in 96-well 
microtitre plates using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules 
CA, USA). A stock solution of bovine serum albumin (BSA; 1.44 mg/ml) was 
prepared in PBS to obtain a standard series in the final reaction volume. PBS was 
used as a blank control. Aliquots of the sample/blank/standards (5 μl/well) were 
added to translucent 96-well microtitre plates and a volume of the assay reagent A 
(25 μl) and reagent B (200 µl) was added to each well. Plates were covered and 
mixed on a plate shaker for 1 minute at medium speed, and further incubated at 
room temperature for 15 minutes. Sample/blank/standards absorbencies were 
measured spectrophotometrically at 630 nm on a plate reader (Synergy Mx, BioTek) 
and quantified against the BSA standard curve and expressed in mg/ml protein. 
 
5.2.9 Statistical analyses 
One way analysis of variance (1-ANOVA) was performed on all the variables to 
compare all group means (i.e. control, S, SB, SF and SBF). A post hoc Tukey-
Kramer multiple comparisons test determined the significant differences between the 
means. Where applicable, main effects by the individual oils (FISH/BORAGE) were 
performed using pooled data, followed by 2-ANOVA if the initial analysis indicated 
significant interactive effects. Significant effects were determined using the NCSS 
Statistical analysis package (NCSS 9 Statistical software, Kaysville, Utah, USA). 
Statistical significant values were considered at p<0.05 and p<0.0001.  
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5.3 RESULTS 
5.3.1 Modulation of cell viability (ATP production) 
The ATP production of the 2 colon cancer cell lines were monitored as an indicator 
of metabolically active cells. The inhibitory oil emulsion concentrations required to 
produce 50% inhibition (IC50) were determined (Table 5.2). Distinct differences were 
noted when comparing the IC50’s between the HT-29 and Caco-2 cells. The fish oil 
emulsions significantly (p<0.0001) reduced cell viability (main effect) in HT-29 cells, 
whilst borage oil had a lesser reducing effect (p<0.05). Significant interactions 
indicated that fish oil containing emulsions (SF and SBF) significantly reduced 
(p<0.05) cell viability with the SBF emulsion exhibiting the highest effect. In the 
Caco-2 cells, however, both the borage oil and fish oil emulsions (SB, SF and SBF) 
reduced (P<0.05) cell viability when considering the main effects (Table 5.2). 
Significant interactions indicated that the S emulsion was the least active in inhibiting 
Caco-2 cell viability relative to SB, whilst the SBF emulsions was the most (p<0.05) 
effective.  
 
Table 5.2: Oil emulsion concentrations in mg/ml required to produce 50% cell 
activity (IC 50) as indicated by ATP release and BrdU incorporation in the 
colon cancer cells after 48 hour exposure. 
Cancer 
 cell line 
Assay 
Oil emulsions (IC50 – mg/ml) F/B 
Main 
effects S SB SF SBF 
HT-29 ATP 
4.77aA 
(0.45) 
4.47abA 
(0.27) 
4.03bA 
(0.11) 
3.16cA 
(0.44) 
F # 
B  * 
 BrdU 
8.35A 
(0.85) 
8.16A 
(0.78) 
9.75A 
(1.69) 
9.57A 
(1.43) 
F  * 
Caco-2 ATP 
6.69aB 
(0.43) 
5.65bB 
(0.03) 
4.96cB 
(0.17) 
4.16dB 
(0.19) 
F # 
B  # 
 BrdU 
5.54aB 
(0.25) 
5.13bB 
(0.31) 
4.77cB 
(0.35) 
4.80cB 
(0.37) 
F # 
B  * 
Values represent the means  standard deviations of the inhibitory concentration set at 50% (IC50) in 
mg/ml of 4 independent assay runs. Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, 
SF = sunflower + fish oils and SBF = sunflower + borage + fish oils. Values in a row are significantly 
different following different letters (superscript). Values in a column representing the corresponding 
assay variable between the two cell lines (i.e. ATP IC50 vs. BrdU IC50) within the same oil emulsion 
treatments are significantly different at p<0.05 (uppercase subscript). Main FISH (F) or BORAGE (B) 
effects illustrated by an  (increase) and  (decrease) at p<0.05 (*) and p<0.0001 (#). 
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5.3.2 Modulation of cell proliferation (BrdU incorporation) 
Fish oil had a significant (<0.05) increasing main effect on the HT-29 cells 
proliferation response (Table 5.2). However, no significant interactions were 
observed for any of the oil emulsions to effect the IC50 concentrations. In the Caco-2 
cells, however, borage and fish oil reduced (p<0.05) proliferation (main effect; Table 
5.2). Significant interactions indicated that the SB, SF and SBF emulsions decreased 
(p<0.05) proliferation with the fish oil emulsions having the greater (p<0.0001) effect. 
 
5.3.3 Modulation of cell cytotoxicity (LDH release) 
Data were expressed as a function of cell viability by subtracting the % dead cells as 
determined by LDH release. A significant difference (p<0.05) between the 2 colon 
cancer cell lines response to the cytotoxic effects of the oil emulsions was observed 
with the HT-29 cells being more sensitive (p<0.05) when compared to the Caco-2 
cells (Table 5.3). Furthermore, the HT-29 cells displayed a significant dose response 
with increasing concentrations in the S, SB and SBF emulsions decreasing (p<0.05) 
cell viability. In the Caco-2 cells, however, a distinct interaction between dose and 
reduction in cell viability was observed, with borage oil exhibiting a reducing (p<0.05) 
effect when compared to the effects of S and SF which only have a marginal effect 
(Fig. 5.1).  
 
5.3.4 Induction of apoptosis 
In the colon cancer cell lines no significant apoptotic response was noted with any of 
the oil emulsions at the IC50 values for ATP and BrdU (data not shown). Hence, a 
dose response of the oil emulsions at higher concentrations 2 times above the ATP 
IC50 was used to induce apoptosis (Table 5.3). The HT-29 cells showed resistance 
to the induction of apoptosis at any doses of the oil emulsions utilised (Table 5.3). 
However, separate analysis on cell cytotoxicity (LDH release) and cell viability (ATP 
content) showed that all the oil emulsions increased and decreased these cytotoxic 
parameters respectively, in a dose response manner while it tended to decrease 
apoptosis. Of interest is that the SB oil emulsion decreased (p<0.05) apoptosis at the 
two lower concentrations, while no effect was noticed at the highest concentration. A 
similar effect was noticed in the Caco-2 cells where the lowest concentration also 
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Table 5.3: Modulation of cytotoxicity, induction of apoptosis and cell viability by oil emulsions in different colon cancer cells. 
Oil emulsion S SB SF SBF 
HT-29 cells              
   mg/ml  mg/ml  mg/ml  mg/ml 
 control 8.5 10.5 12.5 8.5 10.5 12.5 9.5 10.5 11.5 7.5 8.5 9.5 
LDH cytotoxicity 
(% viable cells) 
79.31a 
(8.68) 
83.87a 
(1.84) 
80.49a 
(4.39) 
59.43b 
(4.47) 
88.54a 
(1.02) 
83.10a 
(4.09) 
61.00b 
(1.92) 
84.75a 
(1.39) 
70.63b 
(2.26) 
69.95b 
(3.25) 
81.64a 
(4.78) 
75.47a 
(3.14) 
65.91b 
(5.82) 
Apoptosis 
(caspase-3 fold) 
1.00a 
(0.22) 
0.51b 
(0.02) 
0.85a 
(0.11) 
0.13c 
(0.04) 
0.55b 
(0.06) 
0.70b 
(0.06) 
1.11a 
(0.18) 
0.79 
(0.06) 
0.82 
(0.05) 
0.78 
(0.02) 
0.56b 
(0.08) 
0.49b 
(0.05) 
0.53b 
(0.06) 
Cell viability 
(%ATP) 
100.00a 
(5.13) 
79.12b 
(2.58) 
38.13c 
(3.32) 
36.35c 
(3.77) 
86.24b 
(9.36) 
54.38c 
(3.92) 
32.96d 
(4.48) 
76.81b 
(2.48) 
43.76c 
(3.92) 
30.48d 
(3.06) 
73.28b 
(2.76) 
66.48b 
(8.42) 
52.57c 
(3.94) 
Caco-2 cells 
  mg/ml mg/ml mg/ml mg/ml 
 control 7.5 9.5 11.5 5.5 7.5 9.5 6 8 10 5 7 9 
LDH 
cytotoxicity 
(% viable cells) 
84.42a 
(3.94) 
88.41b 
(3.19) 
85.30ab 
(2.01) 
82.13a 
(3.27) 
89.44b 
(1.37) 
85.01a 
(2.53) 
77.46c 
(3.55) 
88.35 
(0.55) 
86.88 
(2.46) 
83.85 
(2.55) 
88.83b 
(2.31) 
83.98a 
(2.66) 
77.50c 
(3.70) 
Apoptosis 
(caspase-3 fold) 
1.00a 
(0.09) 
1.93b 
(0.11) 
2.04b 
(0.12) 
0.77c 
(0.16) 
0.77b 
(0.14) 
1.45c 
(0.06) 
1.17a 
(0.14) 
1.42b 
(0.20) 
2.14c 
(0.22) 
1.85d 
(0.11) 
1.41b 
(0.20) 
2.05c 
(0.26) 
1.75bc 
(0.40) 
Cell viability 
(%ATP) 
100.00a 
(5.67) 
77.28b 
(8.21) 
58.47c 
(4.48) 
44.63d 
(4.79) 
58.51b 
(3.26) 
43.89c 
(0.92) 
48.37c 
(4.43) 
41.90b 
(1.10) 
41.48b 
(4.78) 
48.44b 
(4.49) 
55.37b 
(0.73) 
57.24b 
(1.85) 
29.69c 
(3.51) 
Mean and standard deviation (in brackets) of duplicate runs (N = 10 per concentration). Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower + fish oils 
and SBF = sunflower + borage + fish oils. LDH cytotoxicity expressed as a function of cell viability by subtracting the % dead cells as determined by LDH release. 
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Figure 5.1:  Caco-2 cells dose response relative to borage oil. 
 
reduced apoptosis. All the other the oil emulsions increased (p<0.05) apoptosis in a 
dose dependent manner, with the S emulsion increasing (p<0.05) apoptosis at the 
lower concentrations while it tended to decrease (p<0.05) at the higher 
concentration. The SF and SBF oil emulsions increased (p<0.05) apoptosis at higher 
dose levels, which was associated with an increased cell cytotoxicity (Table 5.3).  
 
5.3.5 Modulation of lipid metabolism of Caco-2 cells 
The Caco-2 cells were selected for subsequent studies based on their sensitivity of 
the different oils emulsion regarding the modulation of cell proliferation and the 
induction of apoptosis. Alterations in the Caco-2 cell membrane lipid content were 
compared to the untreated control cells following treatment with the different oil 
emulsion constituting varying ω-6/ω-3 FA ratios. Furthermore, for each oil emulsion 
two different concentrations were used which was associated with: (i) the induction 
of apoptosis (S = 8.5 mg/ml; SB = 7.5 mg/ml; SF = 8.9 mg/ml; SBF = 6 mg/ml) which 
was2 times above the IC50 values in reducing cell viability (ATP), and (ii) the BrdU 
IC50 (S = 5.5 mg/ml; SB = 5.10 mg/ml; SF = 4.8 mg/ml; SBF = 4.8 mg/ml) that 
reduced cell proliferation by 50%. Changes associated with specific dose response 
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effects associated with apoptosis in relation to the inhibition of cell proliferation were 
also highlighted.  
 
5.3.5.1   Cholesterol 
With the induction of apoptosis in the Caco-2 cells, cholesterol content (Fig. 5.2A) 
was significantly increased (p<0.05) by the SF emulsion (8.9 mg/ml) when compared 
to the control and other emulsions (S, SB, SBF) at these treatment concentrations. 
The cholesterol was significantly (p<0.05) increased by the S, SB and SF emulsions 
at the BrdU IC50 emulsion concentrations relative to the untreated control.  
Dose response effects: The S and SB emulsion had a significant reducing (p<0.05) 
effect on membranes cholesterol content with the induction of apoptosis when 
compared to the lower BrdU IC50 treatments.  
 
5.3.5.2   Phosphatidylcholine (PC) 
Compared to the control, Caco-2 cells membrane phospholipid content of PC (Fig. 
5.2B) increased (p<0.05) with the induction of apoptosis by the oil emulsions. The SF 
emulsion significantly (p<0.05) increased PC more effectively than the S emulsion 
and control. All the emulsions increased (p<0.05) the PC content to the same extent 
at the respective BrdU IC50 when compared to the control.  
Dose response effects: With the induction of apoptosis membranes PC content was 
significantly (p<0.05) higher with the SB, SF and SBF emulsions when compared to 
the lower dose (BrdU IC50).  
 
5.3.5.3   Phosphatidylethanolamine (PE) 
When compared to the control, no change in PE content (Fig. 5.2C) was noted with 
the induction of apoptosis. However at the BrdU IC50 treatments, PE was 
significantly (p<0.05) increased by the S, SB and SF emulsions with the S emulsion 
exhibiting a higher response than the SB and SF emulsions. 
Dose response effects: PE content was significantly (p<0.05) decreased with the 
induction of apoptosis by the S, SB and SBF emulsion when compared to the lower 
BrdU IC50 treatments. 
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5.3.5.4   PC/PE ratio 
The PC/PE ratio (Fig. 5.2D) in the membrane of the Caco-2 cells increased (p<0.05) 
significantly with the induction of apoptosis by the oil emulsions when compared to 
the control, with SB, SF and SBF exhibiting the largest increasing effects. At a lower 
dosage (BrdU IC50), only the SF and SBF emulsions increased (p<0.05) the PC/PE 
ratio compared to the control. 
Dose response effects: The PC/PE ratio increased (p<0.05) significantly with the 
induction of apoptosis by the SB, SF and SBF emulsions when compared to the 
lower BrdU IC50 treatments. 
 
5.3.5.5   Cholesterol/phospholipid (chol/PL) ratio 
The chol/PL ratio (Fig. 5.2E) in the Caco-2 cells membrane was decreased (p<0.05) 
by the S, SB and SF emulsions with the induction of apoptosis when compared to 
the control. Including the SBF emulsion, this same reducing (p<0.05) effect was 
noted at the BrdU IC50 treatment. 
Dose response effects: Membranes chol/PL ratio was significantly (p<0.05) 
increased with the induction of apoptosis by the SF and SBF emulsions, whilst S and 
SB resulted in the ratio’s decrease (p<0.05) when compared to the lower BrdU IC50 
treatments.  
 
5.3.6 Modulation of the Caco-2 cells fatty acid composition 
To evaluate the level of FA incorporation, two concentrations were used per oil 
emulsion, (i) high concentration associated with the induction of apoptosis and (ii) a 
low concentration (IC50 for BrdU) related to the reduction of cell proliferation. The FA 
content of the phospholipids PC and PE was expressed qualitatively (%) and 
quantitatively (μg) (Tables 5.5-5.9 in Addendum 3). The percentage reflected the 
distribution of the fatty acid in the respective phospholipid, while the concentration 
(μg FA/mg protein) is the level which is also dependent on the concentration of the 
respective phospholipid. All the data were compared relative to the untreated control 
cells. 
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Figure 5.2: Cholesterol and phospholipids content in the Caco-2 cells membranes after 48 hours exposure to 
different oil emulsion concentrations (apoptosis inducing and BrdU IC50). (A) Cholesterol, (B) Phosphatidylcholine 
(PC) content, (C) Phosphatidylethanolamine (PE) content, (D) PC/PE ratio and (E) cholesterol/phospholipids 
(chol/PL) ratio. Significant differences between groups set at p<0.05 are indicated by different letters: lowercase – 
differences between oil emulsions within assay (ATP IC50 or BrdU IC50); uppercase - corresponding lipid variable 
compared at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion 
treatment. 
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5.3.6.1 Modulation of membranes saturated fatty acids (SATS) composition 
 
Qualitative (%) 
Apoptosis: Compared to the control, the total SATS (summarized in Fig. 5.3) was not 
changed in PC, although C18:0 was reduced (p<0.05) by the S emulsion. In PE, a 
decrease (p<0.05) in SATS was noted with the SF and SBF emulsions. This was 
mainly due to the SF emulsion decreasing (p<0.05) the C16:0 content. The SB 
emulsion also decreased C16:0, while the S and SBF decreased 16:0 marginally. 
BrdU IC50: No significant change in the total SATS was noted in PC when compared 
to the control, whilst in PE the SB emulsion resulted in a significant (p<0.05) 
decrease. This effect was mainly due to a decrease (p<0.05) in C16:0.  
Dose response effects: With the induction of apoptosis, membranes total SATS was 
significantly (p<0.05) decreased by the SBF emulsion in PE when compared to the 
lower BrdU IC50 treatments. 
 
Quantitative (µg) 
Apoptosis: In PC and PE, the total SATS (Fig. 5.3) was significantly (p<0.05) 
decreased by the S, SB and SF emulsions. The emulsions mainly decreased 
(p<0.05) C16:0, whilst the S emulsion only decreased (p<0.05) C18:0 in PC and SF 
having this same reducing (p<0.05) effect in PE. 
BrdU IC50: In PC, the total SATS remained unchanged compared to the control, 
although a decrease (p<0.05) in C16:0 was noted with the SB emulsion. The S and 
SF emulsions increased (p<0.05) total SATS in PE, whilst the SB emulsion resulted 
in a significant (p<0.05) decrease. This latter effect was due to a decrease (p<0.05) 
in C16:0, whereas the S and SF emulsions increased (p<0.05) C18:0. An increase 
(p<0.05) in C16:0 was also noted with the S emulsion in PE. 
Dose response effects: The S and SF emulsions significantly (p<0.05) decreased 
total SATS in PC and PE with the induction of apoptosis when compared to the BrdU 
IC50 treatment. This effect was mainly due to a decrease (p<0.05) in C16:0 and 
C18:0.   
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Figure 5.3: Summary of the modulation of Caco-2 cells SATS composition by the oil emulsions when 
compared to the control. The dose responses indicated are the apoptosis inducing concentrations 
effects on the FA relative to the BrdU IC50 treatments. 
 
5.3.6.2   Modulation of membranes monounsaturated fatty acids (MUFA)     
              composition 
 
Qualitative (%) 
Apoptosis: Compared to the control, no significant change in total MUFA 
(summarized in Fig. 5.4) was noted in PC and PE. However, in both phospholipid 
fractions the SB and SF emulsions decreased (p<0.05) C16:1ω-7 and C18:1ω-9. In 
PC the S and SBF emulsions also decreased (p<0.05) C16:1ω-7, whilst only SBF 
resulted in its decrease (p<0.05) in PE. 
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BrdU IC50: In PC and PE, no significant change in total MUFA was noted compared 
to the control. A decrease (p<0.05) in C16:1ω-7 and C18:1ω-9, however, was 
observed with the SF emulsion in PC. 
Dose response effects: In PC, the S emulsion decreased (p<0.05) total MUFA, whilst 
in PE the SB and SF emulsions resulted in a decrease (p<0.05) with the induction of 
apoptosis. The S emulsion reduced (p<0.05) C16:1ω-7 in PC, whereas the SB and 
SF emulsions decreased (p<0.05) C16:1ω-7 and C18:1ω-9 in PE when compared to 
the BrdU IC50 treatments. 
 
Quantitative (µg) 
Apoptosis: No significant change in the total MUFA (Fig 5.4) was noted in PC, 
although the SF emulsion decreased (p<0.05) C18:1ω-9 when compared to the 
control. In PE the SF emulsion resulted in a decrease (p<0.05) in total MUFA due to 
a reduction (p<0.05) in C16:1ω-7 and C18:1ω-9. 
BrdU IC50: In PC and PE, the total MUFA was significantly (p<0.05) increased by 
the S emulsion, whilst only being increased (p<0.05) by the SF and SBF emulsions 
in PE compared to the control. The latter effect was due to an increase (p<0.05) in 
C16:1ω-7, C18:1ω-9 and C18:1ω-7 by SF, whereas the SBF emulsion only 
increased (p<0.05) C18:1ω-9. 
Dose response effects: Total MUFA decreased (p<0.05) significantly in PC and PE 
with the S and SF emulsions inducing apoptosis. A similar effect was noted with the 
SBF emulsion in PE. The S and SF emulsions decreased (p<0.05) C16:1ω-7, 
C18:1ω-9 and C18:1ω-7 in both phospholipid fractions, whilst SBF reduced (p<0.05) 
C16:1ω-7 in only PE when compared to the BrdU IC50 treatments.  
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Figure 5.4: Summary of the modulation of Caco-2 cells MUFA composition by the oil emulsions when 
compared to the control. The dose responses indicated are the apoptosis inducing concentrations 
effects on the FA relative to the BrdU IC50 treatments. 
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5.3.6.3   Modulation of membranes polyunsaturated fatty acids (PUFA)     
    composition 
 
(a) ω-3 PUFA 
Qualitative (%) 
Apoptosis: Total ω-3 FA (Fig. 5.5) was significantly (p<0.05) increased in PC and PE 
by the SF and SBF emulsions, whilst only increasing (p<0.05) with the S and SB 
emulsions in PE when compared to the control. The SF emulsion increased (p<0.05) 
only C20:5ω-3 in PC, whilst both the SF and SBF emulsions increased (p<0.05) 
C20:5ω-3, C22:5ω-3 and C22:6ω-3 in PE. The S emulsion increased (p<0.05) 
C22:5ω-3 in PE, whereas SB increased (p<0.05) C22:5ω-3 and C22:6ω-3. 
BrdU IC50: Compared to the control, the total ω-3 FA increased (p<0.05) in PC and 
PE with the SB, SF and SBF emulsions. The S emulsion also resulted in the total’s 
increase (p<0.05) in PC only due to an increase (p<0.05) in C22:5ω-3 and C22:6ω-
3, whilst decreasing (p<0.05) C18:3ω-3. In PC and PE, the SF emulsion increased 
(p<0.05) C20:5ω-3 and C22:5ω-3. 
Dose response effects: In PC, the oil emulsions decreased (p<0.05) the total ω-3 FA, 
whilst being significantly (p<0.05) increased in PE with the induction of apoptosis. 
The reduction in PC was due to the oil emulsions decreasing (p<0.05) effect on 
C22:6ω-3, with the S and SF emulsions also decreasing (p<0.05) C20:5ω-3 and 
C22:5ω-3, and SB reducing (p<0.05) C22:5ω-3. The total increase in PE was the 
result of the oil emulsions increasing (p<0.05) effect on C22:5ω-3 and C22:6ω-3, 
whilst the S, SF and SBF emulsions also increased C20:5ω-3 when compared to the 
BrdU IC50 treatments. 
 
Quantitative (µg) 
Apoptosis: The total ω-3 FA was significantly (p<0.05) increased in PC by the SBF 
emulsion, whilst the SF and SBF emulsions increased the content in PE when 
compared to the control. In PC, the SBF emulsion resulted in an increase (p<0.05) in 
C18:3ω-3 and C22:5ω-3.  The SF and SBF emulsions increased (p<0.05) C20:5ω-3 
and C22:6ω-3 in PE. 
BrdU IC50: Compared to the control, the total ω-3 FA increased (p<0.05) with all the 
oil emulsions in PC, whilst in PE content was only increased (p<0.05) by the SF and 
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SBF emulsions and decreased by SB. The change in PC was due to an increase 
(p<0.05) in C22:5ω-3 and C22:6ω-3. An increase (p<0.05) in C18:3ω-3 and C20:5ω-
3 was also noticed with the SF and SBF emulsions and only C18:3ω-3 with SB. In 
PE, the SF and SBF emulsions significantly (p<0.05) increased C20:5ω-3 and 
C22:5ω-3, whilst only SF increased (p<0.05) C18:3ω-3 and C22:6ω-3. The SB 
emulsion decreased (p<0.05) C22:5ω-3 and C22:6ω-3 in PE, whereas an increase 
(P<0.05) in C18:3ω-3 and C22:5ω-3 was noted with the S emulsion. 
Dose response effects: In PC, the total ω-3 content significantly (p<0.05) decreased 
due to a reduction (p<0.05) in C20:5ω-3 and C22:6ω-3. Also, membrane content in 
C18:3ω-3 decreased with the SB and SF emulsions, whilst C22:6ω-3 decreased 
(p<0.05) with S, SB and SF.  In PE, however, the total ω-3 FA increased (p<0.05) as 
the membrane content in C20:5ω-3 and C22:6ω-3 increased (p<0.05) with the SB 
and SBF emulsions as apoptosis was induced. The SB emulsion also increased 
(p<0.05) C22:5ω-3, whilst SF decreased (p<0.05) the total FA content in PE by 
reducing (p<0.05) C18:3ω-3, C20:5ω-3, C22:5ω-3 and C22:6ω-3 when compared to 
the BrdU IC50 treatments. The S emulsion also decreased (p<0.05) the total ω-3 FA 
content by reducing (p<0.05) C18:3ω-3 and C22:5ω-3. 
 
 
 
 
 | 150 
 
 
 
 
Figure 5.5: Summary of the modulation of Caco-2 cells ω-3 FA composition by the oil emulsions 
when compared to the control. The dose responses indicated are the apoptosis inducing 
concentrations effects on the FA relative to the BrdU IC50 treatments. 
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(b) ω-6 PUFA 
Qualitative (%) 
Apoptosis: In PC and PE, a significant (p<0.05) increase in total ω-6 FA (Fig. 5.6) 
was noted with the oil emulsions due to an increase (p<0.05) in C18:2ω-6 and 
C20:4ω-6 when compared to the control. In PC, the SB and SBF emulsions 
increased (p<0.05) C20:3ω-6, whilst also being increased (p<0.05) by all the oil 
emulsions in PE. 
BrdU IC50: Changes in membrane total ω-6 FA composition was similar to that of 
the cells in which apoptosis was induced. 
Dose response effects: With the induction in apoptosis, membranes total ω-6 FA 
decreased (p<0.05) in PC with the SF emulsion due to a reduction (p<0.05) in 
C18:2ω-6. A decrease (p<0.05) in C20:4ω-6 was also noted with the S and SB 
emulsions, whilst SBF reduced (p<0.05) C20:3ω-6. In PE, the SBF emulsion 
increased (p<0.05) the total ω-6 FA due to an increase (p<0.05) in C20:4ω-6, which 
was also increased (p<0.05) by the S and SF emulsions. The SB and SF emulsions 
decreased (p<0.05) C18:2ω-6 when compared to the BrdU IC50 treatments. 
 
Quantitative (μg) 
Apoptosis: Compared to the control, in PC and PE the total ω-6 FA content 
increased (p<0.05) due to a significant (p<0.05) increase in C18:2ω-6. In PC the S, 
SB and SBF emulsions increased (p<0.05) C20:3ω-6, whilst C20:4ω-6 was reduced 
(p<0.05) by S, SB and SF. All the oil emulsions increased (p<0.05) C20:3ω-6 in PE, 
but only SB, SF and SBF resulted in an increase (p<0.05) in C20:4ω-6. 
BrdU IC50: Total ω-6 FA content was significantly (p<0.05) increased in PC and PE 
due to an increase in C18:2ω-6, C20:3ω-6 and C20:4ω-6 when compared to the 
control. 
Dose response effects: To induce apoptosis the total ω-6 content in PC was reduced 
(p<0.05) by the S, SB and SF emulsions. These effects were due to a decrease 
(p<0.05) in C20:4ω-6, but only the SF and SBF emulsions reduced C20:3ω-6. In PC, 
the content of C18:2ω-6 was decreased (p<0.05) by the S and SF emulsions, whilst 
being increased (p<0.05) by SBF. The total ω-6 FA decreased (p<0.05) in PE due to 
a reduction (p<0.05) in C18:2ω-6.  An increase (p<0.05) C20:4ω-6 was noted with 
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the SB and SBF emulsions, whilst being decreased (p<0.05) by SF in PE when 
compared to the BrdU IC50 treatments. 
 
 
 
Figure 5.6: Summary of the modulation of Caco-2 cells ω-6 FA composition by the oil emulsions 
when compared to the control. The dose responses indicated are the apoptosis inducing 
concentrations effects on the FA relative to the BrdU IC50 treatments. 
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5.3.6.4   Modulation of membranes total PUFA and FA ratios composition 
 
Qualitative (%) 
Apoptosis: The oil emulsions increased (p<0.05) the Caco-2 cells total PUFA and the 
Δ6 substrate/product (S/P) ratio in PC and PE (Fig. 5.7). Membranes ω-6/ω-3 FA 
and PUFA/SATS ratios increased (p<0.05) in PC, whilst being decreased (p<0.05) in 
PE. The C20:4ω-6/C20:5ω-3 ratio increased with the S and SB emulsions in PC and 
PE, but the C20:4ω-6 ratio decreased (p<0.05) with all the oil emulsions. 
BrdU IC50: Compared to the control, in PC and PE the total PUFA, ω-6/ω-3 FA and 
Δ6 S/P ratios were increased (p<0.05) b the oil emulsions. In both PC and PE the 
PUFA/SATS ratio increased (p<0.05) with the SB and SF emulsions, whilst 
increasing (p<0.05) only with S and SBF in PC. The C20:4ω-6/C20:5ω-3 ratio was 
increased (p<0.05) by the S and SB emulsions in PC and PE, but only increased 
(p<0.05) in PE by SBF. 
Dose response effects: To induce apoptosis, the total PUFA was decreased (p<0.05) 
in PC by the S, SB and SF emulsions in PC, whilst being increased (p<0.05) in PE 
by the S and SBF emulsions. The oil emulsions increased (p<0.05) the ω-6/ω-3 FA 
ratio in PC, but resulted in a decrease (p<0.05) in PE. A similar decrease (p<0.05) in 
membranes Δ6 S/P ratio was noticed in PE, whilst the SB, SF and SBF emulsions 
increased (p<0.05) the ratio in PC. The PUFA/SATS ratio was decreased (p<0.05) 
by the SB and SF emulsions in PC, but increased (p<0.05) with S, SF and SBF in 
PE. Membranes C20:4ω-6/C20:5ω-3 ratio decreased (p<0.05) with only the S 
emulsion in PE, but the 20:4ω-6 PC/PE ratio decreased with all the emulsions. 
 
Quantitative (µg) 
Apoptosis: The total PUFA content was significantly (p<0.05) increased by the oil 
emulsions in PC, whilst only SB, SF and SBF increased the total in PE. In PC and 
PE the Δ6 S/P ratio increased (p<0.05) with the SB, SF and SBF emulsions. All oil 
emulsions increased the ω-6/ω-3 FA ratio in PC, whilst an increase (p<0.05) by only 
S and SB was noted in the ratio. The PUFA/SATS ratio increased (p<0.05) with the 
SF and SBF emulsions in PC and PE, but only increased (p<0.05) with S in PC. In 
PC an increase (p<0.05) in the C20:4ω-6/C20:5ω-3 ratio was noted with S and SB 
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emulsions, but only SB increased (p<0.05) the ratio in PE. The C20:4ω-6 PC/PE 
ratio decreased (p<0.05) with the oil emulsions. 
BrdU IC50: Compared to the control, all the oil emulsions increased (p<0.05) the 
total PUFA in PC and PE, whilst the SB, SF and SBF emulsions increased (p<0.05) 
the PUFA/SATS ratio. The ω-6/ω-3 FA ratio was increased (p<0.05) in PC by only 
the S, SB and SF emulsions, but increased (p<0.05) by all the emulsions in PE. An 
increase (p<0.5) in membranes Δ6 S/P ratio with the SB, SF and SBF emulsions 
was noted in PC, while all the oil emulsions increased(p<0.05) the ratio in PE. The 
C20:4ω-6/C20:5ω-3 ratio increased (p<0.05) in both PC and PE due to the effects of 
the S and SB emulsions, but decreased (p<0.05) with SF in PE. Membrane C20:4ω-
6 PC/PE ratio decreased (p<0.05) with the SF emulsion. 
Dose response effects: To induce apoptosis, the total PUFA content was significantly 
(p<0.05) decreased in PC by the S, SB and SF emulsions, whilst in PE the S and SF 
emulsions decreased (p<0.05) the content and SB resulted in an increase (p<0.05). 
The membrane ω-6/ω-3 FA ratio was increased (p<0.05) by all the oil emulsions in 
PC, but decreased (p<0.05) in PE. A similar decrease (p<0.05) in the C20:4ω-6 
PC/PE ratio was noted. The PUFA/SATS ratio was decreased (p<0.05) by the SB 
and SF emulsions in PC, and the C20:4ω-6/C20:5ω-3 ratio decreased (p<0.05) by S 
in PE. In PC the SB, SF and SBF emulsion increased (p<0.05) the Δ6 S/P ratio, but 
was decreased (p<0.05) in PE by S, SF and SBF. 
 
 
 
 
 
 
 
 | 155 
 
 
 
 
Figure 5.7: Modulation of Caco-2 cells total PUFA and FA ratios composition by the oil emulsions 
when compared to the control. The dose responses indicated are the apoptosis inducing 
concentrations effects on the FA relative to the BrdU IC50 treatments. 
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5.4 DISCUSSION 
In the current study, the survival of two human colon cancer cells were assessed and 
compared after exposure to certain oil ratio emulsions. This was done to establish 
whether the use of dietary fats with well-defined FA compositions exhibited 
chemopreventive potential against the survival of cancer cells. Numerous studies 
show that ω-3 FA possess anti-cancer properties (Bartsch et al., 1999; Larsson et 
al., 2004), whereas certain ω-6 FA appear to enhance the altered phenotype of 
cancer cells (Cabral et al., 2013; Whelan and McEntee, 2004). With neither class of 
FA being consumed in isolation, it has been suggested that manipulating the balance 
of ω-6 and ω-3 of FA (i.e. ω-6/ω-3 ratio) may be an important strategy in inhibiting 
the survival of cancerous cells (Simopoulos, 2008). With dietary intake providing a 
major source of these unsaturated carbon chains, such an approach is feasible. A 
key observation made in this investigation was the differing cellular responses 
between the HT-29 and Caco-2 colon cancer cell lines that were elicited by exposure 
to different oil emulsions with distinctive FA content and ω-6/ω-3 ratio. In addition 
specific changes in membrane lipid and FA composition, associated with apoptosis 
and the inhibition of cell proliferation were characterised using the Caco-2 cancer 
cells. 
 
5.4.1 Modulation of colon cancer cells survival by the oil emulsions 
The two colon cancer cell lines displayed differential sensitivity to the effects of the 
different oil emulsions and its respective FA constituents. This has been reported to 
occur in other cancer cells as well (Ding et al., 2004; Mengeaud et al., 1992; 
Schønberg et al., 2006). In the HT-29 and Caco-2 cancer cells, initial analyses 
showed that the reduction of ATP production (cell viability) and inhibition of BrdU 
incorporation (cell proliferation) was dependent on the dose of the oil emulsion 
treatment. Regarding reduction in cell viability, the HT-29 cells exhibited greater 
sensitivity to the modulating effects of the fish oil containing emulsions (SF and 
SBF), whilst borage oil (SB) was less active. However, in the HT-29 cells a higher 
amount of the different oil emulsions was required to elicit an inhibitory response on 
cell proliferation when compared to its effect on the inhibition of ATP production. A 
similar dose was required in the Caco-2 cells. This response could be related to an 
increased resistance of the HT-29 cells to cellular oxidative stress triggered by LC 
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PUFA. In this regard, the SF and SBF emulsions were more effective in reducing the 
cell growth parameters in both cell types. This is in accordance with the literature as 
fish oil has been shown to increase mitochondrial membranes level of unsaturation, 
which enhances cells level of ROS (Hong et al., 2002). This is due to the supply of 
LC ω-3 PUFA, C20:5ω-3 and C22:6ω-3 (SF and SBF) that are highly susceptible to 
lipid peroxidation (LPO) and has been shown to inhibit cancer cell growth (Das, 
1999; Larsson et al., 2004). In contrast, in the Caco-2 cells borage oil and fish oil 
required similar IC50 concentrations for the inhibition of cell viability and proliferation. 
Borage oil also exhibited a greater reducing effect when compared to the S 
emulsion, though the SF and SBF emulsions were still more active. The borage oil 
containing emulsions (SB and SBF) increased the supply of C18:3ω-6 to the cells, 
which has demonstrated anti-proliferative properties due to modifying membranes 
FA pattern, decreasing the mitochondrial membrane potential and increasing 
oxidative stress (Hrelia et al., 1996; Itoh et al., 2010).  
 
Further investigation showed that interesting associations seems to exist when 
considering the oil emulsions effect on ATP production, cytotoxicity (necrosis) and 
the induction of apoptosis. It would appear that a threshold with respect to the level 
of cellular ATP determines whether the colon cancer cells are removed via apoptosis 
or necrosis (Tsujimoto, 1997). Apoptosis is widely accepted as an efficient, energy 
dependent and stepwise process ensuring the removal of damaged cells. 
Conversely, necrosis is an accidental form of cell death lacking any underling 
signalling events and results from exposure to severe stress conditions or toxic 
agents. In addition, necrotic cell death occurs in the absence of ATP (Eguchi et al., 
1997). As noticed with the HT-29 cells, the significant reduction of ATP and ATP-
dependent apoptosis by the S, SB and SBF emulsions suggests that the 
uncontrolled degenerative form of cell removal was obtained, particularly at the 
highest cytotoxic concentrations. Interestingly, it has been shown that the HT-29 
cells have a highly apoptosis-resistant phenotype due to its ability to thrive under 
conditions of micro environmental stresses (Suzuki et al., 1998). This suggests that 
the cell line has adapted mechanisms to maintain its survival.  
 
The dietary FA-induced depletion of the energy status within the cancer cell line is 
indicative of metabolic reprogramming centred on the mitochondria that play a critical 
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role in initiating a necrotic or apoptotic response in cells (Eguchi et al., 1997). In 
normal cells, the mitochondria play a pivotal role in mediating apoptosis and 
regulating the cellular energy supply via oxidative phosphorylation. However, in 
cancer cells, both these processes are defective due to mitochondrial dysfunction 
(Costa et al., 2014). Therefore, cancer cells are characterised by a loss in apoptosis 
and a shift in energy production occurring via glycolysis (Warburg effect), which 
supports its proliferative nature (Lunt and Vander Heiden, 2011). To further 
supplement its energy reserves, cells also utilize FA to increase the energy supply 
via mitochondrial beta-oxidation (Nakamura et al., 2014). Regardless, with the 
decrease in ATP, this supplementary effect is not evident here with the HT-29 cells 
at the specified emulsion concentrations. This is likely due to cancer cells 
preferentially using FA for the biosynthesis of membranes and signalling molecules 
to generate more daughter cells (Baenke et al., 2013). Consequently, the level of 
ATP is likely insufficient to induce apoptosis despite the increased supply of FA 
energy sources and associated substrates susceptible to free radical attack. In this 
regard, cancer cells are known to contain highly effective antioxidant defence 
mechanisms to combat adverse effects mediated by excessive levels of free radicals 
(Trachootham et al., 2009).  
 
In contrast, the Caco-2 cells responded to the apoptotic inducing effects of all the oil 
emulsions with increasing concentration. The induction of apoptosis was also 
decreased as low levels in ATP production was reached, effecting marginal cytotoxic 
effects. As mentioned, the induction of apoptosis relies on mitochondrial metabolism, 
which supplies energy to activate the cell death executing cysteine protease 
caspase-3 (Budihardjo et al., 1999). With a reduction in mitochondrial ATP 
production being apparent, it is plausible that as a result of the mitochondrial energy 
crisis, the glycolytic route likely contributes sufficient intracellular ATP to induce 
apoptosis (Zheng, 2012). At low cytotoxicity, particularly with borage oil (SB), the 
induction of alternate mechanisms, such as cell cycle arrest may also be a possible 
reason for the reduction in energy status. Inhibition of mitochondrial ATPase, the 
enzyme that catalyzes the formation of ATP from ADP, has been shown to block cell 
cycle progression in the G1 phase, thus inhibiting an increase in cell numbers 
(Gemin et al., 2005). Meanwhile, the increase in apoptosis at the higher 
concentrations in S, SF and SBF is presumably due to the cancer cells enhanced 
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level in cellular oxidative stress arising from the oil emulsions FA supply and cellular 
metabolism. Consequently, only the Caco-2 cell line was selected to investigate the 
level of FA incorporated into membranes associated with the induction of apoptosis 
and inhibition of cell proliferation. 
 
5.4.2 Caco-2 cells membranes lipid content and FA incorporation and 
distribution facilitating the induction of apoptosis and inhibition of cell 
proliferation 
In cancer cells, the continuous biosynthesis of cell membrane building components 
plays a critical role in sustaining its abnormal proliferative state. As a result, 
alterations in lipid and FA metabolism have been identified as a major adaptation of 
cancer cells to ensure its survival (Zhang and Du, 2012). The oil emulsions utilised in 
the current study resulted in significant modification of membranes qualitative and 
quantitative FA composition in the Caco-2 cells, hereby altering their structure and 
function (Kremmyda et al., 2011; Tvrzicka et al., 2011). As a consequence of the 
membrane alterations, either apoptosis was induced or cell proliferation was 
inhibited.  
 
5.4.2.1   Modulation of membranes total PUFA and ω-6/ω-3 FA ratio  
              composition   
PUFA have been identified for having both chemopreventive and promoting effects 
on cancer development due to its effects on various cell regulatory processes (Serini 
et al., 2009; Tapiero et al., 2002; McEntee and Wheelan, 2002). Mammalian cells 
are inefficient at synthesizing PUFA due to a lack in Δ12- and Δ15- desaturases 
(Pereira et al., 2003). Therefore, the supply of PUFA is largely dependent on dietary 
intake, particularly of parent FA C18:2ω-6 and C18:3ω-3 that is further metabolized 
into the longer chain PUFA or is consumed directly.  
 
The total percentage of PUFA increased in the Caco-2 cell membranes in response 
to the S and SBF emulsions in PE when compared to the inhibitory effect of the oil 
emulsions on cell proliferation. However, PUFA content (μg) decreased with the S 
and SF emulsions in both PC and PE, but increased with SB (PE). The decrease of 
PUFA content in membranes has been linked to the activity of the FA metabolising 
enzyme ∆6-desaturase, which is much lower in tumours (Hrelia et al., 1994). 
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Although not physically measured, a decrease in this enzyme’s activity was indicated 
by the emulsions enhancement of the Δ6 substrate/product ratio in PC and PE (% 
and μg), which showed that more Δ6 substrates such as C18:2ω-6 was incorporated 
into the membranes. However, a decrease in the ratio with respect to the dose 
required for the induction of apoptosis was also observed in PE (µg). Therefore, the 
Δ6 substrate/product ratio may not be an efficient indicator for this process. Also, 
apart from an increase in protective antioxidant responses, tumour cells reduction in 
membrane unsaturation contributes towards resistance to oxidative stress, which 
reduces the opportunity to initiate apoptosis via LPO (Horrobin, 1990). Although the 
Caco-2 cells total PUFA content decreased, the emulsions dose response resulted in 
a decreased ω-6/ω-3 FA ratio in PE. This effect enhanced membranes LC ω-3 FA 
(C20:5ω-3 and C22:6ω-3) content with the SB and SBF emulsions. Of importance, 
the increase of Δ6-desaturase product C22:6ω-3 was supplied by exposure and 
uptake, and not FA metabolism. This increase in ω-3 FA enhances membranes 
susceptibility to LPO and likely contributed to the induction of apoptosis (Das, 1999; 
Hofmanová et al., 2005; Song and Miyazawa, 2001).  
 
Borage oil’s (SB and SBF) increasing effect on membranes C20:4ω-6 content in PE 
of the Caco-2 cells appears to also favour the induction of apoptosis. Elevated levels 
of C20:4ω-6 is considered a risk factor associated with colon cancer development 
due to its metabolites amplifying cancer cells proliferative nature (Cathcart et al., 
2012). However, dependent on its concentration in cells, C20:4ω-6 participates in 
apoptosis upon its release from membranes acyl backbone by phospholipase A2 
(PLA2), and subsequently acting as a secondary messenger activating the process 
(Cao et al., 2000).  
 
Evidently, different thresholds with regards to modification of membranes PUFA 
composition appears to determine the oil emulsions anti-cancer effect (apoptosis vs. 
inhibition of proliferation). To inhibit proliferation, membranes PUFA composition 
differed significantly at the lower emulsion concentrations, favouring an increase in 
PUFA and the ω-6/ω-3 FA ratio in both phospholipid fractions. With the increase in 
membrane C20:3ω-6, C20:5ω-3 in PC, an anti-inflammatory effect likely occurred 
due to the incorporated PUFA being metabolized into prostanoids (prostaglandins 
PGE1 and PGE3) that results in the reduction of cancer cells proliferation (Larsson et 
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al., 2004; Wang and Gu, 2012). Although membranes content in C20:4ω-6 and the 
C20:4ω-6/C20:5ω-3 ratio increased as well, the PUFA metabolizing enzyme 
cyclooxygenase-2 preferentially catalyzes the 20-carbon substrates initiating an anti-
inflammatory response (Larsson et al., 2004). Thus, any cancer promoting effects by 
PGE2, a product of C20:4ω-6 metabolism (Cabral et al., 2013), is counteracted by 
these aforementioned FA.  
 
5.4.2.2   Modulation of membranes SATS and MUFA composition 
To further facilitate the induction of apoptosis in the Caco-2 cells, the oil emulsions 
altered membranes SATS and MUFA content. In cancer cells, the relative amount of 
SATS and MUFA increases due to a high rate of de novo synthesis (Rysman et al., 
2010). A significant decrease in total SATS, C16:0 and C18:0 (S and SF) and total 
MUFA, C16:1ω-7, C18:1ω-7 and C18:1ω-9 (S, SF and SBF) in PC and PE was 
observed in the Caco-2 cells due to preferential incorporation of PUFA. Increased 
incorporation of SATS like C16:0 into cancer cell membranes appears to have a role 
in enhancing the synthesis of structural and signalling lipids (Louie et al., 2013). The 
MUFA C18:1ω-9 displays antioxidant properties, providing additional protection to 
cancer cells against oxidative damage (Schuhr, 2008). Therefore, its reduction in PC 
and PE probably assists in the Caco-2 cancer cells removal through LPO-induced 
apoptosis. Opposite effects was observed in the inhibition of cell proliferation, with an 
increase in SATS and MUFA in PE. In response to the dose of emulsions S and SF, 
the cancer cells increase in C16:0 appears to have an inhibitory effect on 
proliferation. Hardy and colleagues demonstrated in MDA-MB breast cancer cells 
that the FA significantly reduces the activity of phosphatidylinositol 3-kinase, which 
phosphorylates inositol lipids that act as secondary messengers for several 
pathways related to cell proliferation (Hardy et al., 2000). 
 
5.4.2.3   Modulation of membranes lipid components 
Membranes lipid bilayers are mainly composed of phospholipids of various classes 
that are distributed asymmetrically. PC and PE are the predominant lipids, with PC 
dominating the outer leaflet of plasma membranes, whereas PE in localised to the 
inner leaflet (Devaux, 1991). Both phospholipids serve as reservoirs for FA, and their 
content in membranes can be affected by dietary fat intake (Khuu Thi-Dinh et al., 
1990).  
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With the induction of apoptosis, in the Caco-2 cells, membranes PC content was 
increased as a result of the SB, SF and SBF emulsions dose response. This 
increase likely reflects the incorporation of the emulsifier L-alpha-
phosphatidylcholine, which was used to enhance FA incorporation into membranes 
and is not indicative of cell requirement for phospholipids to produce more cell 
(Jackowski, 1996). Cells usually maintain a strict level of PC homeostasis to ensure 
for optimal functioning in terms of its role of maintaining membrane integrity and 
participating in signal transduction pathways (Dennis et al., 1991; Ehehalt et al., 
2010). Therefore, an abnormal accumulation of PC could compromise the integrity of 
the membrane and alter signalling responses. In liver cancer cells, it has been 
demonstrated that enhanced uptake of PC results in an apoptotic response via the 
death ligands (Fas and/or TNF-alpha) pathway followed by caspase-8 and -3 
inductions (Sakakima et al., 2009). A decrease in PE content was also noted in 
response to S and SB emulsions. The phospholipids role in apoptosis is linked to its 
distribution between the inner and outer leaflet of membranes. Externalisation of PE 
and a loss of membranes asymmetric distribution of aminophospholipids during the 
early stages of apoptosis appear to have a significant role in the process, although 
the exact mechanism is not fully understood (Emoto et al., 1997; Wang et al., 2004). 
Of interest, exogenous PE has been shown to induce apoptosis in a dose dependent 
manner by reducing the mitochondrial transmembrane potential, and resulting in 
increased caspase-3 activity (Yao et al., 2009). Evidently, the decrease of the 
C20:4ω-6 PC/PE ratio adds to the emulsions modulating effect on the Caco-2 cells 
lipid membrane profile that predisposes it to apoptosis.  
 
With regards to the inhibition cell proliferation, an opposite response relating to an 
increase in PE content was in effect. The increase in PC was much lower to that 
required to initiate apoptosis. This again highlights the dependence of a lipid 
threshold required to elicit a specific cellular response (apoptosis vs. inhibition of 
proliferation). An accumulation of PC in cells has been shown to inhibit proliferation, 
presumably through its interaction with PLA2, which mediates the formation of 
C20:4ω-6 derived metabolites that participate in the regulation of cell proliferation 
and apoptosis (Baburina and Jackowski, 1999; Chiu and Jackowski, 2001). 
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5.4.2.4    Modulation of membrane fluidity 
The distribution of FA within the PC and PE lipid fractions were greatly influenced by 
the oil emulsions variation in concentration and FA content, with each phospholipid 
displaying preferential incorporation of certain FA classes. These compositional 
changes greatly affect membranes fluidity, influencing embedded protein receptors 
and its associated functionality (Wiseman, 1996). Changes in the PC/PE, 
PUFA/SATS and chol/PL ratios and cholesterol content have been utilized as 
indicators of membrane fluidity (Abel et al., 2001).  
 
With the induction of apoptosis, an increase in the PC/PE ratio and the PUFA/SATS 
ratio in PE in response to both borage oil and fish oil occurred. This effect suggests 
that the Caco-2 cells membrane fluidity is increased. This is due to the lipid fractions 
increased PUFA content, whose double bond, kinked chemical structure reduces the 
tight packaging of the lipid components (Eyster, 2007). Membranes increase in 
fluidity by PUFA may affect specialized lipid micro domains or lipid rafts that 
participate in signal transduction pathways regulating cell survival (Patra, 2008). It 
has been demonstrated that increasing lipid rafts ω-3 FA enhances the apoptotic 
response in human breast cancer cells by deactivating epidermal growth factor 
receptor associated signalling (Schley et al., 2007). Therefore, dependent on the 
level of PUFA and type of unsaturated chains that are being incorporated into 
membranes, the cellular response is swayed towards either apoptosis or inhibition of 
cell proliferation as determined by the signalling pathways activated. 
 
Cholesterol is an integral and stabilizing component of membranes and lipid rafts. In 
the Caco-2 cells, the emulsions (S and SB) resulted in a decrease in cholesterol 
content of the cancer cell membranes to initiate an apoptotic response.  Depletion of 
cholesterol results in the destabilization of membranes and lipid rafts, thus affecting 
critical signalling responses (Li et al., 2006). Consequently, the relative decrease in 
cholesterol as compared to the phospholipids (chol/PL ratio) will elicit an increase in 
the fluidity as it stabilizes the fatty acyl groups in the lipid bilayer (Ohvo-Rekila et al., 
2002). A decrease in lipid rafts cholesterol content by cholesterol depleting agents 
has been shown to activate the apoptotic process by increasing caspase-3 activity 
and also resulting in the deactivation of Akt/protein kinase B, which phosphorylates 
pro-apoptotic proteins and decreases their activities (Li et al., 2006). To sustain its 
 
 
 
 
 | 164 
 
 
 
proliferative nature, cancer cells tend to maintain a high content of cholesterol (Sun 
et al., 2014) Therefore, a decrease in cholesterol resulted in the inhibition of cell 
proliferation, but at a different content threshold in the Caco-2 cell membranes 
compared to the induction of apoptosis.    
 
5.5 CONCLUSIONS 
The oil emulsions elicited variable responses in the two colon cancer cell lines, 
demonstrating their differential sensitivity to the FA supplied, with the HT-29 cells 
displaying resistance to apoptosis. Meanwhile, the Caco-2 cancer cells showed a 
greater responsiveness to the oil emulsions. Evidently, the concentration and level of 
FA incorporated into the cancer cell membranes determines the cellular response: 
apoptosis versus cell proliferation inhibition. The induction of apoptosis by both fish 
oil and borage oil in the cell line is predetermined by a decreased content in 
membranes ω-6/ω-3 FA ratio and preferential incorporation of LC ω-3 FA (C20:5ω-3 
and C22:6ω-3) in PE. This modulatory effect likely resulted in an anti-cancer 
response through enhanced oxidative stress reactions such as LPO. Alterations in 
the lipid and FA composition influences membrane fluidity, which has a great effect 
on the execution of signalling cascade regulating cell survival. In addition, the 
membranes altered PUFA composition may determine the production of specific 
eicosanoid effectors. Overall, this study shows that the supply of variable dietary FA 
content, with a defined ω-6/ω-3 ratio can modulate specific cancer cells 
development, particularly those provided by fish oil and borage oil, thus providing 
selective strategies for chemoprevention.  
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6.1 GENERAL DISCUSSION 
Over the last few decades numerous lifestyle factors, including diet, have been 
identified as being major contributors in the development of numerous non-
communicable diseases that includes colon cancer (Huxley et al., 2009). Regarding 
diet, food intake patterns characterised by high saturated and ω-6 fatty acids (FA) 
and low fibre are considered as risk factors associated with the development of colon 
cancer (Giovannucci and Goldin, 1997; Slattery et al., 1998). In contrast, dietary ω-3 
FA are associated with several beneficial health effects, including cancer prevention 
(Larsson et al., 2004; Rose and Connolly, 1999).  
 
FA, which include the saturated, mono- and polyunsaturated classes, are important 
macromolecules required by cells, but especially the ω-6 and ω-3 polyunsaturated 
FA (PUFA) play an essential role in normal cellular function (Ibarguren et al., 2014). 
With its supply being diet dependent, however, research suggests that a balanced 
intake of these two PUFA families is the critical factor determining the physiological 
and biochemical processes within cells. It has been demonstrated that an 
imbalanced intake, i.e. high ω-6/ω-3 FA ratio, may ultimately influence the growth 
kinetics of cancer cells allowing them to persist (Simopoulos, 2008). Some of these 
mechanisms include the FA modulating effects on signal transduction pathways that 
results in an uninhibited proliferative activity, affecting redox homeostasis, as well as 
enhancing their resistance to apoptosis that favours their survival (Bartsch et al., 
1999). Consequently, as a preventive measure against malignancy, the selective 
management of the amount and type of dietary FA intake is advocated to modulate 
and inhibit the progress of colon cancer development (Reddy, 1994; Shike, 1999).  
 
6.1.1 Studies utilising an animal colon cancer model 
A reduction in hepatocyte nodules was observed in laboratory animals consuming 
dietary fats constituting a low ω-6/ω-3 FA (12:1) ratio (Abel et al., 2004). 
Furthermore, this dietary pattern increased membrane incorporation of ω-3 FA, 
altering the animals’ tissue oxidative status by enhancing the level of lipid 
peroxidation (LPO), which favoured the reduction in the pre-neoplastic liver lesions. 
Similar dietary FA ratio dependent anti-cancer effects have also been noted in other 
cancer studies (Kobayashi et al., 2006; Sarotra et al., 2010). 
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In the current study, the effect of different dietary fats with varying ω-6/ω-3 FA ratios 
and reference dietary oils (canola and olive oils) on carcinogen-induced rat colon 
aberrant crypt foci (ACF) development during cancer promotion was monitored. The 
modulation of proliferative and apoptotic indices were assessed in the colon crypt 
epithelium. In addition, alterations in the cells redox homeostasis was elucidated in 
the colon by monitoring the expression of oxidative stress and antioxidant defence 
genes. Specific combinations of fats normally associated with a human diet 
(MacKenzie, 2007; Meyer et al., 2003) were included and consisted of sunflower (S), 
borage (B) and fish (F) oils, each with a distinct FA profile. These fats were 
combined to generate different ω-6/ω-3 FA ratios designated as SB, SF and SBF for 
dietary treatment regimens. Canola and olive oils were used as comparative 
reference oils. No toxic effects on the liver and kidney were noticed when utilising 
serum biochemical chemistry analyses, which is a key characteristic for any 
chemopreventive approach (Kelloff et al., 1995).  
 
The development of ACF, the earliest biomarkers for cancer in the colon tissue 
appears to be enhanced by the fish oil containing diet, SF (Table 6.1). Furthermore, 
ACF multiplicity was differentially altered in response to the fat diets with the SF and 
the S oils, favouring an increased development of larger lesions containing 7 or more 
crypts/focus, that are known to progress into a more aggressive cancer phenotype 
(Raju, 2008; Srivastava et al., 2001). Relative to the other combined fats (SB and 
SBF) and the two reference oils, canola and olive, the SF and S diets seem to 
enhance both cell proliferation and apoptosis in the colon crypt epithelium. The latter 
result is of interest as the development of ACF and crypt multiplicity is determined by 
a critical balance between cell proliferation and apoptosis. Evidently, in early 
precursor lesions the balance is disrupted and cell proliferation seems to dominate 
resulting in their outgrowth (Roncucci et al., 2000). This occurred despite the 
increased dietary supply of C20:5ω-3 and C22:6ω-3, and subsequent elevation in 
cellular oxidative stress effected by long chain (LC) ω-3 FA known to enhance 
apoptosis in the colon (Hong et al., 2005).  
 
A previous study in rat colon mucosa utilizing the same oil mixtures (S, SB, SF and 
SBF) illustrated that the fish oil containing diets significantly altered membranes 
content of LC ω-3 PUFA due to an increase in C20:5ω-3 and C22:6ω-3 (Abrahams, 
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2009, Addendum 4). This effect enhanced the membranes susceptibility to LPO, 
which increased the level of oxidative stress in the colon mucosa. Dependent on the 
level of oxidative stress, signalling pathways promoting cell division or apoptosis can 
be activated (Schumacker, 2006), which essentially determines the survival of the 
pre-neoplastic lesions. Consequently, an altered apoptotic response relative to the 
cell proliferative response contributes significantly to cancer cells growth and survival 
(Hanahan and Weinberg, 2011), as noted with the SF diet under the current 
experimental conditions. This effect is contrary to numerous studies demonstrating 
the anti-cancer effects of fish oil (Rao et al., 2001; Reddy and Sugie, 1988; Reddy et 
al., 1991), and may be related to the stage of intervention and the resistance of pre-
neoplastic lesions to oxidative stress resulting in the differential stimulation of their 
growth.  
 
Table 6.1: Effects of the dietary oil ratios on ACF development and cell survival 
indices. 
Tissue response 
Dietary oils 
SB SF SBF Canola Olive 
Total ACF      
Multiplicity (≥7 crypts/focus)      
Proliferation      
Apoptosis      
                                                           ; increased =, decreased =.  
 
Cancer cells display escalated rates in generating ROS that aids in sustaining its 
proliferative nature (Grek and Tew, 2010). This is usually counterbalanced by an 
increase in cells antioxidant activities, which maintain ROS accumulation to a level 
that bypasses oxidative stress induced apoptosis (Valko et al., 2007). In the colon, 
the expression of Nudt1 and Gpx4 (see Chapter 4) was up-regulated due to the 
increased level of oxidative stress induced by the SF diet. The enhancement of ACF 
development and increased crypt multiplicity of larger lesions through the up-
regulated expression of Nudt1 may be associated with its subsequent translation and 
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supply of protein that eliminates the accumulation of oxidised DNA bases such as 8-
oxo-dGTP, thus protecting cells from oxidative stress induced apoptosis (Garre et 
al., 2011; Nakabeppu, 2014). As a result, the repair of damaged DNA is enhanced, 
favouring the pre-neoplastic cells growth and survival. Up-regulation in the cells 
antioxidant capacity with Gpx4 (Table 6.2) likely reduced the SF diet induced 
oxidative stress, thus minimizing the apoptotic response in relation to cell 
proliferation and hereby sustaining the development of the higher level of crypt 
multiplicity. Thus, in this case the SF diet appears to have a protective effect on 
existing pre-neoplastic lesions in the colon (Landriscina et al., 2009). 
 
In contrast to the SF diet, crypt multiplicity was significantly reduced by the borage oil 
containing diets (SB and SBF) (Table 6.1). The latter diets decreased both the 
proliferative and apoptotic activity in the animals’ colon mucosa. It would appear that 
these cell growth indices followed a similar pattern and that induction of apoptosis 
seems to be dominant in the large ACF, hence the decrease in size. Down-
regulation of Errc2 expression by the SB oil diet was noted earlier in this study 
(Chapter 4). This effect results in the reduction of DNA replication due to inhibiting 
the activity of RNA polymerase, which is a critical initiating factor for DNA 
transcription (Schaeffer et al., 1994). Hereby, the proliferative response in the 
transformed colonic cells is reduced.  
 
The SB diet’s up-regulation of Gpx4 (Table 6.2) protects the aberrant crypts against 
the eliminating effects of hydrogen peroxide (H2O2) (Imai and Nakagawa, 2003). A 
similar response in enhanced antioxidant capacity was noted with the canola and 
olive oil diets, with the latter displaying the greater effect. Increased levels of H2O2 
have been linked to promoting cancer development by enhancing signal 
transductions mediating a proliferative response and resistance to apoptosis (del 
Bello et al., 1999; Burdon, 1995; Polytarchou et al., 2005). The combination of 
borage and fish oil with diet SBF also resulted in a decreased apoptotic response, 
mainly due to the increased DNA repair effect exerted by the up-regulation in the 
expression of Xpa (Pascucci et al., 2011). This occurred despite an increase in LC 
FA, C20:4ω-6, C20:5ω-3 and C22:6ω-3 that are potent inducers of LPO and 
ultimately apoptosis (Brash, 2001; Das, 1999). Also, animals increased intake of total 
polyphenols (TTP: olive>SBF>SB>SF>canola) may be an additional factor 
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contributing to the diet’s reduction in controlled cell death normally initiated by an 
increase in cellular oxidative stress. Dietary polyphenols are noted for their 
antioxidant capacity and subsequent reduction in free radical induced damage in 
cells (Fresco et al., 2006). 
 
Table 6.2: Dietary oil ratios protective effects against increased oxidative 
stress during the promotion. 
Cellular response 
Dietary oils 
SB SF SBF Canola Olive 
Increased protection against oxidative 
stress 
+Gpx4 +Gpx4  +Gpx4 +Gpx4 
(i.e. antioxidant capacity)    +Srxn1 +Gsr 
    +Ngb +Srxn1 
     +Idh1 
     +Ppp1r15b 
     +Prnp 
Genes expression: up-regulated (+) 
 
The canola and olive oil diets provided the highest protection against the continued 
survival of the pre-neoplastic lesions in the colon mucosa as noted with the decline 
in crypt multiplicity (Table 6.1). This effect resulted from the oils decreasing 
modulation of both proliferation and apoptosis in the aberrant crypts similar to the SB 
and SBF diets that favoured a reduction in the larger lesions, thus inhibiting colon 
cancer development. The reference oils up-regulated the expression of several 
genes that functioned in enhancing the colon crypt cells protection against oxidative 
stress induced apoptosis (Table 6.2). Both oils mutually up-regulated the expression 
of Gpx4 and Srxn1, which lead to the reduction of cells H2O2 levels (Li et al., 2013). 
Oxidative stress induced apoptosis was further reduced by canola oil’s up-regulation 
of Ngb, who’s translated protein acts as a scavenger of ROS (Ascenzi et al., 2004). 
Similarly, olive oil reduced cells influx of ROS through the up-regulated antioxidant 
activity of Gsr, and increased the expressions of Idh1, Ppp1r15b and Prnp that 
mediate cellular responses that increases cells resistance against oxidative stress 
(Harvey et al., 2009; Reitman and Yan, 2010; Sauer et al., 2003). Hereby, 
modulating cells oxidative status can affect the induction of apoptotic mediators 
regulated by cells increased level of ROS (Chandra et al., 2000). The reduction of 
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cell proliferation and apoptosis by the SB, SBF and canola and olive oil, therefore 
could be related to the expression of these genes. The disruption of these growth 
indices in the colon crypts could then selectively reduce the outgrowth of the 
aberrant crypt lesions. 
 
Increased intake of C18:1ω-9, a FA recognized for its antioxidant activity (Diplock et 
al., 1988; Schuhr, 2008), was also noted with the canola and olive oils diets (Chapter 
3). This provided additional protection against ROS accumulation that has a 
modulating effect on the apoptotic and proliferative responses in the pre-neoplastic 
colonic cells. Relating to cells proliferative response, the expression of Ehd2 and 
Apoe (Table 6.3) was enhanced by both the canola and olive oil diets. Both these 
genes encodes for proteins that are potent inhibitors of tumour cell proliferation 
(Niemi et al., 2002; Shi et al., 2015). Although the oils resulted in a decreased 
apoptotic response, their mutual up-regulation of pro-apoptotic genes (Table 6.3) 
Cygb and LOC36198 (Helt et al., 2005; Shivapurkar et al., 2008) was indicative of 
the diets modulation of crypts cells level of oxidative stress that favoured the 
reduction of crypt multiplicity. Canola oil enhanced the expression of Mpo that also 
contributes towards oxidative stress mediated apoptosis (Nakazato et al., 2007), 
while olive oil up-regulated Apc, Ctbs and Dnm2 (Table 6.3). Up-regulated 
expression of Apc impacts on cell turnover by inhibiting COX-2 expression and 
functions as a tumour suppressor. (Fodde, 2002; Lew et al., 2002). Protein 
translated from the up-regulated expression of Dnm2 can function as an upstream 
regulator of p53-dependent apoptosis in dividing cells (Fish et al., 2000; Johnson et 
al., 1996). Similarly, up-regulated expression of Ctbs by the olive oil diet facilitates 
crypt cell regulation by activating initiator caspases, thus increasing apoptosis 
(Vancompernolle et al., 1998; Wang et al., 2008). Furthermore, the marginal 
apoptotic response in effect appears to be enhanced by canola and olive oil’s up-
regulation of Tpo, Duox1 and Ncf2, whose protein mediate an increased oxidative 
stress response (Grandvaux et al., 2007; Harvey et al., 2009; Ruf and Carayon, 
2006), thus effecting the crypts survival parameters. As a result of its high C18:3ω-3 
content, canola oil appears to exert an anti-inflammatory effect by suppressing 
inflammatory mediators that impact on proliferation and apoptosis (Larsson et al., 
2004). This was also noted with the diet’s up-regulation in the expression of immune 
response regulator, gene Rag2, who’s translated protein function as an anti-
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inflammatory mediator (Erdman et al., 2009). In this study the anti-cancer properties 
of canola and olive oils appears to be exerted primarily through a polypenolic effect, 
which protected cells against oxidative stress. A similar change in the expression of 
genes regulation of the oxidative status in the liver was noted in response to tea 
polyphenols enhancing the cellular antioxidant defences (van der Merwe, 2012). In 
the aberrant crypts, the cell proliferation and apoptosis balance is likely to shift in 
favour of the latter response with the noticeable reduction in crypt multiplicity 
suggesting that a certain level of oxidative stress (threshold) was reached to 
suppress ACF development. 
 
Table 6.3: The anti-cancer effects of canola and olive oil relating to its 
modification of oxidative stress and antioxidant defence genes expression in 
ACF. 
Cellular response 
 
Canola Olive 
Redox responsive genes expression effects 
Cancer inhibition   
Anti-proliferative +Ehd2 +Ehd2 
 +Apoe +Apoe 
Pro-apoptotic +Mpo +Apc 
 +Cygb +Ctbs 
 +LOC367198 +Cygb 
  +Dnm2 
  +LOC367198 
   
Increases oxidative stress +Tpo +Tpo 
 +Duox1 +Duox1 
 +Ncf2 +Ncf2 
Anti-inflammatory +Rag2  
Genes expression: up-regulated (+) or down regulated (-) 
 
Regulation of cell proliferative indices by ω-6 and ω-3 fatty acids 
An increased intake of C18:3ω-6 provided by borage oil’s intake with both the SB 
and SBF diets increases the incorporation of C20:3ω-6 as well as C20:5ω-3 in the 
mucosal membrane phospholipids (Abrahams, 2009 – Addendum 4) known for its 
anti-proliferative and anti-inflammatory effects via the effect of the PGE1 type of 
prostaglandins (Kapoor and Huang, 2006; Wang et al., 2012). Interesting 
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interactions seems to exist regarding the role of the SF and S diets, which stimulate 
ACF multiplicity, and the reduction effect induced by the SBF. It would appear that 
thresholds of specific membranal FA seem to exist when considering the levels of 
C20:3ω-6, C20:4ω-6 and C20:5ω-3 as detailed in Chapter 3. The respective roles of 
their prostanoid metabolites in the regulation of cell growth indices appear to be 
critical in the differential stimulation and/or inhibition of the development of ACF in 
the colon. Hence various combinations of oils, as indicated by the chemopreventive 
effect of the SBF oil diet, provide interesting futuristic research opportunities in the 
regulation of colon cancer development in humans. 
 
6.1.2 Investigations utilising human colon cancer cells 
Colon cancer is a complex disease, and animal carcinogenesis models (in vivo) 
provides invaluable information regarding the multistage nature of the disease and 
the effects potential chemopreventive agents have on integrated cellular systems 
(Dommels et al., 2002). Cell culture or in vitro studies, however, are isolated cellular 
systems that serve as a useful tool in evaluating the mechanistic pathways mediating 
cancer development and the different ways natural or synthetic agents/compounds 
can interfere with the process under controlled conditions (Grajek and Olejnik, 2004). 
In the current study, utilizing oil ratio emulsions of defined ω-6/ω-3 FA ratio resulted 
in differential effects in two human adenoma colon cancer cell lines (HT-29 and 
Caco-2) with respect to their survival indices.  
 
Modulation of colon cancer cells survival indices 
The HT-29 cells displayed greater sensitivity to the effects of the fish oil containing 
emulsions (SF and SBF) that resulted in its reduction of cell viability and cell 
proliferation. It was suggested that the oil’s supply of polyunsaturates, C20:5ω-3 and 
C22:6ω-3 increases the level of oxidative stress due to its susceptibility to LPO, 
which in turn affects cell growth regulatory signals (Catalá, 2009). This effect at 
higher oil emulsion concentrations, however, was insufficient to elicit an apoptotic 
response despite a decrease in the energy status (ATP production), which is a 
critical determinant of this cellular process. Consequently, the HT-29 cells undergo 
necrotic cell death, which occurs when the level of ATP fall beyond a certain 
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threshold inside the cell (Eguchi et al., 1997), indicating the pivotal role mitochondrial 
metabolism plays in cell death processes related to necrosis and apoptosis.  
 
Apoptotic responses in cancer cells are usually blocked due to mitochondrial 
dysfunction and its reduced sensitivity to oxidative stress (Pelicano et al., 2004). 
Thus, cancer cells tend to favour the glycolytic pathway (Warburg effect) to maintain 
its energy status and are not dependent on mitochondrial production of ATP 
(DeBerardinis et al., 2008). The latter seems to apply to the HT-29 cells, which 
displayed resistance to apoptosis, and exhibited a reduction in cell viability through 
the inhibition of ATP production by the oil emulsions. As a result, the cancer cells 
were depleted via necrotic cell death. The HT-29 cells resistance to apoptosis is 
likely associated with an impaired glycolytic pathway (Graz and Cowley, 1997), 
which would further exhaust the ATP yield to levels that are insufficient to stimulate 
the process. Conversely, at high oil emulsion concentration, cell cytotoxicity in the 
Caco-2 cells was not overtly triggered despite the fact that cell viability is adversely 
affected. Apart from the inhibitory effect exerted on cell viability and cell proliferation, 
the fish oil (SF) and borage oil (SBF) emulsions also induced an apoptotic response 
dependent on the cells ATP production at higher concentrations presumably 
involving mitochondrial production. Borage oil (SB) tended to only increase the 
apoptotic response at the highest concentrations. The differences in the emulsion 
induced responses are likely indicative of the cells shift in energy production. 
Therefore, in the Caco-2 cells, as mitochondrial ATP is depleted the glycolytic 
pathway supplies sufficient ATP for apoptosis to be activated (Tsujimoto, 1997).  
 
The anti-cancer effect (i.e. induction of apoptosis or inhibition of cell proliferation) of 
the oil emulsions was associated with modification of the FA and lipid composition of 
the Caco-2 cell membranes that are summarised in Fig. 6.1 and Fig. 6.2. As result of 
these alterations, specific cell signals were activated dependent on the FA and lipid 
content of the cellular membranes. Cells undergoing apoptosis displayed a 
significant decrease in membranes content of SATS and MUFA, which studies show 
are increased in cancer cells and provides protection against oxidative stress 
(Rysman et al., 2010). Although PUFA content tended to decrease, the reduced 
membrane ω-6/ω-3 FA ratio enhanced its LC ω-3 FA (C20:5ω-3 and C22:6ω-3) 
composition, that predisposes membranes to LPO and subsequent removal via 
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apoptosis ( Falconer et al., 1994; Hawkins et al., 1999; Udilova et al., 2003). Borage 
oil’s (SB) increase of C20:4ω-6 in PE also appears to facilitate this process 
(Hofmanová et al., 2012; Seegers et al., 1997). Cancer cells increase in C20:4ω-6 is 
well known to have a stimulatory effect on proliferation due to the activity of 
prostanoid, PGE2 (Castellone et al., 2005). However, excessive accumulation of the 
FA can result in an increase of ceramides that are potent stimulators of apoptosis 
(Cao et al., 2000; Surette et al., 1999). Alternate mechanisms of cancer cell removal 
likely involved the participation of eicosanoid signalling. The metabolism of 
membranes increased content of C20:3ω-6 and C20:5ω-3 (SB and SBF) results in 
an anti-inflammatory response that indirectly triggers apoptosis (Gillis et al., 2002; 
Kapoor and Huang, 2006; Roynette et al., 2004). In addition, changes in the Caco-2 
cells lipid parameters also had a role in activating this process (Fig. 6.2). 
 
 
 
Figure 6.1: Summary of the Caco-2 cell membranes altered FA content required to elicit apoptosis or 
inhibit cell proliferation in response to oil emulsion exposure. 
 
In apoptotic cells, the respective increase and decrease of PC and PE reflected the 
disruption of membranes homeostatic balance of phospholipids content in response 
to the oil emulsions. PC increased mainly due to its increased incorporation via the 
synthetic PC molecule (L-alpha phosphatidylchholine), which enhanced the uptake 
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of the oil emulsions FA supply. Excessive PC incorporation can affect the integrity of 
the membrane structure and modify associated functions. This increased effect has 
been shown to enhance the apoptotic response via the death ligands (Fas and/or 
TNF-alpha) pathway followed by caspase-8 and -3 inductions in the liver (Sakakima 
et al., 2009). A decrease in PE (S and SB) was effected by the emulsions in the 
apoptotic response as well. Externalisation of PE and a loss of membranes 
asymmetric distribution of aminophospholipids during the early stages of apoptosis 
appear to have a significant role in the process, although the exact mechanism is not 
fully understood (Emoto et al., 1997; Wang et al., 2004). 
 
 
 
Figure 6.2: Summary of the Caco-2 cell membranes altered lipid content required to elicit 
apoptosis or inhibit cell proliferation in response to oil emulsion exposure. 
 
Furthermore, modulation of the lipid parameters affecting membrane fluidity also 
affected the survival of the Caco-2 cells. A decrease in cholesterol and subsequent 
increase in the cholesterol/phospholipids (chol/PL) ratio increased membranes 
fluidity affecting the function of membrane associated proteins and specialised 
microdomains (lipid rafts) (Baritaki et al., 2007). Lipid rafts, characterized by its high 
cholesterol content that provides greater structural stability than the surrounding 
membrane, are important co-ordinators of various signalling pathways, and is often 
dysregulated in cancer cells (Patra, 2008; Wassall and Stillwell, 2009). Higher 
incorporation of LC ω-3 FA such as C20:5ω-3 and C20:6ω-3 into PE in response to 
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the borage oil containing emulsions (SB and SBF), increased membranes fluidity 
due to the FA structural configuration. This change could result in acylated proteins 
being displaced from lipid rafts (Stulnig et al., 2001) and reduce its cholesterol 
content, as noted with the Caco-2 cells. Consequently, lipid rafts modified 
biophysical properties may result in apoptosis being induced.  
 
To inhibit the proliferative activity of the Caco-2 cells, significant alterations of 
membranes FA and lipid composition was applied by the oil emulsions at much lower 
concentrations (Fig. 6.1 and 6.2). These changes were opposite of that required for 
the induction of apoptosis. Evidently, specific anti-cancer responses are dependent 
on a certain threshold being reached pertaining to FA incorporation into membrane 
compartments (Abel et al., 1997). A decline in generating daughter was cells were 
characterized by an increase in SATS and MUFA, and a decrease in PUFA. This 
effect reduced cancer membranes susceptibility to oxidative stress as a result of a 
decrease in membranes LC ω-3 FA content. Consequently, membranes C20:3ω-6 
content increased with all the emulsions, promoting an anti-proliferative effect (Fan 
and Chapkin, 1998). Furthermore, the lipid components PC, PE and cholesterol were 
all increased by the oil emulsions. Hereby, the physical structure of the Caco-2 cell 
membranes were also altered, thus affecting membrane associated signal 
transductions regulating proliferative responses (Eling and Glasgow, 1994) 
 
6.1.3 Animal cancer model versus cell culture studies 
Regarding the effect of the oil ratio combinations (SB, SF and SBF), different 
responses was observed with respect to the rat colon carcinogenesis model and the 
human colon cancer cell lines. Borage oil (SB and SBF) appears to have protective 
effects against cancer development in both models. This effect was probably due to 
modulating proliferative signals that resulted in its inhibition, presumably through 
specific interactions and the anti-proliferative effects of C20:3ω-6, C20:4ω-6 and 
C20:5ω-5 as previously discussed.  
 
The cell culture study demonstrated that the oil ratio combinations constituting 
different ω-6/ω-3 FA ratios significantly modified the cancer cells FA and lipid 
composition, which determined the anticancer response. Similar modulatory effects 
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have been observed in animals (Abel et al., 2004). A previous study in rat colon 
mucosa showed that borage oil (SB and SBF diet) enhanced membranes 
incorporation of C20:5ω-3, C20:3ω-6 and C20:4ω-6 (Abrahams, 2009), which are 
the precursory FA required for the biosynthesis of the 3-, 1- and 2- series 
eicosanoids, respectively having opposing effects regarding cell proliferation and 
inflammatory responses (Levin et al., 2002). Elevated C20:4ω-6 content appears to 
enhance the survival of cancer cells by increasing its proliferative response through 
prostanoid PGE2 stimulation (Whelan and McEntee, 2004). However, this effect can 
be counteracted by the SBF oil due to the resultant increase in membrane C20:5ω-3 
and C20:3ω-6, which increases the availability of the anti-inflammatory eicosanoids 
(3- and 1- series prostanoid) (Barham et al., 2000). This effect reduces the potential 
for persistent cell proliferation promoted by C20:4ω-6 derived metabolites.  
 
Fish oil (SF diet) and sunflower oil (S diet) enhanced cell proliferative indices as well 
as the development of ACF and its multiplicity of larger lesions when compared to 
the effects of the borage oil and fish oil combination diets (SB and SBF). The colon 
crypts homeostatic balance between apoptosis and cell proliferation shifted in favour 
of the latter with the S and SF diets, thereby resulting in the formation of the larger 
lesions (Yamashita et al., 1994). The increase and persistence of these aberrant 
crypts of high multiplicity appears to favour disease progression. In addition, it was 
indicated that an enhanced antioxidant response (up-regulated Gpx4) protected the 
aberrant crypt cells from oxidative stress induced removal.  
 
In contrast, both colon cancer lines (HT-29 and Caco-2) were responsive to the 
effects of fish oil. The HT-29 cells favoured a reduction in cell proliferation, whilst fish 
oil induced apoptosis and inhibited cell proliferation in the Caco-2 cells. The 
apoptotic response exerted by fish oil was associated with its increasing effect on 
cancer cell membranes C20:5ω-3 and C22:6ω-3 content that predisposes cells to 
LPO and subsequent removal via apoptosis. Changes in the PUFA content in 
cellular membranes also resulted from an increase in PC and a reduction in PE. 
These changes in membrane phospholipid as well as the cholesterol content affect 
membrane fluidity parameters likely to further alter signal transduction pathways 
related to cell survival. A threshold level pertaining to the incorporation of FA and 
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these lipid parameters into the cancer cell membranes determines whether cells will 
be sensitised or exhibit resistance towards the induction of apoptosis. 
 
6.2 Conclusions 
The dietary FA ratios employed in this investigation displayed differential effects on 
the development of cancer in both the animal cancer and cell culture models. 
However, altering the ω-6/ω-3 FA ratio intake and cancer cell membranes FA and 
lipid profile demonstrated a favourable reducing effect on the survival indices of 
colon cancer pre-neoplastic lesions in vivo and cancer cells in vitro. Borage oil 
combinations (SB and SBF) consistently displayed anti-cancer effects by inhibiting 
cell proliferation through the modulation of cell growth indices, presumably due to 
specific ratios of ω-6 and ω-3 FA. Fish oil had opposing effects on the animal and in 
vitro models, demonstrating threshold effects while specific combinations with 
borage oil exhibited a protective effect against the development of pre-neoplastic 
lesion (SBF diet). A reduction in cells level of oxidative stress effected by the SB and 
SBF oil diets demonstrated an enhanced antioxidant response through the up-
regulation of Gpx4 in the colon, which facilitated the decrease in apoptosis by both 
diets. However, the fish oil only diet (SF) appears to impart a selective resistance 
against oxidative stress, thus favouring the increase in proliferation of pre-neoplastic 
lesions during the promotion stage of colon carcinogenesis. In contrast, the HT-29 
and Caco-2 colon cancer cells showed differential anti-cancer effects in response to 
fish and borage oil dependent on the level of ω-3 PUFA incorporated into 
membranes. Consequently, alteration in membrane FA and other lipid constituents, 
such as phospholipids and cholesterol, impacted on the survival indices. Overall, 
modulating colon cancer development with dietary fats constituting defined ω-6/ω-3 
FA ratio is extremely complex but shows promise as a chemopreventive tool under 
specific defined conditions.  
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ADDENDUM 2 – CHAPTER 4 
 
2A. 
Table 4.1 Total polyphenol content of the dietary oils. 
Dietary oil 
TTP 
(mg gallic acid/kg oil) 
S 11.37±1.00a 
SB 12.65±1.65a 
SF 13.20±1.05a 
SBF 13.64±2.13a 
Canola 6.37±0.63b 
Olive 19.20±2.46c 
Values are the mean±standard deviation of the total polyphenol (TPP) 
content expressed in mg gallic acid/kg oil. Dietary oils: sunflower oil = 
S, sunflower + borage oil = SB, sunflower + fish oil (SF), sunflower + 
borage + fish oil = SBF, Canola = canola oil and Olive = olive oil. 
Values in column followed by different letters (superscript) are 
significantly different at p<0.05.
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2B. 
 
Figure 4.11: PCR microarray plate layout.
Array layout  
Aass Als2 Apc Apoe Aqr Cat Ccs Xirp1 Ctsb Duox2 Cygb Dhcr24 
A01  A02  A03  A04  A05  A06  A07  A08  A09  A10  A11  A12  
Dnm2 Duox1 Ehd2 Epx Errc2 Ercc6 Fancc Fmo2 Gab1 Gpx1 Gpx2 Gpx3 
B01  B02  B03  B04  B05  B06  B07  B08  B09  B10  B11  B12  
Gpx4 Gpx5 Gpx6 Gpx7 Gsr Gstk1 Hba-a2 Hbz Idh1 LOC367198 Lpo Mb 
C01  C02  C03  C04  C05  C06  C07  C08  C09  C10  C11  C12  
Mpo Mpp4 Ncf1 Ncf2 Ngb Nos2 Nox4 Noxa1 Noxo1 Nqo1 Nudt1 Nudt15 
D01  D01  D03  D04  D05  D06  D07  D08  D09  D10  D11  D12  
Nxn Park7 Ppp1r15b Prdx1 Prdx2 Prdx3 Prdx4 Prdx5 Prdx6 Prnp Psmb5 Ptgs1 
E01  E02  E03  E04  E05  E06  E07  E08  E09  E10  E11  E12  
Ptgs2 Rag2 Gpx8 Serpinb1b Kif9 Scd1 Ift172 Slc38a1 Scl38a4 Scl38a5 Scl41a3 Sod1 
F01  F02  F03  F04  F05  F06  F07  F08  F09  F10  F11  F12  
Sod2 Sod3 Srxn1 Tmod1 Tpo Txnip Txnrd1 Txnrd2 Ucp3 Vim Xpa Zmynd17 
G01  G02  G03  G04  G05  G06  G07  G08  G09  G10  G11  G12  
Rplp1 Hprt1 Rpl13a Ldha Actb RGDC RTC RTC RTC PPC PPC PPC 
H01  H02  H03  H04  H05  H06  H07  H08  H09  H10  H11  H12  
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2C. 
Table 4.2: Complete list of genes associated with oxidative stress and 
antioxidant defences in the RT2 ProfileTM PCR array (PARN-065). Presented as 
obtained from www.sabiosciences.com on 18-11-2014. 
Position Symbol Description Gene Name 
A01 Aass Aminoadipate-semialdehyde synthase 
A02 Als2 Amyotrophic lateral sclerosis 2 (juvenile) homolog (human) 
A03 Apc Adenomatous polyposis coli RATAPC 
A04 Apoe Apolipoprotein E APOEA 
A05 Aqr Aquarius homolog (mouse) 
A06 Cat Catalase 
CS1, Cas1, Cs-1, RATCAT01, 
RATCATL 
A07 Ccs Copper chaperone for superoxide dismutase 
A08 Xirp1 Xin actin-binding repeat containing 1 Cmya1 
A09 Ctsb Cathepsin B 
A10 Duox2 Dual oxidase 2 Thox2 
A11 Cygb Cytoglobin MGC95105, Staap, Stap 
A12 Dhcr24 24-dehydrocholesterol reductase 
B01 Dnm2 Dynamin 2 DYIIAAB 
B02 Duox1 Dual oxidase 1 
B03 Ehd2 EH-domain containing 2 MGEPS 
B04 Epx Eosinophil peroxidase 
B05 Ercc2 
Excision repair cross-complementing rodent repair deficiency, 
complementation group 2 

B06 Ercc6 
Excision repair cross-complementing rodent repair deficiency, 
complementation group 6 

B07 Fancc Fanconi anemia, complementation group C Facc 
B08 Fmo2 Flavin containing monooxygenase 2 
B09 Gab1 GRB2-associated binding protein 1 
B10 Gpx1 Glutathione peroxidase 1 GSHPx, GSHPx-1 
B11 Gpx2 Glutathione peroxidase 2 GPX-GI, GSHPx-2, GSHPx-GI 
B12 Gpx3 Glutathione peroxidase 3 GSHPx-3, GSHPx-P, Gpxp 
C01 Gpx4 Glutathione peroxidase 4 Phgpx, gpx-4, snGpx 
C02 Gpx5 Glutathione peroxidase 5 
C03 Gpx6 Glutathione peroxidase 6 OBPII, Ry2d1 
C04 Gpx7 Glutathione peroxidase 7 
C05 Gsr Glutathione reductase 
C06 Gstk1 Glutathione S-transferase kappa 1 GST13-13, GSTkappa 
C07 Hba-a2 Hemoglobin alpha, adult chain 2 HBAM, Hba-a1, Hba1 
C08 Hbz Hemoglobin, zeta RGD1307486 
C09 Idh1 Isocitrate dehydrogenase 1 (NADP+), soluble 
C10 LOC367198 
Similar to Serine/threonine-protein kinase ATR (Ataxia telangiectasia 
and Rad3-related protein) 

C11 Lpo Lactoperoxidase 
C12 Mb Myoglobin 
D01 Mpo Myeloperoxidase 
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Table 4.2 (cont.) 
Position Symbol Description Gene Name 
D02 Mpp4 Membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) Dlg6 
D03 Ncf1 Neutrophil cytosolic factor 1 Ncf-1, p47phox 
D04 Ncf2 Neutrophil cytosolic factor 2 
D05 Ngb Neuroglobin 
D06 Nos2 Nitric oxide synthase 2, inducible Nos2a, iNos 
D07 Nox4 NADPH oxidase 4 
D08 Noxa1 NADPH oxidase activator 1 
D09 Noxo1 NADPH oxidase organizer 1 
D10 Nqo1 NAD(P)H dehydrogenase, quinone 1 Dia4, MGC93075 
D11 Nudt1 Nudix (nucleoside diphosphate linked moiety X)-type motif 1 Mth1 
D12 Nudt15 Nudix (nucleoside diphosphate linked moiety X)-type motif 15 
E01 Nxn Nucleoredoxin 
E02 Park7 Parkinson disease (autosomal recessive, early onset) 7 CAP1, DJ-1, Dj1, SP22 
E03 Ppp1r15b Protein phosphatase 1, regulatory (inhibitor) subunit 15b 
E04 Prdx1 Peroxiredoxin 1 Hbp23, MGC108617 
E05 Prdx2 Peroxiredoxin 2 Tdpx1 
E06 Prdx3 Peroxiredoxin 3 Prx3 
E07 Prdx4 Peroxiredoxin 4 MGC72744 
E08 Prdx5 Peroxiredoxin 5 Aoeb166 
E09 Prdx6 Peroxiredoxin 6 
E10 Prnp Prion protein PrP, Prn 
E11 Psmb5 Proteasome (prosome, macropain) subunit, beta type 5 
E12 Ptgs1 Prostaglandin-endoperoxide synthase 1 Cox-3, Cox1, Cox3 
F01 Ptgs2 Prostaglandin-endoperoxide synthase 2 COX-2, Cox2 
F02 Rag2 Recombination activating gene 2 
F03 Gpx8 Glutathione peroxidase 8 RGD1307506 
F04 Serpinb1b Serine (or cysteine) peptidase inhibitor, clade B, member 1b RGD1560658 
F05 Kif9 Kinesin family member 9 RGD1565187 
F06 Scd1 Stearoyl-Coenzyme A desaturase 1 
F07 Ift172 Intraflagellar transport 172 homolog (Chlamydomonas) Slb 
F08 Slc38a1 Solute carrier family 38, member 1 Ata1, GlnT, Sat1 
F09 Slc38a4 Solute carrier family 38, member 4 Ata3 
F10 Slc38a5 Solute carrier family 38, member 5 SN2 
F11 Slc41a3 Solute carrier family 41, member 3 
F12 Sod1 Superoxide dismutase 1, soluble CuZnSOD 
G01 Sod2 Superoxide dismutase 2, mitochondrial 
G02 Sod3 Superoxide dismutase 3, extracellular ECSODPT 
G03 Srxn1 Sulfiredoxin 1 homolog (S. cerevisiae) Ab2-390, Npn3 
G04 Tmod1 Tropomodulin 1 E-Tmod, Tmod 
G05 Tpo Thyroid peroxidase 
G06 Txnip Thioredoxin interacting protein MGC94673, Vdup1 
G07 Txnrd1 Thioredoxin reductase 1 MGC93353, Tr 
G08 Txnrd2 Thioredoxin reductase 2 MGC93435, Tr3, Trxr2, Trxrd2 
G09 Ucp3 Uncoupling protein 3 (mitochondrial, proton carrier) 
G10 Vim Vimentin 
G11 Xpa Xeroderma pigmentosum, complementation group A 
G12 Zmynd17 Zinc finger, MYND-type containing 17 
H01 Rplp1 Ribosomal protein, large, P1 MGC72935 
H02 Hprt1 Hypoxanthine phosphoribosyltransferase 1 Hgprtase, Hprt, MGC112554 
H03 Rpl13a Ribosomal protein L13A 
H04 Ldha Lactate dehydrogenase A Ldh1 
H05 Actb Actin, beta Actx 
H06 RGDC Rat Genomic DNA Contamination RGDC 
H07 RTC Reverse Transcription Control RTC 
H08 RTC Reverse Transcription Control RTC 
H09 RTC Reverse Transcription Control RTC 
H10 PPC Positive PCR Control PPC 
H11 PPC Positive PCR Control PPC 
H12 PPC Positive PCR Control PPC 
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ADDENDUM 3   CHAPTER 5 
Table 5.4: Cholesterol and phospholipids content in Caco-2 cell membranes after 48 hours exposure to oil emulsions. 
Lipid 
Oil emulsions 
Control S SB SF SBF 
 Apoptosis inducing 
 0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 
Cholesterol 1.600.38
a 
1.570.33
a
A 2.610.39
a
A 4.710.31
b 
2.120.33
a 
PC 61.115.22
a 
128.314.61
b 
258.5012.05
c
A 225.8011.41
c
A 197.0019.91
c
A 
PE 30.882.28 45.795.93A 39.124.67A 39.993.80 42.542.61 
PC/PE 1.600.23
a 
3.560.12
b
A 7.870.55
c
A 7.440.55
c
A 7.331.21
c
A 
chol/PL 0.0470.006
ad 
0.0200.005
b
A 0.0170.004
b
A 0.0320.003
c
A 0.0480.002
d
A 
      
 BrdU IC50 
 0 mg/ml 5.5  mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 
Cholesterol 1.600.38
a 
4.300.88
b
B 3.490.18
b
B 4.910.91
b 
2.070.19
a 
PC 61.115.22
a 
121.005.99
b 
101.605.01
b
B 111.506.41
b
B 112.15.69
b
B 
PE 30.882.28
a 
80.356.00
b
B 66.730.72
b
B 46.694.61
c 
42.933.65
c 
PC/PE 1.600.23
a 
1.390.10
a
B 1.880.24
abc
B 2.760.18
bd
B 2.270.23
cd
B 
chol/PL 0.0470.006
a 
0.0320.002
b
B 0.0380.003
b
B 0.0190.002
c
B 0.0240.001
c
B 
Values represent the means  standard deviations (N = 4-5)     h   h l      l ( h l)   d  h   h l   d (PL)          x      d    μg  h l      l     h   h   )     mg 
protein in the Caco-2 cell membranes.  Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower + fish oils and SBF = sunflower + borage + fish oils. PC = 
phosphatidylcholine and PE = phosphatidylethanolamine. Values in a row followed by different letters (superscript) are significantly different at p<0.05. Values in a column 
representing the corresponding lipid variable at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion treatments are significantly 
different at p<0.05 following different letters (uppercase subscript). 
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Table 5.5: Saturated fatty acids content of Caco-2 cell membranes after 48 hours exposure to oil emulsions. 
Fatty 
Acid 
Variable 
PC fraction PE fraction 
control S SB SF SBF control S SB SF SBF 
  Apoptosis inducing Apoptosis inducing 
  0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 
C16:0 % 25.72±2.97 24.99±6.54 22.50±3.45 20.80±3.34 23.79±4.89 17.19±4.64a 13.73±1.64ab 8.23±1.43b 8.51±0.91b 10.97±2.54ab 
 μg 30.77±7.41
a 
12.09±0.80
b
A 16.06±1.87
b 
13.87±3.99
b
A 23.24±2.34
ab 
12.44±5.04
a 
10.37±1.49
b
A 5.51±2.14
b 
5.57±0.98
b
A 10.24±2.25
b 
C18:0 % 9.19±0.80
a 
4.66±0.90
b 
7.93±1.39
 
6.04±1.41
 
7.03±1.86
 
16.29±4.94 17.76±4.18 23.48±3.81 17.92±8.63 17.50±3.26 
 μg 6.90±3.17
a 
2.76±0.35
b
A 6.69±1.70
a 
7.72±1.53
a 
8.31±2.55
a 
13.85±5.72
ab 
12.42±3.14
ab
A 19.06±4.12
a
A 7.61±0.46
b
A 16.95±3.83
ab 
Total 
SATS 
% 31.19±2.80 30.87±6.61 29.87±1.06 26.57±2.98 31.81±3.76 34.98±3.74
a 
29.77±6.85
a 
31.14±2.24
a 
23.97±3.70
b 
24.47±2.13
b
A 
 μg 37.62±5.58
a 
16.16±0.46
b
A 24.63±3.42
b 
20.99±7.50
b
A 33.80±5.54
a 
33.01±6.95
a 
24.39±4.71
b
A 24.23±1.84
b
 13.92±1.54
c
A 28.30±6.18
ab 
    
  BrdU IC50 BrdU IC50 
  0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 
C16:0 % 25.72±2.97 21.35±3.04 19.52±1.26 19.98±1.97 22.17±2.31 17.19±4.64a 16.82±3.10a 8.98±0.76b 12.89±2.64ab 15.27±3.98ab 
 μg 30.77±7.41
a 
26.96±8.70
ab
B 17.36±2.35
b 
25.33±3.85
ab
B 30.25±8.40
a 
16.15±2.39
ad 
21.38±1.67
b
B 6.07±0.60
c 
18.31±1.05
ab
B 12.66±2.43
d 
C18:0 % 9.19±0.80 6.71±1.49 6.99±0.93 6.67±1.20 5.72±0.64 16.29±4.94 19.14±2.55 14.25±1.03 18.55±1.09 20.86±4.32 
 μg 6.90±3.17 6.21±1.01B 6.26±1.27 8.82±2.09 6.61±1.25 13.85±5.72
ac 
26.64±4.45
b
B 9.83±0.33
c
B 33.34±2.96
d
B 17.39±3.80
a 
Total 
SATS 
% 31.19±2.80 28.28±1.92 28.67±2.11 27.25±2.30 28.27±1.03 34.98±3.74
ac 
39.17±3.18
ac 
24.50±1.00
b 
32.56±3.83
c 
38.13±6.53
a
B 
 μg 37.62±5.58 33.76±8.87B 25.70±4.20 36.29±5.17B 34.72±5.03 33.01±6.95
a 
46.17±8.89
b
B 16.50±0.51
c 
52.76±2.74
b
B 31.79±6.32
a 
Values represent the means  standard deviations (N = 4-5)     h  q  l     v  (%        l          d )   d q         v  (μg        mg        )          d                -2 cell 
membrane phospholipid fractions phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower 
+ fish oils and SBF = sunflower + borage + fish oils. SATS = saturated fatty acids. Values in a row followed by different letters (superscript) are significantly different at p<0.05. 
Values in a column representing the corresponding fatty acid variable at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion 
treatments are significantly different at p<0.05 following different letters (uppercase subscript). 
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Table 5.6: Monounsaturated fatty acids content of Caco-2 cell membranes after 48 hours exposure to oil emulsions. 
Fatty Acid Variable 
PC fraction PE fraction 
control S SB SF SBF control S SB SF SBF 
  Apoptosis inducing Apoptosis inducing 
  0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 
C16:1ω-7 % 6.29±1.52
a 
3.67±1.07
b
A 3.85±0.75
b
A 3.45±0.67
b 
3.45±0.46
b
A 2.62±0.67
a 
2.01±0.35
ab
 1.63±0.24
b
A 1.71±0.32
b
A 1.49±0.20
b
A 
 μg 4.24±1.05 4.55±0.54A 3.23±0.64A 3.00±0.44A 3.74±0.78A 2.50±0.99
a 
1.60±0.29
ab
A 2.28±0.40
a 
1.18±0.21
b
A 1.51±0.43
ab
A 
C18:1ω-9 % 18.22±2.37
a 
15.44±2.06
ab 14.93±1.07b 14.59±0.67b 15.68±1.69ab 17.02±2.35a 15.46±1.53ab 12.93±1.62bA 13.11±0.64
b
A 14.13±1.31
ab 
 μg 19.39±5.11
a 
18.44±0.66
ab
A 11.49±2.04
ab 
10.50±2.93
b
A 17.57±2.47
ab 
12.79±2.83
ab 
13.06±2.51
ab
A 15.07±4.85
a 
8.37±0.51
b
A 14.47±3.66
a 
C18:1ω-7 % 5.21±1.57 4.83±1.14 4.75±0.89 5.09±0.47 4.40±1.39 4.27±0.98 3.48±0.75 3.01±0.50 3.14±1.11 2.91±0.63 
 μg 5.96±1.80 4.97±0.51A 3.74±0.73 4.06±0.68A 6.08±0.75 3.59±0.55 2.58±0.37A 3.13±0.33 2.41±0.18A 3.16±0.52 
Total 
MUFA 
% 28.93±3.15 22.99±4.89A 23.95±2.71 22.92±3.69 25.29±3.54 23.53±4.94 21.86±2.51 18.68±2.11A 18.76±1.49A 19.96±0.93 
 μg 27.15±7.38 29.17±1.24A 18.81±3.84 19.00±4.00A 26.69±6.48 21.92±3.02
a 
17.77±3.26
ab
A 21.03±6.44
ab 
12.70±0.96
b
A 19.42±2.43
ab
A 
    
  BrdU IC50 BrdU IC50 
  0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 
C16:1ω-7 % 6.29±1.52
ab 
6.94±1.08
a
B 7.18±0.35
a
B 4.77±0.61
b 
6.14±1.44
ab
B 2.62±0.67 3.05±0.30 3.18±0.31B 2.59±0.35B 2.44±0.13B 
 μg 4.24±1.05
a 
9.09±1.66
b
B 6.37±0.58
ab
B 6.95±1.34
b
B 8.04±0.56
b
B 2.50±0.99
a 
4.25±0.42
b
B 2.29±0.20
a 
4.30±0.09
b
B 3.02±0.63
ab
B 
C18:1ω-9 % 18.22±2.37
a 
17.45±1.43
ab 
17.93±0.90
ab 
15.14±0.83
b 
17.67±1.12
ab 
17.02±2.35 18.84±0.85 19.04±0.52B 18.27±1.25B 17.42±2.16 
 μg 19.39±5.11
ac 
27.38±5.17
b
B 15.88±1.11
a 
19.96±1.95
ab
B 23.55±4.09
bc 
12.79±2.83
a 
26.14±1.65
b
B 12.88±1.03
a 
31.42±1.05
b
B 19.16±1.72
c 
C18:1ω-7 % 5.21±1.57 5.25±0.89 5.15±0.38 4.58±0.35 4.85±1.07 4.27±0.98 3.78±0.52 4.00±0.19 4.34±0.49 3.78±0.72 
 μg 5.96±1.80
ab 
7.99±1.53
a
B 4.56±0.34
b 
7.25±1.71
a
B 6.08±0.83
ab 
3.59±0.55
ac 
4.97±0.57
b
B 2.71±0.25
c 
7.00±0.67
d
B 4.15±0.60
ab 
Total 
MUFA 
% 28.93±3.15 30.32±3.79B 31.21±1.74 25.34±1.75 29.45±3.60 23.53±4.94 26.39±0.59 27.28±1.06B 25.10±1.62B 25.41±2.23 
 μg 27.15±7.38
a 
43.46±6.41
b
B 27.70±2.15
a 
33.88±3.63
ab
B 37.29±2.55
ab 
21.92±3.02
ad 
36.74±2.84
bc
B 17.98±2.39
ab 
43.22±2.39
c
B 27.54±2.78
d
B 
Values represent the means  standard deviations (N = 4-5)     h  q  l     v  (%        l          d )   d q         v  (μg        mg        )          d                -2 cell membrane 
phospholipid fractions phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower + fish oils and SBF = 
sunflower + borage + fish oils. MUFA = monounsaturated fatty acids. Values in a row followed by different letters (superscript) are significantly different at p<0.05. Values in a column 
representing the corresponding fatty acid variable at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion treatments are significantly different 
at p<0.05 following different letters (uppercase subscript). 
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Table 5.7: Polyunsaturated fatty acid (ω-3) content of Caco-2 cell membranes after 48 hours exposure to oil emulsions. 
Fatty Acid Variable 
PC fraction PE fraction 
control S SB SF SBF control S SB SF SBF 
  Apoptosis inducing Apoptosis inducing 
  0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 
 18 3ω-3 % 0.13±0.10 0.09±0.03 0.08±0.01 0.06±0.03 0.12±0.02 0.07±0.02 0.10±0.04 0.07±0.01 0.06±0.02 0.11±0.05 
 μg 0.04±0.01
a 
0.04±0.02
ab 
0.06±0.01
ab
A 0.04±0.01
a
A 0.14±0.02
b 
0.05±0.01 0.07±0.02A 0.04±0.01 0.04±0.02A 0.07±0.01 
 20 5ω-3 % 0.95±0.34
a 
0.40±0.11
a
A 0.63±0.15
ab 
1.35±0.30
b
A 1.06±0.09
ab
A 1.11±0.14
a 
1.39±0.12
a
A 0.98±0.39
a
 3.51±0.25
b
A 2.67±0.27
c
A 
 μg 1.56±0.26
a 
0.38±0.14
b
A 0.47±0.13
b
A 1.05±0.38
a
A 1.18±0.06
a
A 0.94±0.14
a 
1.00±0.11
a 
1.03±0.05
ac
A 2.35±0.19
bc
A 2.39±0.24
b
A 
 22 5ω-3 % 0.48±0.30
a 
0.51±0.12
a
A 0.70±0.12
a
A 0.82±0.03
a
A 1.37±0.37
b 
0.81±0.42
a 
1.90±0.23
b
A 2.31±0.10
bc
A 3.13±0.37
c
A 2.32±0.71
bc
A 
 μg 0.29±0.09
a 
0.62±0.19
a
A 0.52±0.16
a
A 0.55±0.17
a
A 1.20±0.18
b 
0.91±0.70 1.25±0.34A 1.49±0.28A 1.94±0.36A 2.64±0.14A 
 22 6ω-3 % 0.98±0.20 1.33±0.37A 1.03±0.09A 1.03±0.17A 1.10±0.42A 1.98±0.82
a 
3.16±0.65
ab
A 3.80±0.91
bc
A 4.70±0.37
c
A 4.38±0.70
bc
A 
 μg 0.60±0.27 1.31±0.48A 0.90±0.37A 0.74±0.11A 1.41±0.17A 2.64±0.31
ab 
2.03±0.39
a 
2.81±0.41
ab
A 3.31±0.19
b
A 4.35±0.56
c
A 
    l ω-3 % 2.58±0.44
a 
2.35±0.52
a
A 2.55±0.41
a
A 3.35±0.58
bc
A 3.37±0.60
c 
4.01±0.80
a 
6.63±1.30
b
A 7.48±1.56
c
A 11.55±2.10
d
A 9.72±1.80
e
A 
 μg 2.52±0.64
a 
2.39±0.53
a
A 2.01±0.35
a
A 2.44±0.44
a
A 4.04±0.63
b
A 4.57±1.06
a 
4.45±0.83
a
A 5.40±1.15
a
A 7.74±1.44
b
A 9.70±1.79
b
A 
  BrdU IC50 BrdU IC50 
  0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 
 18 3ω-3 % 0.13±0.10
a 
0.04±0.02
b 
0.13±0.02
a 
0.05±0.02
ab 
0.08±0.03
ab 
0.07±0.02
a 
0.16±0.01
b 
0.09±0.02
a 
0.09±0.03
ab 
0.07±0.02
a 
 μg 0.04±0.03
a 
0.05±0.02
a 
0.12±0.01
b
B 0.11±0.01
b
B 0.11±0.02
b 
0.05±0.01
a 
0.21±0.02
b
B 0.06±0.01
a
 0.15±0.05
b
B 0.08±0.03
a 
 20 5ω-3 % 0.95±0.34
a 
0.98±0.15
a
B 1.02±0.12
a 
2.09±0.35
b
B 2.03±0.64
b
B 1.11±0.14
a 
0.63±0.12
a
B 0.88±0.09
a
 2.49±0.33
b
B 1.33±0.30
a
B 
 μg 1.56±0.26
ac 
1.41±0.44
ac
B 0.84±0.12
a
B 3.62±0.84
b
B 2.19±0.91
c
B 0.94±0.14
a 
0.87±0.18
a 
0.64±0.03
a
B 4.63±0.97
b
B 1.89±0.59
c
B 
 22 5ω-3 % 0.48±0.30
a 
1.29±0.10
b
B 1.28±0.13
b
B 2.25±0.14
c
B 0.93±0.24
b 
0.81±0.42
a 
1.02±0.41
a
B 1.01±0.11
a
B 2.11±0.52
b
B 1.15±0.07
ab
B 
 μg 0.29±0.09
a 
1.38±0.23
b
B 1.13±0.10
b
B 3.47±0.93
c
B 1.32±0.19
b 
0.91±0.70
a 
1.81±0.17
b
B 0.73±0.02
c
B 3.99±0.04
d
B 3.24±1.69
d
B 
 22 6ω-3 % 0.98±0.20
a 
2.22±0.18
b
B 2.25±0.20
b
B 2.29±0.57
b
B 2.02±0.53
b
B 1.98±0.82 1.46±0.16B 2.23±0.12B 2.27±0.15B 1.80±0.17B 
 μg 0.60±0.27
a 
2.40±0.41
b
B 1.99±0.15
b
B 3.87±0.96
c
B 2.60±0.80
b
B 2.64±0.31
a 
2.04±0.29
ab 
1.51±0.11
b
B 4.06±0.82
c
B 2.00±0.04
ab
B 
    l ω-3 % 2.58±0.44
a 
4.60±0.91
b
B 4.78±0.89
b
B 6.76±1.18
c
B 5.15±0.97
b 
4.01±0.80
a 
3.33±0.59
a
B 4.32±0.88
a
B 7.18±1.18
b
B 4.54±0.75
a
B 
 μg 2.52±0.64
a 
5.33±1.00
b
B 4.17±0.79
bd
B 11.21±1.94
c
B 6.33±1.15
d
B 4.57±1.06
a 
5.02±0.90
a
B 3.01±0.59
b
B 13.16±2.20
c
B 7.39±1.34
d
B 
Values represent the means  standard deviations (N = 4-5)     h  q  l     v  (%        l          d )   d q         v  (μg        mg        )          d                -2 cell membrane 
phospholipid fractions phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower + fish oils and SBF = 
sunflower + borage + fish oils. Values in a row followed by different letters (superscript) are significantly different at p<0.05. Values in a column representing the corresponding fatty acid 
variable at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion treatments are significantly different at p<0.05 following different letters 
(uppercase subscript). 
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Table 5.8: Polyunsaturated fatty acid (ω-6) content of Caco-2 cell membranes after 48 hours exposure to oil emulsions. 
Fatty Acid Variable 
PC fraction PE fraction 
control S SB SF SBF control S SB SF SBF 
  Apoptosis inducing Apoptosis inducing 
  0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 
 18 2ω-6 % 1.68±0.30
a 
6.22±1.85
b 
7.12±1.44
bc 
9.31±0.94
c
A 9.34±2.27
bc 
1.27±0.08
a 
4.22±0.32
b 
3.04±0.48
c
A 3.95±1.39
b
A 4.11±0.84
b 
 μg 1.85±0.31
a 
5.51±0.57
b
A 5.95±1.09
b 
7.29±1.22
c
A 11.60±0.71
d
A 1.07±0.08
a 
3.30±0.21
b
A 3.79±0.52
b 
3.23±0.29
b
A 4.84±0.98
c 
 20 3ω-6 % 0.43±0.22
a 
0.45±0.16
a 
0.79±0.10
b 
0.39±0.09
a 
0.77±0.21
b
A 0.40±0.12
a 
0.69±0.13
b 
0.99±0.26
c 
0.74±0.06
b 
1.23±0.28
d 
 μg 0.24±0.08
a 
0.34±0.06
b 
0.45±0.07
c 
0.23±0.03
a
A 0.85±0.29
d
A 0.55±0.09
a 
1.02±0.03
b 
2.53±0.04
c 
1.34±0.06
b 
1.22±0.48
b 
 20 4ω-6 % 1.04±0.34
a 
1.78±0.46
b
A 2.28±0.08
c
A 2.27±0.16
c 
2.37±0.64
c 
2.55±0.87
a 
6.81±0.71
b
A 7.51±1.79
c 
9.17±0.70
d
A 8.94±1.36
d
A 
 μg 2.47±0.05
a 
1.57±0.38
b
A 1.58±0.28
b
A 1.46±0.22
b
A 2.75±0.46
a 
3.25±0.40
a 
3.64±0.41
ab 
6.16±0.59
bc
A 5.99±0.72
bc
A 8.36±0.96
c
A 
    l ω-6 % 4.13±0.60
a 
9.33±2.36
b 
11.55±2.64
b 
13.03±3.58
b
A 13.90±3.52
b 
9.06±0.79
a 
13.54±2.67
bc 
13.64±2.74
b 
15.55±3.49
c 
16.04±3.36
bc
A 
 μg 5.77±0.95
a 
8.89±2.05
b
A 8.97±2.24
b
A 9.79±2.82
b
A 16.90±4.39
c 
7.57±1.00
a 
9.66±1.49
b
A 14.40±2.27
c 
11.67±2.27
b
A 15.89±3.28
c 
    
  BrdU IC50 BrdU IC50 
  0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.8 mg/ml 
 18 2ω-6 % 1.68±0.30
a 
7.34±1.12
b 
7.61±0.54
b 
12.75±1.04
c
B 6.84±1.64
b 
1.27±0.08
a 
5.21±0.81
b 
6.08±0.27
b
B 10.10±1.27
c
B 5.06±1.03
b 
 μg 1.85±0.31
a 
11.96±1.38
b
B 6.74±0.56
c 
17.01±1.61
d
B 8.56±1.07
c
B 1.07±0.08
a 
7.23±1.19
b
B 4.11±0.38
c 
15.98±1.03
d
B 5.55±0.88
bc 
 20 3ω-6 % 0.43±0.22
a 
0.53±0.12
a 
0.76±0.07
b 
0.41±0.04
a 
1.14±0.16
c
B 0.40±0.12
a 
0.98±0.17
b 
1.21±0.14
bc 
0.92±0.05
b 
1.37±0.13
c 
 μg 0.24±0.08
a 
0.45±0.08
b 
0.68±0.12
c 
0.52±0.07
a
B 1.75±0.70
d
B 0.55±0.09
a 
1.38±0.22
b 
2.55±0.05
c 
1.39±0.23
b 
1.49±0.21
b 
 20 4ω-6 % 1.04±0.34
a 
3.47±0.30
b
B 3.53±0.30
b
B 3.16±0.29
b 
3.28±1.08
b 
2.55±0.87
a 
3.31±0.62
b
B 5.67±0.45
c 
5.33±0.45
c
B 4.48±0.86
d
B 
 μg 2.47±0.05
a 
3.61±0.54
ab
B 3.12±0.28
ab
B 4.34±0.50
b
B 3.30±1.03
ab 
3.25±0.40
a 
4.14±0.52
a 
4.05±0.02
a
B 10.07±1.71
b
B 4.94±0.58
a
B 
    l ω-6 % 4.13±0.60
a 
12.23±2.88
b 
12.78±2.97
b 
17.46±4.95
c
B 12.07±2.64
b 
9.06±0.79
a 
12.04±1.88
b 
13.94±2.78
c 
18.04±3.95
d 
13.71±1.98
c
B 
 μg 5.77±0.95
a 
16.97±4.66
b
B 16.25±2.64
b
B 23.35±6.61
c
B 14.53±3.24
b 
7.57±1.00
a 
15.11±2.66
b
B 13.01±1.72
b 
29.90±6.51
c
B 18.03±1.89
b 
Values represent the means  standard deviations (N = 4-5)     h  q  l     v  (%        l          d )   d q         v  (μg        mg        )          d                -2 cell 
membrane phospholipid fractions phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower + fish 
oils and SBF = sunflower + borage + fish oils. Values in a row followed by different letters (superscript) are significantly different at p<0.05. Values in a column representing the 
corresponding fatty acid variable at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion treatments are significantly different at p<0.05 
following different letters (uppercase subscript). 
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Table 5.9: Total polyunsaturated fatty acid (ω-3 and ω-6) and ratios content of Caco-2 cell membranes after 48 hours exposure to 
oil emulsions.  
Fatty Acid Variable 
PC fraction PE fraction 
control S SB SF SBF control S SB SF SBF 
  Apoptosis inducing Apoptosis inducing 
  0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 0 mg/ml 8.5 mg/ml 7.5 mg/ml 8.9 mg/ml 6.0 mg/ml 
Total PUFA % 6.71±0.11
a 
11.06±1.55
b
A 14.29±0.92
c
A 15.98±1.21
d
A 17.34±2.88
e 
13.09±0.01
a 
20.17±0.27
b
A 21.12±2.37
b 
27.10±0.35
c 
25.76±1.24
c
A 
 μg 8.29±0.22
a 
11.28±0.51
b
A 10.91±0.35
bc
A 12.26±0.57
c
A 20.94±1.21
d 
12.16±1.03
a 
14.11±0.36
a
A 19.88±1.53
b
A 19.44±0.35
b
A 25.62±1.38
c 
ω-6/ω-3 % 1.60±0.12
a 
3.97±0.01
b
A 4.57±0.06
c
A 3.92±0.02
b
A 4.15±0.03
c
A 2.28±0.01
a 
2.04±0.39
b
A 1.82±0.01
c
A 1.38±0.03
d
A 1.65±0.10
e
A 
 μg 2.29±0.01
a 
3.72±0.02
b
A 4.49±0.22
c
A 4.04±0.44
d
A 4.20±0.01
e
A 1.68±0.03
a 
2.19±0.02
b
A 2.64±0.05
c
A 1.52±0.04
a
A 1.67±0.06
a
A 
 20 4ω-6/ 20 5ω-3 % 1.80±0.10
a 
4.45±0.79
b 
3.72±0.80
bc 
1.85±0.47
a 
2.24±0.62
ac 
2.64±1.08
a 
4.98±0.05
b
A 6.68±0.35
c 
2.61±0.05
a 
3.34±0.27
a 
 μg 1.94±0.01
a 
3.79±1.35
b 
3.72±0.80
b 
1.65±0.49
a 
2.31±0.49
ab 
3.43±0.07
a 
3.89±0.82
a
A 5.90±0.40
b 
2.60±0.05
a 
3.53±0.51
a 
PUFA/SATS % 0.22±0.03
a 
0.40±0.13
b 
0.49±0.05
b
A 0.62±0.06
c
A 0.58±0.16
c 
0.37±0.08
a 
0.71±0.05
b
A 0.53±0.06
c 
1.31±0.13
d
A 0.94±0.14
e
A 
 μg 0.22±0.01
a 
0.54±0.03
b 
0.37±0.07
a
A 0.59±0.24
b
A 0.56±0.06
b 
0.37±0.01
a 
0.36±0.04
a 
0.63±0.09
b 
1.16±0.33
c 
0.77±0.31
d 
Δ6 S/P % 1.41±0.04
a 
3.53±0.48
b
 7.25±1.90
c
A 7.74±2.28
c
A 6.41±2.31
d
A 0.51±0.16
a 
1.83±0.30
b
A 1.01±0.29
c
A 1.67±0.08
b
A 1.55±0.19
b
A 
 μg 1.86±0.04
a 
2.65±0.48
a
A 6.54±2.15
b
A 13.19±4.17
c
A 7.53±1.62
b
A 0.94±0.18
a 
1.26±0.78
a
A 1.77±0.01
b 
1.64±0.06
b
A 1.51±0.20
b
A 
 20 4ω-6 PC/PE % 0.78±0.02
a 
0.26±0.07
b
A 0.27±0.02
b
A 0.26±0.02
b
A 0.26±0.04
b
A      
 μg 0.82±0.02
a 
0.31±0.03
b
A 0.26±0.07
b
A 0.23±0.02
b
A 0.31±0.07
b
A      
  BrdU IC50 BrdU IC50 
  0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.6 mg/ml 0 mg/ml 5.5 mg/ml 5.1 mg/ml 4.8 mg/ml 4.6 mg/ml 
Total PUFA % 6.71±0.11
a 
17.19±1.35
b
B 17.45±1.47
b
B 24.26±0.15
c
B 17.10±2.72
b 
13.09±0.01
a 
15.38±0.09
b
B 18.02±1.06
c 
25.20±0.03
d 
18.23±0.15
c
B 
 μg 8.29±0.22
a 
22.30±0.01
b
B 20.41±0.01
c
B 34.54±0.01
d
B 20.86±0.01
c 
12.16±1.03
a 
20.12±0.01
b
B 15.99±0.02
b
B 42.98±0.03
c
B 25.42±0.01
b 
ω-6/ω-3 % 1.60±0.12
a 
2.66±0.01
b
B 2.65±0.14
b
B 2.58±0.01
b
B 2.34±0.01
c
B 2.28±0.01
a 
3.65±0.01
b
B 3.21±0.08
c
B 2.51±0.01
d
B 3.05±0.01
e
B 
 μg 2.29±0.01
a 
3.200.02
b
B 3.88±0.01
c
B 2.06±0.01
d
B 2.30±0.84
a
B 1.68±0.03
a 
2.98±0.01
b
B 4.30±0.01
c
B 2.28±0.01
d
B 2.43±0.01
e
B 
 20 4ω-6/ 20 5ω-3 % 1.80±0.10
a 
3.61±0.59
b 
3.54±0.69
b 
1.54±0.25
a 
1.65±0.55
a 
2.64±1.08
ac 
6.45±0.89
b
B 6.49±0.34
b 
2.16±0.19
a 
3.38±0.16
c 
 μg 1.94±0.01
a 
3.78±0.13
b 
3.68±0.70
b 
1.44±0.08
a 
1.97±0.02
a 
3.43±0.07
a 
5.64±0.77
b
B 6.36±0.27
b 
2.19±0.18
c 
2.87±0.79
ac 
PUFA/SATS % 0.22±0.03
a 
0.61±0.09
b 
0.60±0.08
b
B 1.06±0.21
c
B 0.61±0.08
b 
0.37±0.08
a 
0.30±0.04
a
B 0.74±0.06
b 
0.68±0.16
b
B 0.30±0.09
a
B 
 μg 0.22±0.01
a 
0.39±0.04
ab 
0.58±0.09
b
B 0.92±0.08
c
B 0.58±0.03
b 
0.37±0.01
a 
0.29±0.06
a 
0.89±0.18
b 
0.81±0.27
b 
0.60±0.14
c 
Δ6 S/P % 1.41±0.04
a 
3.80±0.29
b
 3.56±0.40
b
B 5.39±0.32
c
A 4.00±0.89
d
A 0.51±0.16
a 
3.63±1.06
bc
B 2.95±0.39
b
B 4.36±0.88
c
B 3.33±0.12
bc
B 
 μg 1.86±0.04
a 
4.65±0.05
b
B 3.85±0.31
c
B 5.38±0.32
d
B 4.10±0.87
e
A 0.94±0.18
a 
3.33±1.20
b
B 2.19±0.82
c 
3.90±0.16
b
B 3.07±0.34
b
B 
 20 4ω-6 PC/PE % 0.78±0.02
ab 
1.12±0.22
a
B 0.61±0.04
b
B 0.60±0.06
b
B 0.91±0.63
ab
B      
 μg 0.82±0.02
ac 
0.88±0.12
a
B 0.77±0.07
ab
B 0.55±0.05
b
B 0.61±0.18
bc
B      
Values represent the means  standard deviations (N = 4-5)     h  q  l     v  (%        l          d )   d q         v  (μg        mg        )          d                -2 cell 
membrane phospholipid fractions phosphatidylcholine (PC) and phosphatidylethanolamine (PE). Oil emulsions: S = sunflower oil, SB = sunflower + borage oils, SF = sunflower + fish 
oils and SBF = sunflower + borage + fish oils. PUFA = polyunsaturated fatty acids, PU  /S  S     l           d/        d          d      , Δ6 S/P   d l  -6 substrate/product ratio, 
 20 4ω-6/ 20 5ω-3 = arachidonic acid/eicosapentaenoic acid ratio. Values in a row followed by different letters (superscript) are significantly different at p<0.05. Values in a column 
representing the corresponding fatty acid variable at different concentrations (i.e. apoptosis inducing vs. BrdU IC50) within the same oil emulsion treatments are significantly 
different at p<0.05 following different letters (uppercase subscript).
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 ADDENDUM 4 
 
MSc Thesis reference  
Abrahams, C.H. (2009). The modulating effect of fatty acids on the lipid profile in 
colon epithelial mucosa in vivo. (Master’s thesis). University of the Western Cape, 
South Africa.  
Website: http://etd.uwc.ac.za/xmlui/handle/11394/2802 
Chapter 3 (pg. 77-143) referred to in current study: “Lipid modulation of colon 
mucosa and red blood cell membranes by dietary fat varying in n-6/n-3 fatty acid 
ratios”. 
 
Abstract 
This study investigated the effects of different dietary n-6/n-3 fatty acid (FA) ratios on 
the lipid profile of rat colon mucosa and red blood cell (RBC) membranes. Sunflower, 
fish and borage oils were utilized to vary the diets n-6/n-3 FA ratio. The lipid profiles 
of the colon mucosa and RBC membranes responded differently to the dietary FA 
presumably due to functional and proliferative properties. Fish oil reduced membrane 
phospholipid phosphatidylethanoamine (PE) in the mucosa, while increasing 
phosphatidylcholine (PC) and PE in the RBC membranes. Borage oil significantly 
reduced the PC/PE ratio in the mucosa, while fish oil increased the ratio in both 
membranes. The dietary FA significantly altered the membranes fluidity due to 
modifications to the fluidity lipid parameters including cholesterol/phospholipid ratio, 
PC/PE and polyunsaturated/saturated (P/S) ratios. Differential effects of fish and 
borage oil on the saturated and monounsaturated FA levels suggest that they may 
be involved in regulating cell survival responses. Modulation of the membrane lipid 
profiles by the different FA ratio diets particularly those using fish oil content, showed 
a reduction in the membrane n-6/n-3 ratio due to a higher n-3 long chain (LC) PUFA 
content. Borage oil exhibited a similar effect although to a lesser extent while it also 
increased in the n-6 FA level. Both dietary oils reduced the C20:4n-6/C20:5n-3 ratio 
suggesting a reduced production of the prostaglandin 2- series. The n-6/n-3 
interactions are also reflected by variations in the membrane incorporation of 
LCPUFA, which is orchestrated by a reduced ∆6-desaturase activity as well as 
negative feedback regulation by FA product of the enzyme. The combination of fish 
and borage oil in the diet either counteracted or enhanced the individual effects 
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exerted by the oils. The intake of fish and borage oil was associated with an 
elevation in lipid peroxidation presumably due to an increase in LCPUFA. This study 
suggests that a low n-6/n-3 PUFA ratio diet could potentially be used as a cancer 
therapeutic tool due to its ability to alter prostaglandin synthesis and enhance the 
susceptibility to lipid peroxidation. 
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